Omnicell Inc
Buy, Hold or Sell?

Let's analyse Omnicell together

Penke I guess you are interested in Omnicell Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Omnicell Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Omnicell Inc

I send you an email if I find something interesting about Omnicell Inc.

Quick analysis of Omnicell (30 sec.)

What can you expect buying and holding a share of Omnicell? (30 sec.)

How much money do you get?

$0.04

When do you have the money?

1 year

How often do you get paid?

2.5%

What is your share worth?

Current worth

$25.89

Expected worth in 1 year

$27.18

How sure are you?

90.0%

+ What do you gain per year?

Total Gains per Share

$1.32

Return On Investment

4.6%

For what price can you sell your share?

Current Price per Share

$28.43

Expected price per share

$25.69 - $32.15

How sure are you?

50%

1. Valuation of Omnicell (5 min.)

Live pricePrice per Share (EOD)

$28.43

Book Value per Share

$25.89

Intrinsic Value Per Share

$-28.70 - $26.18

Total Value Per Share

$-2.81 - $52.08

My calculation of the intrinsic value of Omnicell is based how much money is coming from the company's main activities (Free Cash Flow).

The following numbers are based on moving averages and per share and per quarter.
I use a 6% discount rate for the low estimation and 3% for the high estimation.
The current Free Cash Flow Per Share is 10Y: ($0.35) 3Y: ($0.57) TTM: ($0.69)
The change per quarter (trend) of the Free Cash Flow Per Share is 10Y: ($0.01) 3Y: ($-0.07) TTM: ($-0.21)

Years	Total Low est.	Total High est.	Added Free Cash Flow
1	$0.68	$2.32	$0.28 - $2.42
2	$0.30	$4.72	$-0.84 - $2.58
3	$-1.02	$7.19	$-1.97 - $2.74
4	$-3.18	$9.74	$-3.09 - $2.90
5	$-6.08	$12.35	$-4.22 - $3.05
6	$-9.62	$15.02	$-5.34 - $3.21
7	$-13.72	$17.75	$-6.47 - $3.37
8	$-18.32	$20.52	$-7.59 - $3.53
9	$-23.33	$23.33	$-8.71 - $3.69
10	$-28.70	$26.18	$-9.84 - $3.85

2. Growth of Omnicell (5 min.)

Is Omnicell growing?

	Current year	Previous year	Grow	Grow %
How rich?	$1.1b	$1.1b	$62.3m	5.3%

How much money is Omnicell making?

	Current year	Previous year	Grow	Grow %
Making money	-$5m	$1.4m	-$6.5m	-127.7%
Net Profit Margin	-1.9%	0.1%	-	-

How much money comes from the company's main activities?

Quarterly Yearly

3. Financial Health of Omnicell (5 min.)

4. Comparing to competitors in the Health Information Services industry (5 min.)

Industry Rankings (Health Information Services)

Richest
#9 / 120

Most Revenue
#15 / 120

Most Profit
#81 / 120

Most Efficient
#44 / 120

What can you expect buying and holding a share of Omnicell? (5 min.)

Welcome investor! Omnicell's management wants to use your money to grow the business. In return you get a share of Omnicell.

What can you expect buying and holding a share of Omnicell?

First you should know what it really means to hold a share of Omnicell. And how you can make/lose money.

Speculation

The Price per Share of Omnicell is $28.43. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

The fundamentals: the financial health trends of Omnicell.
The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Omnicell, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $25.89. Based on the TTM, the Book Value Change Per Share is $0.32 per quarter. Based on the YOY, the Book Value Change Per Share is $0.40 per quarter.
You may receive quarterly/yearly dividend in the form of additional shares.
You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.01 per quarter.

Based on historical numbers we can estimate the returns while holding a share of Omnicell.

How much money are you going to get?

	MRQ		TTM		YOY		5Y		10Y
	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share
Usd Eps	-0.31	-1.1%	-0.11	-0.4%	0.03	0.1%	0.17	0.6%	0.15	0.5%
Usd Book Value Change Per Share	0.03	0.1%	0.32	1.1%	0.40	1.4%	0.55	2.0%	0.46	1.6%
Usd Dividend Per Share	0.04	0.1%	0.01	0.0%	0.00	0.0%	0.00	0.0%	0.00	0.0%
Usd Total Gains Per Share	0.07	0.2%	0.33	1.2%	0.40	1.4%	0.56	2.0%	0.46	1.6%
Usd Price Per Share	37.63	-	53.75	-	95.17	-	92.88	-	66.42	-
Price to Earnings Ratio	-30.05	-	65.80	-	93.28	-	77.00	-	112.15	-
Price-to-Total Gains Ratio	531.79	-	249.12	-	-122.91	-	768.21	-	465.90	-
Price to Book Ratio	1.45	-	2.11	-	4.04	-	4.34	-	4.16	-
Price-to-Total Gains Ratio	531.79	-	249.12	-	-122.91	-	768.21	-	465.90	-

When do you get the money?

Usd Investment	$.00
Usd Price Per Share	28.43
Number of shares	35

Gains per Quarter	Trailing 12 Months	5 Year
Usd Dividend Per Share	0.01	0.00
Usd Book Value Change Per Share	0.32	0.55
Usd Total Gains Per Share	0.33	0.56
Gains per Quarter (35 shares)	11.54	19.48
Gains per Year (35 shares)	46.15	77.91

Years	Return on Investment (TTM)			Return on Investment (5Y)
	Dividend	Book Value gain	Total gains	Dividend	Book Value gain	Total gains
Broker costs	-	-	-10	-	-	-10
1	1	45	36	0	78	68
2	3	90	82	1	155	146
3	4	135	128	1	233	224
4	5	179	174	1	311	302
5	7	224	220	1	388	380
6	8	269	266	2	466	458
7	9	314	312	2	544	536
8	11	359	358	2	621	614
9	12	404	404	2	699	692
10	13	448	450	3	777	770

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %

	Trailing 12 Months				3Y				5 Year				10 Year				ALLTIME
				%				%				%				%				%
Earnings Per Share	2.0	2.0	0.0	50.0%	9.0	3.0	0.0	75.0%	16.0	4.0	0.0	80.0%	33.0	7.0	0.0	82.5%	79.0	13.0	1.0	84.9%
Book Value Change Per Share	4.0	0.0	0.0	100.0%	10.0	2.0	0.0	83.3%	18.0	2.0	0.0	90.0%	36.0	4.0	0.0	90.0%	78.0	15.0	0.0	83.9%
Dividend per Share	1.0	0.0	3.0	25.0%	1.0	0.0	11.0	8.3%	1.0	0.0	19.0	5.0%	1.0	0.0	39.0	2.5%	1.0	0.0	92.0	1.1%
Total Gains per Share	4.0	0.0	0.0	100.0%	10.0	2.0	0.0	83.3%	18.0	2.0	0.0	90.0%	36.0	4.0	0.0	90.0%	78.0	15.0	0.0	83.9%

Fundamentals of Omnicell

About Omnicell Inc

https://www.omnicell.com
Health Information Services
3650
4220 North Freeway, Fort Worth, TX, United States, 76137
Google Maps Bing Maps

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Fundamental data was last updated by Penke on 2024-04-11 16:52:03.

Financial Health

Profitability Details

	Compared to previous year	Compared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.

Operating Efficiency Details

	Compared to previous year	Compared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.

Liquidity Details

	Compared to previous year	Compared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.

Solvency Details

	Compared to previous year	Compared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details

	Compared to previous year	Compared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Omnicell Inc.

1.1. Profitability

1.1.1. Net Profit Margin

Measures how much net profit Omnicell earns for each $1 of revenue.

Above 10% is considered healthy but always compare Omnicell to the Health Information Services industry mean.
A Net Profit Margin of -5.6% means that $-0.06 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Omnicell Inc:

The MRQ is -5.6%. The company is making a loss. -1
The TTM is -1.9%. The company is making a loss. -1

Trends

Current period		Compared to		+/-
MRQ	-5.6%	TTM	-1.9%	-3.6%
TTM	-1.9%	YOY	0.1%	-2.1%
TTM	-1.9%	5Y	3.0%	-4.9%
5Y	3.0%	10Y	3.5%	-0.5%

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	-5.6%	-21.3%	+15.7%
TTM	-1.9%	-20.1%	+18.2%
YOY	0.1%	-29.8%	+29.9%
5Y	3.0%	-34.6%	+37.6%
10Y	3.5%	-42.2%	+45.7%

Measures how much net profit Omnicell earns for each $1 of revenue.

Revenue is the amount of profit Omnicell generates before taxes and all other costs. For example, when you buy a cup of coffee it will cost you $3. The company does not earn $3 in profit but also has to pay various costs and taxes to create that cup of coffee. Let's assume the cost of creating a cup of coffee is $1.5.

The $3 you pay for a cup of coffee is called revenue.
The $1.5 that’s left over when all costs to create that cup of coffee (including taxes) are deduced from the revenue is called net profit.

The net profit margin looks at how much net profit Omnicell earns for each $1 in revenue.

How to use net profit margin

Higher profit margin is better (more profit).
Above 10% is considered healthy but always compare Omnicell to the Health Information Services industry mean.
Can be used to compare companies within the Health Information Services industry.

You typically want a high profit margin. This means that for each $1 in sales, Omnicell makes more profit. This shows the investor how efficiently Omnicell is operating in general and compared to other companies in the same industry. Omnicell operates in the Health Information Services industry.

Why do investors use net profit margin in their analysis

It helps investors to determine the efficiency of Omnicell. If profit margins remain low (compared to the Health Information Services industry mean) and there are no improvements to make in production costs or other areas that might be a warning sign. If profit margins are high that means the company has low overhead costs and is efficiently using its resources to generate profit.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Net Profit Margin of Omnicell is -0.06. This means that Omnicell earned $-0.06 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Net Profit Margin of the Health Information Services industry is -21.3%.
What is the trend?
The trend is important because it shows you how Omnicell is performing over time. The most recent quarter might be important if Omnicell released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Omnicell up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare Omnicell with other companies in the same industry (Health Information Services).
Net profit margin should rise over the years.
Can be influenced when Omnicell sells assets (profit will increase while costs remain the same).
It won’t show what part of Omnicell is doing great or needs improvement (it only looks at total revenue and total net income).

How to calculate net profit margin

Net profit margin = net income / total revenue * 100%

Real example of Omnicell

You need the following data to determine net profit margin:

Income statement from the period you want to calculate (for example, MRQ or TTM).

Net income MRQ Omnicell = -14,375
Total revenue MRQ Omnicell = 258,847
$-14,375 / $258,847 = -0.06 or -5.6%

Higher is better

The higher the net profit margin, the more efficient the company is generating income. This helps investors to determine how the company is managing money. The net profit margin is an important indicator when diving into the financial health of a company. Overall, you want to see the net profit margin rising over the years. That means the company improved their production and made it more efficient (if possible).

You can use the net profit margin to compare companies within the same industry. If there are two companies where one is much bigger but the smaller one has a higher net profit margin, that means the smaller company is more efficiently using operational costs.

Important: Profit margins can be very different between industries. Companies with assembly lines or transports are much more prone to see shifting in prices for fuel, ingredients and maintenance compared to companies that only provide services. You should never compare net profit margin between different industries.

1.1.2. Return on Assets

Shows how efficient Omnicell is using its assets to generate profit.

Above 5% is considered healthy but always compare Omnicell to the Health Information Services industry mean.
-0.6% Return on Assets means that Omnicell generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Omnicell Inc:

The MRQ is -0.6%. Using its assets, the company is very inefficient in making profit. -2
The TTM is -0.2%. Using its assets, the company is very inefficient in making profit. -2

Trends

Current period		Compared to		+/-
MRQ	-0.6%	TTM	-0.2%	-0.4%
TTM	-0.2%	YOY	0.1%	-0.3%
TTM	-0.2%	5Y	0.5%	-0.7%
5Y	0.5%	10Y	0.7%	-0.2%

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	-0.6%	-6.5%	+5.9%
TTM	-0.2%	-6.0%	+5.8%
YOY	0.1%	-5.4%	+5.5%
5Y	0.5%	-5.4%	+5.9%
10Y	0.7%	-8.2%	+8.9%

Shows how efficient Omnicell is using its assets to generate profit.

For a farm, a tractor is considered an asset. The tractor helps ploughing the land making it possible to plant and harvest crops. But the tractor might be old and needing maintenance all the time reducing its efficiency. Return on assets indicates how effectively the farm is using the tractor (and other assets that help the core business) to plough the land.

How to use return on assets

Higher is better.
Above 5% is considered healthy but always compare Omnicell to the Health Information Services industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on assets in their analysis

Shows the investor how effectively Omnicell is using its resources to generate profit. If the return on assets (-0.6%) from Omnicell are higher than the Health Information Services mean (-6.5%) that means Omnicell is using its resources better than their competitors. If not, that means their competitors are more efficient in using their resources to generate profit.

An investor should always look at:

What is the current return on assets?
The current most recent quarter (MRQ) Return on Assets of Omnicell is -0.6%. This means the company generated $-0.01 for each $1 in assets.
How does it compare to the industry?
The mean MRQ Return on Assets of the Health Information Services industry is -6.5%.
What is the trend?
The trend is important because it shows you how Omnicell is performing over time. The most recent quarter might be important if Omnicell released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Omnicell up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
If a company has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

How to calculate return on assets

Return on assets = net income / total assets * 100%

Real example Omnicell

You need the following data to determine return on assets (ROA):

Income statement
Balance sheet

Net income MRQ (income statement) from Omnicell = -14,375
Total assets MRQ (balance sheet) from Omnicell = 2,226,878
-14,375 / 2,226,878 = -0.01 or -0.6%

ROA is an important ratio as it will tell you how effectively Omnicell is using its resources to generate profits. Example:

Bob and Kristin both sell ice cream in the summer. They both have an ice cream truck. The truck Bob owes cost him $20.000 and the truck Kristin owes cost her $1500. Over the summer, Bob earned $2000 and Kristin earned $200. To calculate the return on assets:

Bob: $2000 / $20.000 * 100% = 10%
Kristin: $200 / $1500 * 100% = 13.3%

This tells you Bob’s company is more valuable but Kristin's company is more efficient. Be aware that total assets can change over time. A transportation business will buy and sell trucks or planes all the time. Before using return on assets as a guideline, you have to know what the exact assets are. For a company that has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

1.1.3. Return on Equity

Shows how efficient Omnicell is using its investors money to generate profit.

Above 15%-20% is considered healthy but always compare Omnicell to the Health Information Services industry mean.
-1.2% Return on Equity means Omnicell generated $-0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Omnicell Inc:

The MRQ is -1.2%. Using its investors money, the company is very inefficient in making profit. -2
The TTM is -0.4%. Using its investors money, the company is very inefficient in making profit. -2

Trends

Current period		Compared to		+/-
MRQ	-1.2%	TTM	-0.4%	-0.8%
TTM	-0.4%	YOY	0.1%	-0.6%
TTM	-0.4%	5Y	0.9%	-1.3%
5Y	0.9%	10Y	1.1%	-0.2%

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	-1.2%	-6.8%	+5.6%
TTM	-0.4%	-6.8%	+6.4%
YOY	0.1%	-7.4%	+7.5%
5Y	0.9%	-9.1%	+10.0%
10Y	1.1%	-9.6%	+10.7%

Shows how efficient Omnicell is using its investors money to generate profit.

A publicly traded company (any company that issues shares to the public) is owned by its shareholders. Return on equity calculates the amount of profit for every $1 the shareholders invested.

How to use return on equity

Higher is better.
Above 15%-20% is considered healthy but always compare Omnicell to the Health Information Services industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on equity in their analysis

To find out the owners/management's attitude toward their company. You typically want the owners/management to invest in the company and focus on generating profit. If not enough profit is generated (compared to the Health Information Services industry mean), the company might not be investing their money efficiently.

The three steps every investor should look at:

What is the current return on equity?
The current most recent quarter (MRQ) Return on Equity of Omnicell is -1.2%. This means Omnicell generated $-0.01 for each $1 the owners (shareholders) invested.
How does it compare to the industry?
The mean MRQ Return on Equity of the Health Information Services industry is -6.8%.
What is the trend?
The trend is important because it shows you how Omnicell is performing over time. The most recent quarter might be important if Omnicell released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Omnicell up to 10 years back (depending if Omnicell existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Does not include intangible assets (non physical assets like licences, computer software, etc.).
Stockholders equity and shareholders equity refer to the same thing.
Liabilities should not be more than three times return on equity.

How to calculate return on equity

Return on equity = net profit / shareholders equity * 100%

Real example of Omnicell

You need the following data to determine ROE:

Income statement
Balance sheet
Net profit MRQ (income statement) Omnicell = -14,375
Shareholders equity (balance sheet) MRQ Omnicell = 1,188,954
-14,375 / 1,188,954 = -0.01 or -1.2%

A negative shareholder equity is a warning sign. It means the company has more liabilities than assets. It might also mean that the owners did not invest enough money or they are taking money out of the business.

1.2. Operating Efficiency of Omnicell Inc.

1.2. Operating Efficiency

1.2.1. Operating Margin

Measures how efficient Omnicell is operating .

Measures how much profit Omnicell makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
Above 15% is considered healthy but always compare Omnicell to the Health Information Services industry mean.
An Operating Margin of -9.0% means the company generated $-0.09 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Omnicell Inc:

The MRQ is -9.0%. The company is operating very inefficient. -2
The TTM is -3.3%. The company is operating very inefficient. -2

Trends

Current period		Compared to		+/-
MRQ	-9.0%	TTM	-3.3%	-5.8%
TTM	-3.3%	YOY	-0.6%	-2.7%
TTM	-3.3%	5Y	3.3%	-6.6%
5Y	3.3%	10Y	3.4%	-0.1%

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	-9.0%	-22.7%	+13.7%
TTM	-3.3%	-16.4%	+13.1%
YOY	-0.6%	-22.8%	+22.2%
5Y	3.3%	-18.4%	+21.7%
10Y	3.4%	-32.1%	+35.5%

Measures how efficient Omnicell is operating .

The more effecient a company creates products or provides services, the more profit it generates.

How to use operating margin

Higher is better
Above 15% is considered healthy but always compare Omnicell to the Health Information Services industry mean.
Can be very different between industries
Can be used to compare companies

Why do investors use operating margin in their analysis

To determine how much profit Omnicell is making from it’s core business.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Operating Margin of Omnicell is -9.0%. This means that Omnicell earned $-0.09 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Margin of the Health Information Services industry is -22.7%.
What is the trend?
The trend is important because it shows you how Omnicell is performing over time. The most recent quarter might be important if Omnicell released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Omnicell up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Can be calculated in different ways

How to calculate operating margin

Operating margin = operating earnings / total revenue

Real example of Omnicell

You need the following data to determine operating margin:

Income statement
Operating earnings MRQ Omnicell = -23,365
Total revenue MRQ Omnicell = 258,847
$-23,365 / $258,847 = -0.09 or -9.0%

Operating margin is used to calculate how much profit a company makes after variable costs of production but before paying interest and taxes. Some variable costs examples are wages, raw materials, packaging, and transaction fees. The amount of variable costs is different for each company and industry. In general, a higher operating margin is better as this implicates that a company is running efficiently.

For investors, a higher operating margin is a good sign. Although you should always look at operating margin in the long term. If operating margin is fluctuating over the years this might be a sign that things are not running efficiently enough. It’s a way to check how much profit a company is making from its core business.

Operation earnings can be calculated in multiple ways:

Operation earnings = EBIT - non operating income + non operating expense
Operation earnings = Gross profit - operating expense - depreciation and amortisation
Operation earnings = Total revenue - COGS (costs of goods sold) - indirect costs

1.2.2. Operating Ratio

Measures how efficient Omnicell is keeping operating costs low.

Below 1 is considered healthy (always compare to Health Information Services industry mean).
An Operation Ratio of 1.09 means that the operating costs are $1.09 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Omnicell Inc:

The MRQ is 1.090. The company is inefficient in keeping operating costs low. -1
The TTM is 1.033. The company is inefficient in keeping operating costs low. -1

Trends

Current period		Compared to		+/-
MRQ	1.090	TTM	1.033	+0.058
TTM	1.033	YOY	1.006	+0.027
TTM	1.033	5Y	0.967	+0.066
5Y	0.967	10Y	0.957	+0.010

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	1.090	1.370	-0.280
TTM	1.033	1.385	-0.352
YOY	1.006	1.389	-0.383
5Y	0.967	1.398	-0.431
10Y	0.957	1.331	-0.374

Measures how efficient Omnicell is keeping operating costs low.

If the operating ratio is below 1 that means the company is making money. The lower the operating ratio, the more efficient the company.

How to use operating ratio

Lower is better.
Below 1 is considered healthy but always compare Omnicell to the Health Information Services industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use operating ratio in their analysis

Shows if costs of creating products and or services is increasing or decreasing. The lower the operating ratio, the more efficient the company is creating products and services.

The three steps every investor should look at:

What is the current Operatin ratio?
The current most recent quarter (MRQ) Operating Ratio of Omnicell is 109.0%. This means that Omnicell earned $1.09 for each $1 in net sales in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Ratio of the Health Information Services industry is 1.37.
What is the trend?
The trend is important because it shows you how Omnicell is performing over time. The most recent quarter might be important if Omnicell released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Omnicell up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
You need COGS to calculate operating ratio which is not always shown in the income statement.
Does not consider debt.

How to calculate operating ratio

Operating ratio = Operating expenses + COGS \ Net sales

Real life example Omnicell

You need the following data to determine operating ratio:

Income statement

COGS is not always specified on the income statement. If so you can use the following calculation:

(cost of revenue + total operating expenses) \ total revenue
(153,443 +128,769) \ 258,847 = 1.09

The operating ratio measures the efficiency of a company at keeping low costs while generating profits from sales. It compares the total operating expenses to the net amount of sales. The total operating expenses exists of:

COGS (materials, labour, rent of facility, repairs)
Operating expenses (legal fees, marketing, wages, rent, maintenance/repairs)

Operating expenses are all the costs the company makes that are not directly tied to the production of the service or product. Where COGS are costs that are directly tied to the production of a product or service.

Do note that COGS is not always available in the income statement. Some companies include COGS in the operating expenses while others list COGS separately. To make it even more confusing, COGS is also known as “costs of sales” and costs of sales is the same as costs of revenue.

The operating ratio tells you how efficient the company is creating its products or services while keeping prices low. In this case, a lower ratio is better. Higher or rising operating ratios might tell you that costs are rising while sales are not improving or staying the same.

1.3. Liquidity of Omnicell Inc.

1.3. Liquidity

1.3.1. Current Ratio

Measures if Omnicell is able to pay off Short-term Debt.

Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
A Current Ratio of 2.52 means the company has $2.52 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Omnicell Inc:

The MRQ is 2.522. The company is able to pay all its short-term debts. +1
The TTM is 2.359. The company is able to pay all its short-term debts. +1

Trends

Current period		Compared to		+/-
MRQ	2.522	TTM	2.359	+0.163
TTM	2.359	YOY	1.809	+0.550
TTM	2.359	5Y	2.276	+0.083
5Y	2.276	10Y	2.121	+0.155

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	2.522	1.811	+0.711
TTM	2.359	1.813	+0.546
YOY	1.809	2.055	-0.246
5Y	2.276	2.589	-0.313
10Y	2.121	2.589	-0.468

Measures if Omnicell is able to pay off Short-term Debt.

How to use current ratio

Higher is better
Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
Can be very different between industries
Can be used to compare companies

Why do investors use current ratio in their analysis

Shows if the company can pay of short term debts if needed. A company that can't pay off it's short term debts might get in trouble if they have to pay off their short term debts for whatever reason. For example, markets can change due to global events like covid-19 or the war in Ukraine versus Russia. Because debts are always taken based on future income, it might become troublesome for Omnicell if something happens in the market that will cause sales to plummet.

The three steps every investor should look at:

What is the current current Ratio?
The current most recent quarter (MRQ) Current Ratio of Omnicell is 2.52. This means Omnicell has $2.52 in assets for each $1 in short-term debts.
How does it compare to the industry?
The mean MRQ Current Ratio of the Health Information Services industry is 1.81.
What is the trend?
The trend is important because it shows you how Omnicell is performing over time. The most recent quarter might be important if Omnicell released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Omnicell up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Might be deluded.
Not all assets can always be quickly sold.
Can be manipulated by increasing or decreasing the assets and/or liabilities.

How to calculate current ratio

Current ratio = current assets \ current liabilities

Real life example Omnicell

You need the following data to determine operating ratio:

Balance sheet
Current ratio = current assets \ current liabilities
927,571 \ 367,792) = 2.52

The current ratio measures if Omnicell is able to pay short-term debts (obligations). Short term in this context means all debt obligations that are about to expire within one year. The current ratio incorporates current liabilities and current assets. Current assets are all the assets a company has that are expected to be consumed or sold within standard business operations. You can find the current assets in the balance sheet. They consist of:

Inventory
Accounts receivable
Marketable securities
Prepaid expenses
Cash
Cash equivalents
liquid assets

The current liabilities are short term obligations that are due within one year. These consist of:

Short term debts
Dividends
Income taxes
Short-term debts
Accounts payable
Interest payments

The result shows an investor if Omnicell is able to pay all its short-term debts if they were due all at once. When the result of the above formula is below 1, then Omnicell does not have enough capital after selling all its assets to pay all short-term debts. If the ratio drops far below 1 that might indicate Omnicell is or will be in financial trouble anytime soon.

Although this gives an investor some clues, the current ratio may also be deluded. Because owning assets does not mean the company can easily sell them. Also, Accounts receivable may be quite old (they will probably never pay) which deludes the current ratio. As with all ratios, you should only compare them between the same industries and companies.

1.3.2. Quick Ratio

Measures if Omnicell is able to pay off Short-term Debt but only using the most liquid assets.

Above 1 is considered healthy but always compare Omnicell to the Health Information Services industry mean.
A Quick Ratio of 2.11 means the company can pay off $2.11 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Omnicell Inc:

The MRQ is 2.112. The company is very able to pay all its short-term debts with the most liquid assets. +2
The TTM is 1.856. The company is very able to pay all its short-term debts with the most liquid assets. +2

Trends

Current period		Compared to		+/-
MRQ	2.112	TTM	1.856	+0.256
TTM	1.856	YOY	1.323	+0.533
TTM	1.856	5Y	1.763	+0.093
5Y	1.763	10Y	1.551	+0.211

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	2.112	1.059	+1.053
TTM	1.856	1.223	+0.633
YOY	1.323	1.813	-0.490
5Y	1.763	1.998	-0.235
10Y	1.551	2.076	-0.525

1.4. Solvency of Omnicell Inc.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Measures how much % of Omnicell assets are financed with debt.

Below 1 (100%) is considered healthy but always compare Omnicell to Health Information Services industry mean.
A Debt to Asset Ratio of 0.47 means that Omnicell assets are financed with 46.6% credit (debt) and the remaining percentage (100% - 46.6%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Omnicell Inc:

The MRQ is 0.466. The company is very able to pay all its debts by selling its assets. +2
The TTM is 0.473. The company is very able to pay all its debts by selling its assets. +2

Trends

Current period		Compared to		+/-
MRQ	0.466	TTM	0.473	-0.007
TTM	0.473	YOY	0.487	-0.014
TTM	0.473	5Y	0.430	+0.044
5Y	0.430	10Y	0.422	+0.008

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	0.466	0.380	+0.086
TTM	0.473	0.383	+0.090
YOY	0.487	0.399	+0.088
5Y	0.430	0.411	+0.019
10Y	0.422	0.450	-0.028

Measures how much % of Omnicell assets are financed with debt.

When there are more debts than assets, that means creditors have a larger stake Omnicell than its shareholders.

How to use debt to asset ratio

Lower is better.
below 1 (100%) is considered healthy but always compare Omnicell to Health Information Services industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to asset ratio in their analysis

It shows how much debt the company used to finance its assets. If a company is almost entirely financed with debt that means the company might get into serious trouble when emergencies arise like a raise in interest.

The three steps every investor should look at:

What is the current debt to asset ratio?
The current most recent quarter (MRQ) Debt to Asset Ratio of Omnicell is 0.47. This means means that Omnicell is financed with 46.6% credit and the remaining percentage is financed by it's owners (shareholders).
How does it compare to the industry?
The mean MRQ Current Ratio of the Health Information Services industry is 181.1%.
What is the trend?
The trend is important because it shows you how Omnicell is performing over time. The most recent quarter might be important if Omnicell released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Omnicell up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Some companies can have higher debt to assets ratio's (for example, banks).
Debt to asset ratio should improve over the years.
If the debt to asset ratio is above 1, look at the industry mean and find out why Omnicell has so much debt.

How to calculate debt to asset ratio

Debt to asset ratio = total debt \ total assets

Real life example Omnicell

You need the following data to determine debt to asset ratio:

Balance sheet
Debt to asset ratio = total debt \ total assets
1,037,924 \ 2,226,878 = 46.6% or 0.47.

The debt to total assets ratio shows if the company is owned by creditors or shareholders. Or in other words, the total debt in relation to the total amount of assets. It shows how much debt the company used to finance its assets.

1.4.2. Debt to Equity Ratio

Measures if Omnicell is able to pay off its debts by using shareholders equity.

Below 2 is considered healthy but always compare Omnicell to the Health Information Services industry mean.
A Debt to Equity ratio of 87.3% means that company has $0.87 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Omnicell Inc:

The MRQ is 0.873. The company is very able to pay all its debts with equity. +2
The TTM is 0.900. The company is very able to pay all its debts with equity. +2

Trends

Current period		Compared to		+/-
MRQ	0.873	TTM	0.900	-0.027
TTM	0.900	YOY	0.950	-0.051
TTM	0.900	5Y	0.777	+0.122
5Y	0.777	10Y	0.767	+0.011

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	0.873	0.595	+0.278
TTM	0.900	0.577	+0.323
YOY	0.950	0.607	+0.343
5Y	0.777	0.709	+0.068
10Y	0.767	0.616	+0.151

Measures if Omnicell is able to pay off its debts by using shareholders equity.

How to use debt to equity ratio

Lower is better.
Below 2 is considered healthy (always use industry average).
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to shareholders equity ratio in their analysis

It shows how much debt the company uses to finance their operations. Shareholders equity is whats left over when you subtract total liabilities from total assets. It's another way to meassure how much of Omnicell is financed with debt or own resources.

The three steps every investor should look at:

What is the current debt to equity ratio?
The current most recent quarter (MRQ) quickRatio of Omnicell is 0.87. This means that Omnicell can pay off $0.87 for each $1 in debt.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Health Information Services industry is 0.60.
What is the trend?
The trend is important because it shows you how Omnicell is performing over time. The most recent quarter might be important if Omnicell released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Omnicell up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Not all debt is equally risky (for example, short term risk is less risky).

How to calculate debt to equity ratio

Debt to equity ratio = total debt \ shareholders equity.

Real life example Omnicell

You need the following data to determine equity ratio:

Balance sheet
Debt to equity ratio = total debt \ shareholders equity
1,037,924 \ 1,188,954 = 0.87 or 87.3%

Debt to equity measures the total debt versus the total shareholders equity. While the total debts to total assets ratio uses total assets, the debt to equity ratio looks at the total equity of shareholders. Where equity of shareholders are:

Common shares.
Preferred shares.
Retained earnings.

You can find the shareholders' equity in the balance sheet. A ratio between 0,5 and 1,5 is preferred. If the ratio is above 1.5, that would indicate creditors have significantly more stake (debt) in the company than the shareholders. In other words, the company is using a lot of debt to finance their operations.

Not all debt is equally risky. Meaning you can adjust the ratio by including or excluding certain amounts of debt. Short term debts are less risky because they have to be paid back within one year anyway. It’s much easier to plan one year ahead versus five or ten years.

2. Market Valuation of Omnicell Inc

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Omnicell generates.

Above 15 is considered overpriced but always compare Omnicell to the Health Information Services industry mean.
A PE ratio of -30.05 means the investor is paying $-30.05 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Omnicell Inc:

The EOD is -22.702. Based on the earnings, the company is expensive. -2
The MRQ is -30.049. Based on the earnings, the company is expensive. -2
The TTM is 65.800. Based on the earnings, the company is expensive. -2

Trends

Current period		Compared to		+/-
EOD	-22.702	MRQ	-30.049	+7.346
MRQ	-30.049	TTM	65.800	-95.849
TTM	65.800	YOY	93.279	-27.478
TTM	65.800	5Y	77.001	-11.201
5Y	77.001	10Y	112.149	-35.148

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
EOD	-22.702	-1.570	-21.132
MRQ	-30.049	-2.188	-27.861
TTM	65.800	-2.131	+67.931
YOY	93.279	-3.673	+96.952
5Y	77.001	-5.005	+82.006
10Y	112.149	-4.981	+117.130

Measures how much money you pay for each share for every $1 in earnings Omnicell generates.

Indicates if the company’s shares are under or overvalued.

How to use PE ratio

Above 15 is considered overpriced but is hard to determine. Always compare Omnicell to the Health Information Services industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use PE ratio in their analysis

The PE ratio tells investors the current sentiment in the market for that company. As with every stock, the stock price never shows the real valuation of a company but rather how the market thinks how much the stock is worth.

In other words, the current stock price also incorporates any future earnings or business opportunities in the future. The best example is the stock market crash in 2000. The PE ratio for any internet based company was going through the roof. Only based on the general assumption the internet and all associated businesses would thrive in the future. But this was based on nothing. A business still needs a good product or service to be able to survive. Instead, every investor bought any stock which did something related to the internet. Result: huge market crash.

Many investors were willing to pay premium prices and that was causing the PE ratio to rise. A high PE ratio is a warning sign that investors might be overvaluing a stock based on future earnings.

The three steps every investor should look at:

What is the current PE Ratio?
The current most recent quarter (MRQ) PE Ratio of Omnicell is -30.05. This means the investor is paying $-30.05 for every $1 in earnings.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Health Information Services industry is -2.19.
What is the trend?
The trend is important because it shows you how Omnicell is performing over time. The most recent quarter might be important if Omnicell released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Omnicell up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Some industries might have very high or very low PE ratios in general.
PE ratios can be high for several years, it does not mean a sudden collapse is imminent.
Earnings growth is not included in the PE ratio.

How to calculate PE ratio

PE ratio = market value per share \ earnings per share

Real life example Omnicell

You need the following data to determine the PE ratio:

Balance sheet
Income statement

The PE ratio is a very commonly used ratio to determine the value of a company by comparing the current stock price relative to its earnings per share (EPS). Before we can calculate the PE ratio we need to know the EPS. EPS is calculated as follows:

EPS = (net profit - preferred dividends) \ end of period outstanding shares*
Net profit = revenue - expenses
0 \ 45,495 = EPS
PE ratio MRQ = -30.05

* The net profit minus preferred dividends can be found in the incomestatement as netIncomeApplicableToCommonShares.

The PE value helps investors to determine if the current stock price is under or overvalued. It also projects future growth.

In general, a higher PE ratio means that investors predict higher future growth. If the PE ratio is too high, then investors expect way too much future growth the company can never fulfil. This is most likely to happen in faster moving companies like tech companies or automobile companies like Tesla. These are hot and booming markets where investors expect much future growth driven by new technology (electric cars). When looking at the current MRQ (most recent quarter) PE ratio of Tesla ( jan. 2021) it's about 247 while the average in the industry is only 6. That might be a clue that Tesla is trading for way too high prices compared to their current assets and is more based on future growth.

2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Omnicell Inc:

The EOD is 12.531. Based on how much money comes from the company's main activities, the company is cheap. +2
The MRQ is 16.587. Based on how much money comes from the company's main activities, the company is underpriced. +1
The TTM is -182.719. Based on how much money comes from the company's main activities, the company is expensive. -2

Trends

Current period		Compared to		+/-
EOD	12.531	MRQ	16.587	-4.055
MRQ	16.587	TTM	-182.719	+199.306
TTM	-182.719	YOY	21.855	-204.574
TTM	-182.719	5Y	-3.489	-179.230
5Y	-3.489	10Y	38.997	-42.486

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
EOD	12.531	-1.438	+13.969
MRQ	16.587	-1.799	+18.386
TTM	-182.719	-2.834	-179.885
YOY	21.855	-5.673	+27.528
5Y	-3.489	-4.197	+0.708
10Y	38.997	-3.814	+42.811

2. Book Value per Share

2.3. Price to Book Ratio

Measures if the stock price of Omnicell is to cheap or to expensive compared to its book value.

At or below 1 is considered healthy (always compare to Health Information Services industry mean).
A PB ratio of 1.45 means the investor is paying $1.45 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Omnicell Inc:

The EOD is 1.098. Based on the equity, the company is underpriced. +1
The MRQ is 1.453. Based on the equity, the company is underpriced. +1
The TTM is 2.115. Based on the equity, the company is underpriced. +1

Trends

Current period		Compared to		+/-
EOD	1.098	MRQ	1.453	-0.355
MRQ	1.453	TTM	2.115	-0.662
TTM	2.115	YOY	4.039	-1.924
TTM	2.115	5Y	4.345	-2.230
5Y	4.345	10Y	4.157	+0.188

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
EOD	1.098	1.776	-0.678
MRQ	1.453	1.873	-0.420
TTM	2.115	1.943	+0.172
YOY	4.039	2.978	+1.061
5Y	4.345	3.998	+0.347
10Y	4.157	4.198	-0.041

2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Omnicell Inc.

3.1. Institutions holding Omnicell Inc

Institutions are holding 100.733% of the shares of Omnicell Inc.

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2023-12-31	BlackRock Inc	17.1778	0.0076	7887234	26144	0.3326
2023-12-31	Vanguard Group Inc	12.1341	0.0046	5571420	434336	8.4549
2023-12-31	State Street Corporation	4.3829	0.0037	2012411	133822	7.1235
2023-12-31	Champlain Investment Partners, LLC	3.293	0.3373	1511970	-72450	-4.5727
2023-12-31	ClearBridge Advisors, LLC	2.5829	0.0384	1185967	-148916	-11.1557
2023-12-31	Morgan Stanley - Brokerage Accounts	2.5716	0.0039	1180745	211900	21.8714
2023-12-31	Bank of New York Mellon Corp	2.5386	0.0089	1165628	-125233	-9.7015
2023-12-31	Dimensional Fund Advisors, Inc.	2.325	0.0117	1067516	21798	2.0845
2023-12-31	Pacer Advisors, INC.	2.3043	0.1127	1058027	1057698	321488.7538
2023-12-31	Geode Capital Management, LLC	2.1729	0.0039	997689	51584	5.4522
2023-12-31	Geneva Capital Management	2.0449	0.6672	938944	-41590	-4.2416
2023-12-31	Macquarie Group Ltd	1.946	0.0388	893499	108337	13.798
2023-12-31	ArrowMark Colorado Holdings, LLC (ArrowMark Partners)	1.5313	0.292	703120	139669	24.7881
2023-12-31	Credit Suisse First Boston (CSFB)	1.4811	0.0247	680058	-378233	-35.74
2023-12-31	Mirae Asset Global Investments (Korea) Co Ltd	1.3909	0.0489	638646	19601	3.1663
2023-12-31	Royal Bank of Canada	1.3017	0.0053	597686	64965	12.1949
2023-12-31	Legal & General Group PLC	1.2351	0.0055	567083	156734	38.1953
2023-12-31	Exchange Traded Concepts, LLC	1.2342	0.5699	566704	184213	48.1614
2023-12-31	Northern Trust Corp	1.1772	0.0037	540514	8933	1.6805
2023-12-31	NORGES BANK	1.0882	0.0033	499644	57546	13.0166
Total		65.9137	2.192	30264505	+1910858	+6.3%

3.2. Funds holding Omnicell Inc

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2024-03-28	iShares Core S&P Small-Cap ETF	6.6879	0.1117	3071326	-11448	-0.3714
2024-03-28	Pacer US Small Cap Cash Cows 100 ETF	3.4005	0.4692	1561645	5516	0.3545
2024-02-29	Vanguard Total Stock Mkt Idx Inv	3.0945	0.0024	1421084	-6528	-0.4573
2024-02-29	Vanguard Small Cap Index	2.5518	0.0219	1171868	10773	0.9278
2024-02-29	Champlain Small Company Fund, LLC	2.486	0.6468	1141660	5930	0.5221
2024-03-28	iShares Russell 2000 ETF	2.4048	0.0493	1104355	534	0.0484
2023-12-31	Vanguard Explorer Inv	1.844	0.149	846819	-939176	-52.5856
2024-03-28	Robo Global® Robotics&Automation ETF	1.613	1.6031	740753	0	0
2023-12-31	Macquarie US Small Cap Core Equity	1.5174	0.3508	696865	88005	14.4541
2024-02-29	Delaware Small Cap Core I	1.4999	0.2455	688804	194	0.0282
2024-02-29	Vanguard Institutional Extnd Mkt Idx Tr	1.4612	0.0173	671050	448	0.0668
2023-12-31	Champlain Small Company Adv	1.3283	0.9373	610000	-45000	-6.8702
2023-12-31	ClearBridge Small Cap Growth A	1.3042	0.541	598924	-6665	-1.1006
2024-03-28	Global X Robotics & Artfcl Intllgnc ETF	1.2644	0.5928	580651	0	0
2024-03-28	iShares S&P Small-Cap 600 Value ETF	1.2197	0.2266	560131	-5576	-0.9857
2024-03-28	L&G ROBO Global Rbtc and Atmtn ETF	1.0902	1.6018	500649	0	0
2024-01-31	Fidelity Small Cap Index	0.9878	0.0589	453632	6699	1.4989
2024-03-28	SPDR® Portfolio S&P 600 Sm Cap ETF	0.8896	0.1136	408520	415	0.1017
2024-02-29	Vanguard Small Cap Value Index Inv	0.8709	0.0197	399934	1680	0.4218
2024-02-29	Vanguard Tax-Managed Small Cap Adm	0.7735	0.1049	355228	0	0
Total		38.2896	7.8636	17583898	-894199	-5.1%

3.3. Insider Transactions

Insiders are holding 1.956% of the shares of Omnicell Inc.

Date	Owner	Type	Amount	Price	Post Transaction Amount	Link
2023-06-09	Christine Marie Mellon	SELL	7951	73.14
2023-06-08	Randall A Lipps	BUY	4000	73.76

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Omnicell Inc compared to the Most Recent Quarter (MRQ).

	End of day	+/-	Most Recent Quarter	Trailing 12 Months	+/-	Year-Over-Year	+/-	5 Year	+/-	10 Year	+/-
Book Value Change Per Share	-	-	0.033	0.320	-90%	0.403	-92%	0.555	-94%	0.458	-93%
Book Value Per Share	-	-	25.895	25.495	+2%	23.847	+9%	21.790	+19%	15.868	+63%
Current Ratio	-	-	2.522	2.359	+7%	1.809	+39%	2.276	+11%	2.121	+19%
Debt To Asset Ratio	-	-	0.466	0.473	-2%	0.487	-4%	0.430	+8%	0.422	+11%
Debt To Equity Ratio	-	-	0.873	0.900	-3%	0.950	-8%	0.777	+12%	0.767	+14%
Dividend Per Share	-	-	0.038	0.009	+300%	-	+100%	0.002	+1900%	0.001	+3900%
Eps	-	-	-0.313	-0.111	-65%	0.029	-1198%	0.167	-288%	0.149	-310%
Free Cash Flow Per Share	-	-	0.567	0.686	-17%	0.101	+463%	0.572	-1%	0.351	+62%
Free Cash Flow To Equity Per Share	-	-	0.853	0.814	+5%	-0.006	+101%	1.098	-22%	0.728	+17%
Gross Profit Margin	-	-	1.000	1.000	0%	1.000	0%	1.000	0%	1.000	0%
Intrinsic Value_10Y_max	-	-	26.182	-	-	-	-	-	-	-	-
Intrinsic Value_10Y_min	-	-	-28.705	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_max	-	-	2.316	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_min	-	-	0.681	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_max	-	-	7.194	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_min	-	-	-1.022	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_max	-	-	12.353	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_min	-	-	-6.077	-	-	-	-	-	-	-	-
Market Cap	1305371979.000	-32%	1727792739.000	2468062163.250	-30%	4444508701.250	-61%	4345050763.000	-60%	3090096736.700	-44%
Net Profit Margin	-	-	-0.056	-0.019	-65%	0.001	-3874%	0.030	-284%	0.035	-257%
Operating Margin	-	-	-0.090	-0.033	-64%	-0.006	-94%	0.033	-374%	0.034	-369%
Operating Ratio	-	-	1.090	1.033	+6%	1.006	+8%	0.967	+13%	0.957	+14%
Pb Ratio	1.098	-32%	1.453	2.115	-31%	4.039	-64%	4.345	-67%	4.157	-65%
Pe Ratio	-22.702	+24%	-30.049	65.800	-146%	93.279	-132%	77.001	-139%	112.149	-127%
Price Per Share	28.430	-32%	37.630	53.753	-30%	95.173	-60%	92.882	-59%	66.425	-43%
Price To Free Cash Flow Ratio	12.531	-32%	16.587	-182.719	+1202%	21.855	-24%	-3.489	+121%	38.997	-57%
Price To Total Gains Ratio	401.777	-32%	531.792	249.123	+113%	-122.913	+123%	768.208	-31%	465.898	+14%
Quick Ratio	-	-	2.112	1.856	+14%	1.323	+60%	1.763	+20%	1.551	+36%
Return On Assets	-	-	-0.006	-0.002	-65%	0.001	-969%	0.005	-226%	0.007	-196%
Return On Equity	-	-	-0.012	-0.004	-64%	0.001	-967%	0.009	-242%	0.011	-213%
Total Gains Per Share	-	-	0.071	0.330	-79%	0.403	-82%	0.557	-87%	0.459	-85%
Usd Book Value	-	-	1188954000.000	1170624000.000	+2%	1108227500.000	+7%	1012269550.000	+17%	734473200.000	+62%
Usd Book Value Change Per Share	-	-	0.033	0.320	-90%	0.403	-92%	0.555	-94%	0.458	-93%
Usd Book Value Per Share	-	-	25.895	25.495	+2%	23.847	+9%	21.790	+19%	15.868	+63%
Usd Dividend Per Share	-	-	0.038	0.009	+300%	-	+100%	0.002	+1900%	0.001	+3900%
Usd Eps	-	-	-0.313	-0.111	-65%	0.029	-1198%	0.167	-288%	0.149	-310%
Usd Free Cash Flow	-	-	26042000.000	31519500.000	-17%	4260250.000	+511%	26547050.000	-2%	16245800.000	+60%
Usd Free Cash Flow Per Share	-	-	0.567	0.686	-17%	0.101	+463%	0.572	-1%	0.351	+62%
Usd Free Cash Flow To Equity Per Share	-	-	0.853	0.814	+5%	-0.006	+101%	1.098	-22%	0.728	+17%
Usd Market Cap	1305371979.000	-32%	1727792739.000	2468062163.250	-30%	4444508701.250	-61%	4345050763.000	-60%	3090096736.700	-44%
Usd Price Per Share	28.430	-32%	37.630	53.753	-30%	95.173	-60%	92.882	-59%	66.425	-43%
Usd Profit	-	-	-14375000.000	-5092750.000	-65%	1412000.000	-1118%	7832900.000	-284%	6921825.000	-308%
Usd Revenue	-	-	258846999.000	286777999.750	-10%	323986750.000	-20%	268215599.950	-3%	212146674.975	+22%
Usd Total Gains Per Share	-	-	0.071	0.330	-79%	0.403	-82%	0.557	-87%	0.459	-85%
	EOD	+3 -5	MRQ	TTM	+15 -20	YOY	+19 -16	5Y	+10 -25	10Y	+18 -17

4.2. Fundamental Score

Let's check the fundamental score of Omnicell Inc based on Penke's default stock scanner.

Penke's Stock Scanner

Indicator	Condition		Value
Price to Earnings Ratio (EOD)	Between	0-15	-22.702
Price to Book Ratio (EOD)	Between	0-1	1.098
Net Profit Margin (MRQ)	Greater than	0	-0.056
Operating Margin (MRQ)	Greater than	0	-0.090
Quick Ratio (MRQ)	Greater than	1	2.112
Current Ratio (MRQ)	Greater than	1	2.522
Debt to Asset Ratio (MRQ)	Less than	1	0.466
Debt to Equity Ratio (MRQ)	Less than	1	0.873
Return on Equity (MRQ)	Greater than	0.15	-0.012
Return on Assets (MRQ)	Greater than	0.05	-0.006
Total			4/10 (40.0%)

Create your own Stock Scanner

Investing is personal. The best investors buy stocks based on their own analysis. Create your personal Stock Scanner with the key performance indicators that are important to you.
Create your own Stock Scanner

4.3. Technical Score

Let's check the technical score of Omnicell Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	55.288
Ma 20	Greater than	Ma 50	27.770
Ma 50	Greater than	Ma 100	27.703
Ma 100	Greater than	Ma 200	31.241
Open	Greater than	Close	28.000
Total			2/5 (40.0%)

Create your own Symbol Scanner

Trading is personal. The best traders buy and sell based on their own technical analysis. Create your personal Symbol Scanner with the technical indicators that are important to you.
Create your own Symbol Scanner

Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary

Total Assets	2,226,878
Total Liabilities	1,037,924
Total Stockholder Equity	1,188,954

	As reported
Total Liabilities	1,037,924
Total Stockholder Equity	+ 1,188,954
Total Assets	= 2,226,878

Assets

Total Assets	2,226,878
Total Current Assets	927,571
Long-term Assets	1,299,307

Total Current Assets

Total Current Assets (as reported)	927,571
Cash And Cash Equivalents	500,979
Short-term Investments	11,867
Net Receivables	263,892
Inventory	110,099
Other Current Assets	52,601
Total Current Assets (calculated)	939,438
+/-	11,867

Long-term Assets

Long-term Assets (as reported)	1,299,307
Property Plant Equipment	133,589
Goodwill	735,810
Long Term Investments	42,954
Intangible Assets	277,832
Long-term Assets Other	64,371
Long-term Assets (calculated)	1,254,556
+/-	44,751

Liabilities & Shareholders' Equity

Total Current Liabilities	367,792
Long-term Liabilities	670,132
Total Stockholder Equity	1,188,954

Total Current Liabilities

Total Current Liabilities (as reported)	367,792
Short-term Debt	10,518
Accounts payable	45,028
Other Current Liabilities	179,961
Total Current Liabilities (calculated)	235,507
+/-	132,285

Long-term Liabilities

Long-term Liabilities (as reported)	670,132
Long term Debt	569,662
Capital Lease Obligations	44,428
Long-term Liabilities Other	6,318
Long-term Liabilities (calculated)	620,408
+/-	49,724

Total Stockholder Equity

Total Stockholder Equity (as reported)	1,188,954
Common Stock	56
Retained Earnings	370,357
Accumulated Other Comprehensive Income	-13,432
Other Stockholders Equity	831,973
Total Stockholder Equity (calculated)	1,188,954
+/-	0

Other

Capital Stock	56
Cash and Short Term Investments	500,979
Common Stock Shares Outstanding	45,495
Current Deferred Revenue	132,285
Liabilities and Stockholders Equity	2,226,878
Net Debt	113,111
Net Invested Capital	1,758,616
Net Working Capital	559,779
Property Plant and Equipment Gross	273,021
Short Long Term Debt Total	614,090

Balance Sheet

Currency in USD. All numbers in thousands.

Trend

2023-12-31

2023-09-30

2023-06-30

2023-03-31

2022-12-31

2022-09-30

2022-06-30

2022-03-31

2021-12-31

2021-09-30

2021-06-30

2021-03-31

2020-12-31

2020-09-30

2020-06-30

2020-03-31

2019-12-31

2019-09-30

2019-06-30

2019-03-31

2018-12-31

2018-09-30

2018-06-30

2018-03-31

2017-12-31

2017-09-30

2017-06-30

2017-03-31

2016-12-31

2016-09-30

2016-06-30

2016-03-31

2015-12-31

2015-09-30

2015-06-30

2015-03-31

2014-12-31

2014-09-30

2014-06-30

2014-03-31

2013-12-31

2013-09-30

2013-06-30

2013-03-31

2012-12-31

2012-09-30

2012-06-30

2012-03-31

2011-12-31

2011-09-30

2011-06-30

2011-03-31

2010-12-31

2010-09-30

2010-06-30

2010-03-31

2009-12-31

2009-09-30

2009-06-30

2009-03-31

2008-12-31

2008-09-30

2008-06-30

2008-03-31

2007-12-31

2007-09-30

2007-06-30

2007-03-31

2006-12-31

2006-09-30

2006-06-30

2006-03-31

2005-12-31

2005-09-30

2005-06-30

2005-03-31

2004-12-31

2004-09-30

2004-06-30

2004-03-31

2003-12-31

2003-09-30

2003-06-30

2003-03-31

2002-12-31

2002-09-30

2002-06-30

2002-03-31

2001-12-31

2001-09-30

2001-06-30

2001-03-31

2000-12-31

> Total Assets

43,905
47,038
47,454
70,330
72,114
67,945
69,468
70,126
65,542
61,418
65,016
71,147
84,467
91,059
95,055
98,705
99,491
94,788
94,592
103,655
100,428
106,800
122,750
138,504
154,630
157,920
277,672
294,914
328,423
307,720
284,065
293,510
308,542
307,117
314,606
323,036
322,260
331,695
333,494
339,737
343,224
345,412
349,453
358,510
361,968
373,928
416,250
422,002
443,731
457,357
472,128
505,165
492,501
510,405
537,251
547,313
560,214
570,926
601,022
576,722
578,747
923,772
913,428
931,415
935,103
909,763
909,901
923,818
980,304
1,040,955
1,026,475
1,052,375
1,081,242
1,177,060
1,196,978
1,244,270
1,240,810
1,231,647
1,222,446
1,719,277
1,824,504
1,886,623
1,960,994
2,051,471
2,142,496
2,122,588
2,131,458
2,179,685
2,210,758
2,250,838
2,193,872
2,221,575
2,226,878

2,226,878

2,221,575

2,193,872

2,250,838

2,210,758

2,179,685

2,131,458

2,122,588

2,142,496

2,051,471

1,960,994

1,886,623

1,824,504

1,719,277

1,222,446

1,231,647

1,240,810

1,244,270

1,196,978

1,177,060

1,081,242

1,052,375

1,026,475

1,040,955

980,304

923,818

909,901

909,763

935,103

931,415

913,428

923,772

578,747

576,722

601,022

570,926

560,214

547,313

537,251

510,405

492,501

505,165

472,128

457,357

443,731

422,002

416,250

373,928

361,968

358,510

349,453

345,412

343,224

339,737

333,494

331,695

322,260

323,036

314,606

307,117

308,542

293,510

284,065

307,720

328,423

294,914

277,672

157,920

154,630

138,504

122,750

106,800

100,428

103,655

94,592

94,788

99,491

98,705

95,055

91,059

84,467

71,147

65,016

61,418

65,542

70,126

69,468

67,945

72,114

70,330

47,454

47,038

43,905

> Total Current Assets

0
38,226
36,228
59,432
59,961
55,645
57,299
53,214
48,445
46,527
51,421
55,012
63,539
67,483
72,030
77,003
77,766
74,250
77,037
88,071
85,592
87,807
103,157
117,602
129,846
131,733
244,492
258,368
252,184
232,757
208,370
216,876
224,987
225,412
235,403
245,941
250,744
259,961
262,994
266,081
268,503
268,137
271,305
280,660
279,394
291,805
155,601
166,518
180,884
197,086
213,221
247,040
233,777
250,842
275,896
268,368
283,384
296,322
285,324
259,886
264,128
310,308
311,916
337,067
315,408
294,379
295,981
315,381
367,121
372,231
358,858
379,119
397,134
413,707
429,839
477,079
483,238
478,323
465,165
963,404
829,414
903,999
984,288
888,716
780,702
775,604
787,770
849,132
881,812
934,969
881,361
913,751
927,571

927,571

913,751

881,361

934,969

881,812

849,132

787,770

775,604

780,702

888,716

984,288

903,999

829,414

963,404

465,165

478,323

483,238

477,079

429,839

413,707

397,134

379,119

358,858

372,231

367,121

315,381

295,981

294,379

315,408

337,067

311,916

310,308

264,128

259,886

285,324

296,322

283,384

268,368

275,896

250,842

233,777

247,040

213,221

197,086

180,884

166,518

155,601

291,805

279,394

280,660

271,305

268,137

268,503

266,081

262,994

259,961

250,744

245,941

235,403

225,412

224,987

216,876

208,370

232,757

252,184

258,368

244,492

131,733

129,846

117,602

103,157

87,807

85,592

88,071

77,037

74,250

77,766

77,003

72,030

67,483

63,539

55,012

51,421

46,527

48,445

53,214

57,299

55,645

59,961

59,432

36,228

38,226

Cash And Cash Equivalents

9,681
2,309
2,402
24,619
16,912
12,966
14,146
21,178
21,400
23,063
26,031
26,822
24,499
25,196
20,171
21,373
19,482
15,251
24,259
29,500
29,536
33,853
43,767
50,081
60,856
64,669
172,137
175,748
169,812
142,578
122,783
125,032
120,439
118,853
126,426
146,312
169,230
180,611
185,156
178,625
175,635
173,669
181,258
179,303
191,762
201,420
54,071
54,818
62,313
69,817
87,334
116,190
104,531
107,558
126,379
104,187
125,888
139,553
88,028
57,757
82,217
53,487
41,029
47,287
54,488
46,348
26,936
7,466
32,424
43,773
46,168
44,174
67,192
77,244
87,482
137,277
127,210
104,080
133,583
629,171
485,928
548,055
614,236
481,549
349,051
265,008
244,953
266,402
330,362
340,413
399,464
446,840
500,979

500,979

446,840

399,464

340,413

330,362

266,402

244,953

265,008

349,051

481,549

614,236

548,055

485,928

629,171

133,583

104,080

127,210

137,277

87,482

77,244

67,192

44,174

46,168

43,773

32,424

7,466

26,936

46,348

54,488

47,287

41,029

53,487

82,217

57,757

88,028

139,553

125,888

104,187

126,379

107,558

104,531

116,190

87,334

69,817

62,313

54,818

54,071

201,420

191,762

179,303

181,258

173,669

175,635

178,625

185,156

180,611

169,230

146,312

126,426

118,853

120,439

125,032

122,783

142,578

169,812

175,748

172,137

64,669

60,856

50,081

43,767

33,853

29,536

29,500

24,259

15,251

19,482

21,373

20,171

25,196

24,499

26,822

26,031

23,063

21,400

21,178

14,146

12,966

16,912

24,619

2,402

2,309

9,681

Short-term Investments

2,286
5,389
2,330
200
6,927
8,940
7,150
99
85
85
1,981
4,074
9,025
11,015
16,177
11,210
11,117
11,047
3,713
2,008
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,074
8,109
0
8,101
8,107
8,117
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,510
10,246
10,222
10,364
10,529
10,665
11,103
12,312
12,586
11,486
11,053
11,078
11,618
11,867

11,867

11,618

11,078

11,053

11,486

12,586

12,312

11,103

10,665

10,529

10,364

10,222

10,246

22,510

8,117

8,107

8,101

8,109

8,074

2,008

3,713

11,047

11,117

11,210

16,177

11,015

9,025

4,074

1,981

7,150

8,940

6,927

200

2,330

5,389

2,286

Net Receivables

0
15,366
14,902
16,552
18,167
14,675
18,518
14,712
10,644
9,878
11,289
11,279
17,266
16,336
17,155
20,157
24,845
25,578
22,432
33,191
32,007
31,155
31,830
33,684
36,050
37,741
36,799
46,927
37,522
44,818
40,784
47,391
57,976
60,779
67,655
58,779
40,826
39,879
37,986
45,070
42,732
39,795
43,105
45,987
36,902
38,973
46,390
53,109
55,116
65,703
63,840
63,999
58,597
75,496
82,560
95,167
82,763
88,107
117,307
115,680
107,957
153,199
159,453
177,019
150,303
131,433
151,010
171,869
189,227
190,678
174,570
206,225
196,238
203,489
205,353
203,391
218,362
233,068
188,918
188,102
190,117
205,658
209,953
233,729
240,894
290,469
310,520
354,098
299,469
322,073
273,899
272,584
263,892

263,892

272,584

273,899

322,073

299,469

354,098

310,520

290,469

240,894

233,729

209,953

205,658

190,117

188,102

188,918

233,068

218,362

203,391

205,353

203,489

196,238

206,225

174,570

190,678

189,227

171,869

151,010

131,433

150,303

177,019

159,453

153,199

107,957

115,680

117,307

88,107

82,763

95,167

82,560

75,496

58,597

63,999

63,840

65,703

55,116

53,109

46,390

38,973

36,902

45,987

43,105

39,795

42,732

45,070

37,986

39,879

40,826

58,779

67,655

60,779

57,976

47,391

40,784

44,818

37,522

46,927

36,799

37,741

36,050

33,684

31,830

31,155

32,007

33,191

22,432

25,578

24,845

20,157

17,155

16,336

17,266

11,279

11,289

9,878

10,644

14,712

18,518

14,675

18,167

16,552

14,902

15,366

Other Current Assets

2,728
2,697
2,960
4,236
5,253
4,841
4,345
4,623
3,575
3,156
3,447
4,203
3,966
4,877
5,531
7,066
7,730
7,083
2,987
8,438
10,286
10,634
13,092
11,954
9,183
5,973
5,746
5,782
9,806
9,825
9,536
8,921
9,434
10,636
7,040
6,083
6,159
5,711
6,456
6,596
7,266
6,337
5,940
6,518
6,107
6,046
7,164
7,046
9,052
7,532
7,899
8,052
7,674
7,799
6,040
6,262
7,215
6,217
6,071
6,802
7,774
9,853
9,024
9,016
12,674
12,593
10,511
15,763
13,273
14,751
16,122
9,871
12,136
12,017
13,419
11,870
15,177
14,235
15,122
22,631
41,044
36,956
41,472
44,417
48,334
58,843
60,980
56,674
77,362
103,364
53,907
50,236
52,601

52,601

50,236

53,907

103,364

77,362

56,674

60,980

58,843

48,334

44,417

41,472

36,956

41,044

22,631

15,122

14,235

15,177

11,870

13,419

12,017

12,136

9,871

16,122

14,751

13,273

15,763

10,511

12,593

12,674

9,016

9,024

9,853

7,774

6,802

6,071

6,217

7,215

6,262

6,040

7,799

7,674

8,052

7,899

7,532

9,052

7,046

7,164

6,046

6,107

6,518

5,940

6,337

7,266

6,596

6,456

5,711

6,159

6,083

7,040

10,636

9,434

8,921

9,536

9,825

9,806

5,782

5,746

5,973

9,183

11,954

13,092

10,634

10,286

8,438

2,987

7,083

7,730

7,066

5,531

4,877

3,966

4,203

3,447

3,156

3,575

4,623

4,345

4,841

5,253

4,236

2,960

2,697

2,728

> Long-term Assets

0
8,812
11,226
10,898
12,153
12,300
12,169
16,912
17,097
14,891
13,595
16,135
20,928
23,576
23,025
21,702
21,725
20,538
17,555
15,584
14,836
18,993
19,593
20,902
24,784
26,187
33,180
36,546
76,239
74,963
75,695
76,634
83,555
81,705
79,203
77,095
71,516
71,734
70,500
73,656
74,721
77,275
78,148
77,850
82,574
82,123
260,649
255,484
262,847
260,271
258,907
258,125
258,724
259,563
261,355
278,945
276,830
274,604
315,698
316,836
314,619
613,464
601,512
594,348
619,695
615,384
613,920
608,437
613,183
668,724
667,617
673,256
684,108
763,353
767,139
767,191
757,572
753,324
757,281
755,873
995,090
982,624
976,706
1,162,755
1,361,794
1,346,984
1,343,688
1,330,553
1,328,946
1,315,869
1,312,511
1,307,824
1,299,307

1,299,307

1,307,824

1,312,511

1,315,869

1,328,946

1,330,553

1,343,688

1,346,984

1,361,794

1,162,755

976,706

982,624

995,090

755,873

757,281

753,324

757,572

767,191

767,139

763,353

684,108

673,256

667,617

668,724

613,183

608,437

613,920

615,384

619,695

594,348

601,512

613,464

314,619

316,836

315,698

274,604

276,830

278,945

261,355

259,563

258,724

258,125

258,907

260,271

262,847

255,484

260,649

82,123

82,574

77,850

78,148

77,275

74,721

73,656

70,500

71,734

71,516

77,095

79,203

81,705

83,555

76,634

75,695

74,963

76,239

36,546

33,180

26,187

24,784

20,902

19,593

18,993

14,836

15,584

17,555

20,538

21,725

21,702

23,025

23,576

20,928

16,135

13,595

14,891

17,097

16,912

12,169

12,300

12,153

10,898

11,226

8,812

Property Plant Equipment

4,913
4,981
5,238
5,128
5,384
5,348
5,147
5,062
5,026
4,703
4,203
4,434
4,833
5,600
5,311
5,764
5,660
5,422
5,009
4,994
4,727
4,505
4,394
4,742
5,226
5,127
5,246
7,945
10,184
11,290
12,632
14,668
16,180
15,929
14,326
13,128
13,209
13,578
13,729
13,512
14,351
15,344
16,320
16,890
17,307
17,112
28,965
32,185
34,260
34,697
34,114
33,492
35,254
35,178
37,257
37,688
36,178
34,373
34,772
34,026
32,309
42,208
40,503
41,034
42,011
40,996
40,713
40,219
42,595
48,290
50,884
50,484
51,500
115,890
114,329
113,918
110,376
107,373
110,403
107,974
114,187
112,460
111,682
113,928
119,690
120,266
128,074
132,489
132,013
126,601
130,910
132,324
133,589

133,589

132,324

130,910

126,601

132,013

132,489

128,074

120,266

119,690

113,928

111,682

112,460

114,187

107,974

110,403

107,373

110,376

113,918

114,329

115,890

51,500

50,484

50,884

48,290

42,595

40,219

40,713

40,996

42,011

41,034

40,503

42,208

32,309

34,026

34,772

34,373

36,178

37,688

37,257

35,178

35,254

33,492

34,114

34,697

34,260

32,185

28,965

17,112

17,307

16,890

16,320

15,344

14,351

13,512

13,729

13,578

13,209

13,128

14,326

15,929

16,180

14,668

12,632

11,290

10,184

7,945

5,246

5,127

5,226

4,742

4,394

4,505

4,727

4,994

5,009

5,422

5,660

5,764

5,311

5,600

4,833

4,434

4,203

4,703

5,026

5,062

5,147

5,348

5,384

5,128

5,238

4,981

4,913

Goodwill

0
0
0
0
0
0
0
0
382
0
0
1,627
2,127
2,127
2,127
2,127
2,127
2,450
2,450
2,450
3,127
3,127
3,127
3,127
4,924
4,843
4,663
3,127
23,076
23,164
24,309
24,310
24,982
24,982
24,982
24,982
24,982
24,982
24,982
28,651
28,543
28,543
28,543
28,543
28,543
28,543
112,083
112,683
113,404
111,343
111,343
111,343
111,343
111,343
111,343
123,090
122,720
122,216
149,654
148,727
147,906
312,511
311,170
311,420
327,724
328,216
332,996
334,780
337,751
338,948
336,550
336,517
335,887
336,119
335,699
334,516
336,539
334,842
335,034
336,456
499,309
499,065
499,266
616,387
738,900
740,426
734,487
731,294
734,274
734,895
735,523
734,328
735,810

735,810

734,328

735,523

734,895

734,274

731,294

734,487

740,426

738,900

616,387

499,266

499,065

499,309

336,456

335,034

334,842

336,539

334,516

335,699

336,119

335,887

336,517

336,550

338,948

337,751

334,780

332,996

328,216

327,724

311,420

311,170

312,511

147,906

148,727

149,654

122,216

122,720

123,090

111,343

113,404

112,683

112,083

28,543

28,651

24,982

24,310

24,309

23,164

23,076

3,127

4,663

4,843

4,924

3,127

2,450

2,127

1,627

382

Long Term Investments

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,826
10,628
13,228
12,943
13,222
12,398
11,485
11,644
10,872
10,823
10,848
10,443
10,208
13,557
14,484
21,037
19,711
18,756
20,585
19,174
17,424
15,986
15,435
16,444
16,707
17,448
17,082
19,469
21,041
21,494
19,750
19,992
20,961
22,510
22,156
21,255
19,615
19,187
18,391
19,051
29,209
33,807
32,924
32,744
35,039
41,631
42,954

42,954

41,631

35,039

32,744

32,924

33,807

29,209

19,051

18,391

19,187

19,615

21,255

22,156

22,510

20,961

19,992

19,750

21,494

21,041

19,469

17,082

17,448

16,707

16,444

15,435

15,986

17,424

19,174

20,585

18,756

19,711

21,037

14,484

13,557

10,208

10,443

10,848

10,823

10,872

11,644

11,485

12,398

13,222

12,943

13,228

10,628

9,826

Intangible Assets

0
0
0
0
0
0
0
0
382
0
0
5,933
6,322
6,721
6,426
6,130
5,806
5,835
5,542
5,248
5,631
2,210
1,917
1,672
1,071
921
771
1,974
9,467
8,732
8,034
7,480
6,706
6,142
5,362
4,847
4,233
3,784
3,270
5,164
4,672
4,533
4,414
4,318
4,231
4,157
87,242
86,234
85,158
84,529
83,468
82,530
81,602
80,573
79,561
84,075
82,667
81,279
94,285
92,042
89,665
206,261
196,475
187,571
190,283
219,518
180,206
174,227
168,107
162,458
155,750
149,968
143,686
138,893
134,101
129,163
124,867
120,063
115,710
111,587
168,211
161,816
155,775
218,956
277,616
269,427
260,159
251,004
242,906
234,689
226,707
218,861
277,832

277,832

218,861

226,707

234,689

242,906

251,004

260,159

269,427

277,616

218,956

155,775

161,816

168,211

111,587

115,710

120,063

124,867

129,163

134,101

138,893

143,686

149,968

155,750

162,458

168,107

174,227

180,206

219,518

190,283

187,571

196,475

206,261

89,665

92,042

94,285

81,279

82,667

84,075

79,561

80,573

81,602

82,530

83,468

84,529

85,158

86,234

87,242

4,157

4,231

4,318

4,414

4,533

4,672

5,164

3,270

3,784

4,233

4,847

5,362

6,142

6,706

7,480

8,034

8,732

9,467

1,974

771

921

1,071

1,672

1,917

2,210

5,631

5,248

5,542

5,835

5,806

6,130

6,426

6,721

6,322

5,933

382

Long-term Assets Other

0
3,831
5,988
5,770
6,769
6,952
7,022
11,850
12,071
10,188
9,392
5,768
9,773
11,255
11,288
9,808
10,259
9,281
7,004
5,342
4,478
9,151
10,155
11,361
13,563
15,296
17,704
18,690
20,631
21,402
20,447
20,182
8,902
9,207
14,660
8,938
9,322
9,331
9,125
8,610
8,365
9,501
9,901
9,442
9,716
9,149
9,959
2,557
15,778
15,633
15,775
17,069
17,938
19,661
21,220
22,294
23,273
24,963
25,382
26,971
27,894
28,809
30,733
32,612
35,051
1,856
36,954
37,596
39,841
93,128
98,275
109,389
120,756
120,939
130,774
137,493
151,898
156,912
161,019
162,361
176,208
172,652
174,809
178,431
191,314
181,760
175,625
165,340
164,500
157,378
151,568
144,716
64,371

64,371

144,716

151,568

157,378

164,500

165,340

175,625

181,760

191,314

178,431

174,809

172,652

176,208

162,361

161,019

156,912

151,898

137,493

130,774

120,939

120,756

109,389

98,275

93,128

39,841

37,596

36,954

1,856

35,051

32,612

30,733

28,809

27,894

26,971

25,382

24,963

23,273

22,294

21,220

19,661

17,938

17,069

15,775

15,633

15,778

2,557

9,959

9,149

9,716

9,442

9,901

9,501

8,365

8,610

9,125

9,331

9,322

8,938

14,660

9,207

8,902

20,182

20,447

21,402

20,631

18,690

17,704

15,296

13,563

11,361

10,155

9,151

4,478

5,342

7,004

9,281

10,259

9,808

11,288

11,255

9,773

5,768

9,392

10,188

12,071

11,850

7,022

6,952

6,769

5,770

5,988

3,831

Deferred Long Term Asset Charges

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,057
9,836
11,677
11,801
0
0
993
1,126
985
1,293
1,102
1,164
1,102
975
1,144
1,330
1,397
1,513
2,361
2,638
2,920
2,955
4,041
5,624
5,627
5,629
9,454
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

9,454

5,629

5,627

5,624

4,041

2,955

2,920

2,638

2,361

1,513

1,397

1,330

1,144

975

1,102

1,164

1,102

1,293

985

1,126

993

11,801

11,677

9,836

10,057

> Total Liabilities

58,816
73,426
74,265
52,954
52,513
45,908
45,310
48,359
49,236
44,243
44,566
42,366
49,709
49,187
50,178
47,772
45,794
45,797
44,511
50,896
45,190
46,393
51,594
58,795
64,634
57,185
62,619
64,626
73,784
82,223
76,079
74,937
74,985
71,221
75,405
78,577
79,956
81,087
77,052
77,799
78,010
78,066
78,223
80,535
79,054
83,038
128,730
125,489
136,147
135,564
138,397
147,379
144,167
145,229
159,630
168,412
170,116
165,476
201,674
185,182
176,359
513,267
500,229
503,850
503,496
470,820
460,399
451,321
463,105
466,453
437,835
433,136
401,625
446,575
423,736
436,737
395,556
353,147
334,985
800,878
857,001
875,612
908,422
940,135
995,807
1,047,847
1,038,821
1,044,290
1,080,621
1,108,297
1,030,307
1,034,139
1,037,924

1,037,924

1,034,139

1,030,307

1,108,297

1,080,621

1,044,290

1,038,821

1,047,847

995,807

940,135

908,422

875,612

857,001

800,878

334,985

353,147

395,556

436,737

423,736

446,575

401,625

433,136

437,835

466,453

463,105

451,321

460,399

470,820

503,496

503,850

500,229

513,267

176,359

185,182

201,674

165,476

170,116

168,412

159,630

145,229

144,167

147,379

138,397

135,564

136,147

125,489

128,730

83,038

79,054

80,535

78,223

78,066

78,010

77,799

77,052

81,087

79,956

78,577

75,405

71,221

74,985

74,937

76,079

82,223

73,784

64,626

62,619

57,185

64,634

58,795

51,594

46,393

45,190

50,896

44,511

45,797

45,794

47,772

50,178

49,187

49,709

42,366

44,566

44,243

49,236

48,359

45,310

45,908

52,513

52,954

74,265

73,426

58,816

> Total Current Liabilities

49,598
55,096
57,044
52,255
52,150
45,588
45,164
47,636
48,473
43,785
44,108
41,908
44,141
44,278
45,814
43,982
42,053
42,695
42,027
48,995
33,781
34,964
40,074
47,189
53,556
44,631
48,839
49,623
57,821
65,015
58,690
57,525
57,355
54,827
58,658
60,644
58,551
59,333
56,739
57,744
58,164
58,519
58,743
61,074
58,749
62,302
73,235
78,552
84,985
85,611
88,535
98,246
93,066
92,100
103,294
111,560
112,330
108,624
138,275
122,644
124,630
199,646
191,315
198,171
180,912
197,480
211,712
205,870
212,536
221,427
201,634
212,582
204,580
210,622
211,384
228,170
236,996
248,440
236,563
233,876
276,423
292,273
317,112
338,662
876,158
951,012
373,514
376,681
428,446
453,968
370,157
369,361
367,792

367,792

369,361

370,157

453,968

428,446

376,681

373,514

951,012

876,158

338,662

317,112

292,273

276,423

233,876

236,563

248,440

236,996

228,170

211,384

210,622

204,580

212,582

201,634

221,427

212,536

205,870

211,712

197,480

180,912

198,171

191,315

199,646

124,630

122,644

138,275

108,624

112,330

111,560

103,294

92,100

93,066

98,246

88,535

85,611

84,985

78,552

73,235

62,302

58,749

61,074

58,743

58,519

58,164

57,744

56,739

59,333

58,551

60,644

58,658

54,827

57,355

57,525

58,690

65,015

57,821

49,623

48,839

44,631

53,556

47,189

40,074

34,964

33,781

48,995

42,027

42,695

42,053

43,982

45,814

44,278

44,141

41,908

44,108

43,785

48,473

47,636

45,164

45,588

52,150

52,255

57,044

55,096

49,598

Short-term Debt

0
1,026
5,011
15,307
0
12,024
10,959
1,189
1,197
1,204
908
608
305
13,735
8,151
9,827
12,918
11,745
9,296
12,215
12,664
2,175
11,779
12,457
12,122
10,322
12,994
12,808
21,182
18,330
19,829
18,701
35,677
30,519
35,157
0
0
0
12,854
0
0
0
0
0
-122
14,173
20,543
3,001
4,736
2,555
3,686
3,453
5,633
3,778
3,656
3,749
4,834
4,825
7,840
7,567
8,327
8,410
8,410
8,410
8,410
8,410
10,910
13,410
15,208
17,708
17,708
17,708
8,993
10,373
10,286
10,281
10,058
9,986
10,463
10,633
12,197
12,236
12,370
13,009
488,152
564,269
11,884
10,658
10,761
10,875
10,951
10,617
10,518

10,518

10,617

10,951

10,875

10,761

10,658

11,884

564,269

488,152

13,009

12,370

12,236

12,197

10,633

10,463

9,986

10,058

10,281

10,286

10,373

8,993

17,708

15,208

13,410

10,910

8,410

8,327

7,567

7,840

4,825

4,834

3,749

3,656

3,778

5,633

3,453

3,686

2,555

4,736

3,001

20,543

14,173

-122

12,854

35,157

30,519

35,677

18,701

19,829

18,330

21,182

12,808

12,994

10,322

12,122

12,457

11,779

2,175

12,664

12,215

9,296

11,745

12,918

9,827

8,151

13,735

305

608

908

1,204

1,197

1,189

10,959

12,024

15,307

5,011

1,026

Short Long Term Debt

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,410
8,410
10,910
13,410
15,208
17,708
17,708
17,708
0
10,373
0
0
0
0
0
0
0
0
0
0
488,152
564,269
0
0
0
0
0
0
0

564,269

488,152

10,373

17,708

15,208

13,410

10,910

8,410

Accounts payable

4,416
5,516
4,925
4,719
4,837
5,591
4,943
5,137
5,975
2,614
3,427
4,085
2,921
6,301
9,059
8,334
4,489
5,137
6,841
4,989
4,059
3,674
7,821
11,872
8,792
8,891
8,581
9,749
10,116
13,755
12,186
11,675
9,377
11,888
10,584
10,430
10,313
10,603
9,968
13,695
13,242
13,870
14,380
14,422
11,000
10,610
15,687
18,635
18,256
18,379
17,459
24,717
16,471
20,154
18,965
23,202
19,432
21,812
26,085
24,691
22,646
32,142
37,365
36,715
27,069
38,466
53,287
51,182
48,290
37,859
35,261
38,367
38,038
38,466
40,183
48,449
46,380
46,788
34,587
37,203
40,309
50,759
56,195
74,656
71,513
71,645
68,400
73,517
63,389
63,407
47,192
49,920
45,028

45,028

49,920

47,192

63,407

63,389

73,517

68,400

71,645

71,513

74,656

56,195

50,759

40,309

37,203

34,587

46,788

46,380

48,449

40,183

38,466

38,038

38,367

35,261

37,859

48,290

51,182

53,287

38,466

27,069

36,715

37,365

32,142

22,646

24,691

26,085

21,812

19,432

23,202

18,965

20,154

16,471

24,717

17,459

18,379

18,256

18,635

15,687

10,610

11,000

14,422

14,380

13,870

13,242

13,695

9,968

10,603

10,313

10,430

10,584

11,888

9,377

11,675

12,186

13,755

10,116

9,749

8,581

8,891

8,792

11,872

7,821

3,674

4,059

4,989

6,841

5,137

4,489

8,334

9,059

6,301

2,921

4,085

3,427

2,614

5,975

5,137

4,943

5,591

4,837

4,719

4,925

5,516

4,416

Other Current Liabilities

45,145
45,148
42,011
25,798
14,514
18,875
19,418
29,659
29,703
27,393
27,210
24,284
28,265
11,187
13,621
10,960
10,724
10,640
10,182
15,166
2,551
22,164
13,114
1,019
24,935
17,428
1,077
1,460
15,260
20,390
14,432
14,731
170
129
87
35,855
33,781
33,796
19,140
15,647
16,415
15,116
14,346
14,854
14,470
1,807
2,736
17,335
20,772
16,918
21,606
22,623
28,379
21,734
28,208
26,395
34,339
34,352
44,152
37,039
40,001
66,821
60,688
59,926
57,917
52,112
62,145
60,441
62,934
70,151
62,889
68,730
75,714
71,679
77,903
81,235
89,664
83,064
83,573
84,399
123,864
109,690
127,242
136,271
204,297
187,100
184,651
178,581
235,349
236,388
187,412
183,833
179,961

179,961

183,833

187,412

236,388

235,349

178,581

184,651

187,100

204,297

136,271

127,242

109,690

123,864

84,399

83,573

83,064

89,664

81,235

77,903

71,679

75,714

68,730

62,889

70,151

62,934

60,441

62,145

52,112

57,917

59,926

60,688

66,821

40,001

37,039

44,152

34,352

34,339

26,395

28,208

21,734

28,379

22,623

21,606

16,918

20,772

17,335

2,736

1,807

14,470

14,854

14,346

15,116

16,415

15,647

19,140

33,796

33,781

35,855

129

170

14,731

14,432

20,390

15,260

1,460

1,077

17,428

24,935

1,019

13,114

22,164

2,551

15,166

10,182

10,640

10,724

10,960

13,621

11,187

28,265

24,284

27,210

27,393

29,703

29,659

19,418

18,875

14,514

25,798

42,011

45,148

45,145

> Long-term Liabilities

0
18,330
17,221
699
363
320
146
723
763
458
458
458
5,568
4,909
4,364
3,790
3,741
3,102
2,484
1,901
11,409
11,429
11,520
11,606
11,078
12,554
13,780
15,003
15,963
17,208
17,389
17,412
17,630
16,394
16,747
17,933
21,405
21,754
20,313
20,055
19,846
19,547
19,480
19,461
20,305
20,736
55,495
46,937
51,162
49,953
49,862
49,133
51,101
53,129
56,336
56,852
57,786
56,852
63,399
62,538
51,729
313,621
308,914
305,679
322,584
273,340
248,687
245,451
250,569
245,026
236,201
220,554
197,045
235,953
212,352
208,567
158,560
104,707
98,422
567,002
580,578
583,339
591,310
601,473
119,649
96,835
665,307
667,609
652,175
654,329
660,150
664,778
670,132

670,132

664,778

660,150

654,329

652,175

667,609

665,307

96,835

119,649

601,473

591,310

583,339

580,578

567,002

98,422

104,707

158,560

208,567

212,352

235,953

197,045

220,554

236,201

245,026

250,569

245,451

248,687

273,340

322,584

305,679

308,914

313,621

51,729

62,538

63,399

56,852

57,786

56,852

56,336

53,129

51,101

49,133

49,862

49,953

51,162

46,937

55,495

20,736

20,305

19,461

19,480

19,547

19,846

20,055

20,313

21,754

21,405

17,933

16,747

16,394

17,630

17,412

17,389

17,208

15,963

15,003

13,780

12,554

11,078

11,606

11,520

11,429

11,409

1,901

2,484

3,102

3,741

3,790

4,364

4,909

5,568

458

763

723

146

320

363

699

17,221

18,330

Long term Debt Total

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
219,046
216,936
214,834
245,731
206,128
183,526
178,923
194,917
190,490
181,062
167,135
135,417
96,990
76,562
77,135
50,000
0
0
462,115
467,201
472,347
477,554
482,822
0
0
565,035
565,803
566,571
567,342
568,114
0
0

568,114

567,342

566,571

565,803

565,035

482,822

477,554

472,347

467,201

462,115

50,000

77,135

76,562

96,990

135,417

167,135

181,062

190,490

194,917

178,923

183,526

206,128

245,731

214,834

216,936

219,046

Capital Lease Obligations Min Short Term Debt

0
-1,026
-5,011
-15,307
0
-12,024
-10,959
-1,189
-1,197
-1,204
-908
-608
-305
-13,735
-8,151
-9,827
-12,918
-11,745
-9,296
-12,215
-12,664
-2,175
-11,779
-12,457
-12,122
-10,322
-12,994
-12,808
-21,182
-18,330
-19,829
-18,701
-35,677
-30,519
-35,157
0
0
0
-12,854
0
0
0
0
0
122
-14,173
-20,543
-3,001
-4,736
-2,555
-3,686
-3,453
-5,633
-3,778
-3,656
-3,749
-4,834
-4,825
-7,840
-7,567
-8,327
-8,410
-8,410
-8,410
-8,410
-8,410
-10,910
-13,410
-15,208
-17,708
-17,708
-17,708
-8,993
57,470
55,237
52,738
50,669
48,851
46,690
44,365
36,700
33,199
30,142
27,427
-448,241
-526,996
31,487
41,862
39,405
25,980
24,559
22,228
33,910

33,910

22,228

24,559

25,980

39,405

41,862

31,487

-526,996

-448,241

27,427

30,142

33,199

36,700

44,365

46,690

48,851

50,669

52,738

55,237

57,470

-8,993

-17,708

-15,208

-13,410

-10,910

-8,410

-8,327

-7,567

-7,840

-4,825

-4,834

-3,749

-3,656

-3,778

-5,633

-3,453

-3,686

-2,555

-4,736

-3,001

-20,543

-14,173

122

-12,854

-35,157

-30,519

-35,677

-18,701

-19,829

-18,330

-21,182

-12,808

-12,994

-10,322

-12,122

-12,457

-11,779

-2,175

-12,664

-12,215

-9,296

-11,745

-12,918

-9,827

-8,151

-13,735

-305

-608

-908

-1,204

-1,197

-1,189

-10,959

-12,024

-15,307

-5,011

-1,026

Deferred Long Term Asset Charges

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,057
9,836
11,677
11,801
0
0
993
1,126
985
1,293
1,102
1,164
1,102
975
1,144
1,330
1,397
1,513
2,361
2,638
2,920
2,955
4,041
5,624
5,627
5,629
9,454
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

9,454

5,629

5,627

5,624

4,041

2,955

2,920

2,638

2,361

1,513

1,397

1,330

1,144

975

1,102

1,164

1,102

1,293

985

1,126

993

11,801

11,677

9,836

10,057

Long-term Liabilities Other

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
625
1,014
1,339
1,733
3,277
5,713
4,809
4,942
5,039
5,423
5,175
5,430
6,004
6,013
7,024
6,012
11,620
11,782
11,932
11,771
12,074
12,173
8,210
8,716
9,879
9,625
9,829
18,216
20,351
20,826
20,144
77,558
74,498
70,515
69,470
66,897
68,861
69,303
73,744
71,864
18,743
10,761
7,839
7,352
8,808
85,666
83,509
6,136
6,265
6,428
6,318

6,318

6,428

6,265

6,136

83,509

85,666

8,808

7,352

7,839

10,761

18,743

71,864

73,744

69,303

68,861

66,897

69,470

70,515

74,498

77,558

20,144

20,826

20,351

18,216

9,829

9,625

9,879

8,716

8,210

12,173

12,074

11,771

11,932

11,782

11,620

6,012

7,024

6,013

6,004

5,430

5,175

5,423

5,039

4,942

4,809

5,713

3,277

1,733

1,339

1,014

625

Deferred Long Term Liability

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,855
18,447
18,966
19,003
40,595
41,224
46,383
45,011
44,823
43,710
45,925
47,699
50,332
50,839
50,762
50,840
51,779
50,756
39,797
82,784
79,904
78,676
68,643
58,496
55,282
56,903
45,823
36,320
34,788
32,593
41,484
61,405
61,292
60,917
39,090
37,810
29,561
35,584
4,253
39,128
3,704
53,313
51,705
28,173
23,906
16,140
2,095
1,558
1,511
0
0

1,511

1,558

2,095

16,140

23,906

28,173

51,705

53,313

3,704

39,128

4,253

35,584

29,561

37,810

39,090

60,917

61,292

61,405

41,484

32,593

34,788

36,320

45,823

56,903

55,282

58,496

68,643

78,676

79,904

82,784

39,797

50,756

51,779

50,840

50,762

50,839

50,332

47,699

45,925

43,710

44,823

45,011

46,383

41,224

40,595

19,003

18,966

18,447

18,855

> Total Stockholder Equity

0
-26,388
-26,811
17,376
19,601
22,037
24,158
21,767
16,306
17,175
20,450
28,781
34,758
41,872
44,877
50,933
53,697
48,991
50,081
52,759
55,238
60,407
71,156
79,709
89,996
100,735
215,053
230,288
254,639
225,497
207,986
218,573
233,557
235,896
239,201
244,459
242,304
250,608
256,442
261,938
265,214
267,346
271,230
277,975
282,914
290,890
287,520
296,513
307,584
321,793
333,731
357,786
348,334
365,176
377,621
378,901
390,098
405,450
399,348
391,540
402,388
410,505
413,199
427,565
431,607
438,943
449,502
472,497
517,199
574,502
588,640
619,239
679,617
730,485
773,242
807,533
845,254
878,500
887,461
918,399
967,503
1,011,011
1,052,572
1,111,336
1,146,689
1,074,741
1,092,637
1,135,395
1,130,137
1,142,541
1,163,565
1,187,436
1,188,954

1,188,954

1,187,436

1,163,565

1,142,541

1,130,137

1,135,395

1,092,637

1,074,741

1,146,689

1,111,336

1,052,572

1,011,011

967,503

918,399

887,461

878,500

845,254

807,533

773,242

730,485

679,617

619,239

588,640

574,502

517,199

472,497

449,502

438,943

431,607

427,565

413,199

410,505

402,388

391,540

399,348

405,450

390,098

378,901

377,621

365,176

348,334

357,786

333,731

321,793

307,584

296,513

287,520

290,890

282,914

277,975

271,230

267,346

265,214

261,938

256,442

250,608

242,304

244,459

239,201

235,896

233,557

218,573

207,986

225,497

254,639

230,288

215,053

100,735

89,996

79,709

71,156

60,407

55,238

52,759

50,081

48,991

53,697

50,933

44,877

41,872

34,758

28,781

20,450

17,175

16,306

21,767

24,158

22,037

19,601

17,376

-26,811

-26,388

Retained Earnings

0
-94,640
-95,854
-95,360
-93,962
-92,312
0
0
-99,000
-99,000
0
0
-91,693
-91,693
0
0
-81,091
-86,883
-86,817
-85,402
-83,165
-83,165
0
0
-72,800
-72,800
0
0
-30,091
-30,091
0
0
-17,367
0
0
0
-16,923
0
0
0
-12,031
-12,031
0
0
-1,642
-1,642
0
0
14,536
14,536
0
0
38,515
38,515
0
0
69,033
66,292
84,102
92,138
99,793
99,415
98,256
100,239
100,396
91,226
92,063
98,294
122,583
162,442
169,033
182,661
197,454
200,738
216,714
236,697
258,792
269,839
265,540
274,345
290,722
304,849
325,273
354,590
368,571
393,293
402,362
419,136
390,728
375,728
379,179
384,732
370,357

370,357

384,732

379,179

375,728

390,728

419,136

402,362

393,293

368,571

354,590

325,273

304,849

290,722

274,345

265,540

269,839

258,792

236,697

216,714

200,738

197,454

182,661

169,033

162,442

122,583

98,294

92,063

91,226

100,396

100,239

98,256

99,415

99,793

92,138

84,102

66,292

69,033

38,515

14,536

-1,642

-12,031

-16,923

-17,367

-30,091

-72,800

-83,165

-85,402

-86,817

-86,883

-81,091

-91,693

-99,000

-92,312

-93,962

-95,360

-95,854

-94,640

Accumulated Other Comprehensive Income

0
-6,060
-5,642
-5,435
-5,218
-5,073
24,158
-10,084
-4,671
17,175
20,450
28,781
-19
41,872
44,877
50,933
-33
135,874
136,898
138,161
12
60,407
71,156
79,709
-20,158
100,735
215,053
230,288
-22,362
225,497
207,986
218,573
-20,777
0
0
0
-27,005
0
0
0
-30,341
-31,871
-33,235
-34,761
1
-35,426
-36,464
-34,792
131
-35,438
-35,392
-37,787
171
-42,905
-45,613
-48,398
-1,361
-2,238
67
-1,488
-2,730
-3,057
-7,524
-7,918
-9,519
-8,414
-7,491
-6,176
-6,113
-3,439
-7,943
-9,084
-10,854
-10,502
-11,576
-14,401
-9,446
-14,140
-13,689
-10,179
-5,522
-6,143
-5,491
-7,790
-8,407
-10,962
-17,372
-24,142
-17,087
-15,608
-14,176
-17,129
-13,432

-13,432

-17,129

-14,176

-15,608

-17,087

-24,142

-17,372

-10,962

-8,407

-7,790

-5,491

-6,143

-5,522

-10,179

-13,689

-14,140

-9,446

-14,401

-11,576

-10,502

-10,854

-9,084

-7,943

-3,439

-6,113

-6,176

-7,491

-8,414

-9,519

-7,918

-7,524

-3,057

-2,730

-1,488

-2,238

-1,361

-48,398

-45,613

-42,905

171

-37,787

-35,392

-35,438

131

-34,792

-36,464

-35,426

-34,761

-33,235

-31,871

-30,341

-27,005

-20,777

218,573

207,986

225,497

-22,362

230,288

215,053

100,735

-20,158

79,709

71,156

60,407

138,161

136,898

135,874

-33

50,933

44,877

41,872

-19

28,781

20,450

17,175

-4,671

-10,084

24,158

-5,073

-5,218

-5,435

-5,642

-6,060

Capital Surplus

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
362,154
0
0
0
382,844
0
0
0
421,232
0
0
0
457,436
476,405
475,209
485,919
490,354
499,176
507,496
520,272
525,758
541,159
549,958
565,406
585,755
600,525
612,576
630,687
678,041
725,273
753,127
770,260
780,931
807,823
820,632
892,290
920,359
950,361
970,846
1,002,591
1,024,580
982,675
997,911
1,030,665
1,046,760
1,072,685
1,088,825
0
0

1,088,825

1,072,685

1,046,760

1,030,665

997,911

982,675

1,024,580

1,002,591

970,846

950,361

920,359

892,290

820,632

807,823

780,931

770,260

753,127

725,273

678,041

630,687

612,576

600,525

585,755

565,406

549,958

541,159

525,758

520,272

507,496

499,176

490,354

485,919

475,209

476,405

457,436

421,232

382,844

362,154

Treasury Stock

-290,319

-238,109

-185,074

-160,074

-135,053

-110,962

-90,000

-77,637

-65,064

Balance Sheet

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31
Accounts Payable	45,028	63,389	71,513	40,309	46,380	38,038	48,290	27,069	22,646	19,432	16,471	18,256	11,000	13,242	10,313	9,377	10,116	8,792	4,059	4,489	2,921	5,975	4,837	4,416
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Other Comprehensive Income	-13,432	-17,087	-8,407	-5,522	-9,446	-10,854	-6,113	-9,519	-2,730	-1,361	171	131	1	-30,341	-27,005	-20,777	-22,362	-20,158	12	-33	-19	-4,671	-5,218	-6,351
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	44,428	50,166	39,911	48,897	60,727	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Stock	56	55	54	53	51	50	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Surpluse	0	1,046,760	1,024,580	920,359	780,931	678,041	585,755	525,758	490,354	457,436	421,232	0	362,154	0	0	0	0	0	0	0	0	0	0	0
Cash	500,979	330,362	349,051	485,928	127,210	67,192	32,424	54,488	82,217	125,888	104,531	62,313	191,762	175,635	169,230	120,439	169,812	60,856	29,536	19,482	24,499	21,400	16,912	9,681
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash And Short Term Investments	500,979	330,362	349,051	485,928	127,210	67,192	32,424	54,488	82,217	125,888	104,531	62,313	199,869	183,709	169,230	120,439	169,812	60,856	29,536	30,599	33,524	21,485	23,839	11,967
Common Stock	56	55	54	53	51	50	48	46	45	43	41	39	38	37	36	35	35	28	26	26	24	22	22	11,728
Common Stock Shares Outstanding	45,212	45,891	47,943	43,743	42,943	40,559	38,712	36,864	36,718	36,622	35,777	34,213	34,103	33,513	32,063	33,108	33,820	28,902	25,906	27,720	25,321	21,725	10,312	1,704
Common Stock Total Equity	0	55	54	53	51	50	48	46	45	43	41	39	38	37	36	35	35	28	26	26	24	22	22	11,728
Current Deferred Revenue	132,285	118,947	112,196	100,053	90,894	81,835	86,104	87,516	53,656	53,725	42,583	41,221	33,401	28,507	14,457	12,084	11,263	7,707	14,507	13,922	12,650	11,598	32,799	3,233
Deferred Long Term Asset Charges	0	0	0	0	0	0	9,454	4,041	2,361	1,144	1,102	0	11,677	0	0	0	0	0	0	0	0	0	0	0
Deferred Long Term Liab	0	2,095	51,705	4,253	39,090	41,484	45,823	68,643	39,797	50,762	45,925	0	18,966	0	0	0	0	0	0	0	0	0	0	0
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Good Will	735,810	734,274	738,900	499,309	336,539	335,887	337,751	327,724	147,906	122,720	111,343	113,404	28,543	28,543	24,982	24,982	23,076	4,924	3,127	2,127	2,127	382	0	0
Intangible Assets	277,832	242,906	277,616	168,211	124,867	143,686	168,107	190,283	89,665	82,667	81,602	85,158	4,231	4,672	4,232	6,706	9,467	1,071	5,631	5,806	6,322	382	0	0
Inventory	110,099	147,549	119,924	96,298	108,011	100,868	96,137	69,297	46,594	31,554	31,457	26,903	18,107	9,785	9,582	12,957	13,732	15,724	13,763	14,592	8,783	12,741	12,702	10,414
Liabilities And Stockholders Equity	2,226,878	2,210,758	2,142,496	1,824,504	1,240,810	1,081,242	980,304	935,103	578,747	560,214	492,501	443,731	361,968	343,303	321,339	309,091	328,423	154,630	100,428	99,491	84,467	65,542	72,114	43,905
Long Term Debt	569,662	566,571	0	467,201	50,000	135,417	194,917	245,731	0	0	0	0	0	0	0	0	0	0	0	0	0	305	0	8,376
Long Term Debt Total	0	566,571	0	467,201	50,000	135,417	194,917	245,731	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments	42,954	32,924	18,391	22,156	19,750	17,082	15,435	20,585	14,484	10,848	11,485	0	0	0	0	0	0	0	0	0	0	0	0	0
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Debt	113,111	286,375	179,012	30,170	-26,541	68,225	177,701	199,653	-82,217	-125,888	-104,531	-62,313	-191,762	-175,635	-169,230	-120,439	-169,812	-60,856	-18,377	-16,258	-24,194	-19,898	-16,549	-1,268
Net Invested Capital	1,758,616	1,696,708	488,152	1,434,704	895,254	815,034	727,324	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Receivables	263,892	299,469	240,894	190,117	218,362	196,238	189,227	150,303	107,957	82,763	58,597	55,116	36,902	42,732	42,511	57,976	37,522	36,050	32,007	24,845	17,266	10,644	18,167	11,036
Net Tangible Assets	0	152,957	130,173	967,503	845,254	200,044	11,341	-86,400	164,817	184,711	156,052	0	250,140	0	0	0	0	0	0	0	0	0	0	0
Net Working Capital	559,779	453,366	-95,456	552,991	246,242	192,554	154,585	134,496	139,498	171,054	140,711	95,899	220,645	210,524	193,589	167,691	194,363	76,290	51,811	35,713	19,398	-28	7,811	-13,453
Non Current Assets Total	1,299,307	1,328,946	1,361,794	995,090	757,572	684,108	613,183	619,695	314,619	276,830	258,724	262,847	82,574	74,815	70,120	83,802	76,239	24,784	14,836	21,725	20,928	17,097	12,153	7,760
Non Current Liabilities Other	6,318	83,509	7,839	73,744	69,470	20,144	9,829	8,210	11,932	7,024	5,175	0	1,339	0	0	0	0	0	0	0	0	0	0	0
Non Current Liabilities Total	670,132	652,175	119,649	580,578	158,560	197,045	250,569	322,584	51,729	57,786	51,101	51,162	20,305	19,846	21,405	17,936	15,963	11,078	11,409	3,741	5,568	763	363	19,331
Non Currrent Assets Other	64,371	164,500	191,314	176,208	151,898	120,756	39,841	35,051	27,894	23,273	17,938	15,778	9,716	8,365	9,322	8,902	20,631	13,563	4,478	10,259	9,773	12,071	6,769	2,847
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	0	138,993	225,588	268,497	100,720	96,216	77,038	26,444	4,244	3,096	3,029	2,900	12,553	10,307	10,514	16,358	13,326	555	839	7,040	7,316	8,787	1,221	0
Other Current Assets	52,601	77,362	48,334	41,044	15,177	12,136	13,273	12,674	7,774	7,215	7,674	9,052	6,107	7,066	5,870	9,721	9,806	9,183	10,286	7,730	3,966	3,575	5,253	2,728
Other Current Liab	179,961	235,349	204,297	123,864	89,664	75,714	62,934	57,917	40,001	34,339	28,379	20,772	14,470	16,415	33,781	217	15,260	24,935	2,551	10,724	28,265	29,703	14,514	41,912
Other Liab	0	46,199	79,738	64,480	57,891	61,628	61,898	76,853	51,729	27,332	22,938	24,701	20,305	19,846	21,405	17,630	15,963	11,078	11,409	3,741	5,568	458	363	842
Other Stockholder Equity	831,973	756,441	786,471	682,250	595,857	492,967	400,681	340,684	305,280	322,383	310,270	292,844	284,517	277,487	259,191	250,889	284,695	162,768	138,365	134,795	126,446	119,955	46,645	2
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	72,505
Property Plant And Equipment Gross	273,021	132,013	119,690	114,187	110,376	51,500	42,595	42,011	32,309	36,178	35,254	34,107	17,306	14,351	13,209	16,180	10,184	5,226	4,727	5,660	4,833	5,026	5,384	4,913
Property Plant And Equipment Net	133,589	132,013	119,690	114,187	110,376	51,500	42,595	42,011	32,309	36,178	35,254	34,260	17,307	14,351	13,209	16,179	10,184	5,226	4,727	5,660	4,833	5,026	5,384	4,913
Property Plant Equipment	0	93,961	119,690	59,073	54,246	51,500	42,595	42,011	32,309	36,178	35,254	34,107	17,306	14,351	13,209	16,180	10,184	5,226	4,727	5,660	4,833	5,026	5,384	4,913
Retained Earnings	370,357	390,728	368,571	290,722	258,792	197,454	122,583	100,396	99,793	69,033	38,515	14,536	-1,642	-12,031	-16,923	-17,367	-30,091	-72,800	-83,165	-81,091	-91,693	-99,000	-93,962	-92,795
Retained Earnings Total Equity	0	390,728	368,571	290,722	258,792	197,454	122,583	100,396	99,793	69,033	38,515	0	-1,642	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt	0	0	488,152	0	0	0	15,208	8,410	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt Total	614,090	616,737	528,063	516,098	100,669	135,417	210,125	254,141	0	0	0	0	0	0	0	0	0	0	11,159	3,224	305	1,502	363	8,413
Short Term Debt	10,518	10,761	488,152	12,197	10,058	8,993	15,208	8,410	8,327	4,834	5,633	4,736	-122	-200	-921	35,920	21,182	12,122	12,664	12,918	305	1,197	0	37
Short Term Investments	11,867	11,486	10,665	10,246	0	0	0	0	0	0	0	0	8,107	8,074	0	0	0	0	0	11,117	9,025	85	6,927	2,286
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	2,226,878	2,210,758	2,142,496	1,824,504	1,240,810	1,081,242	980,304	935,103	578,747	560,214	492,501	443,731	361,968	343,303	321,339	309,091	328,423	154,630	100,428	99,491	84,467	65,542	72,114	43,905
Total Current Assets	927,571	881,812	780,702	829,414	483,238	397,134	367,121	315,408	264,128	283,384	233,777	180,884	279,394	268,488	251,219	225,289	252,184	129,846	85,592	77,766	63,539	48,445	59,961	36,145
Total Current Liabilities	367,792	428,446	876,158	276,423	236,996	204,580	212,536	180,912	124,630	112,330	93,066	84,985	58,749	57,964	57,630	57,598	57,821	53,556	33,781	42,053	44,141	48,473	52,150	49,598
Total Liab	1,037,924	1,080,621	995,807	857,001	395,556	401,625	463,105	503,496	176,359	170,116	144,167	136,147	79,054	77,810	79,035	75,534	73,784	64,634	45,190	45,794	49,709	49,236	52,513	68,929
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Stockholder Equity	1,188,954	1,130,137	1,146,689	967,503	845,254	679,617	517,199	431,607	402,388	390,098	348,334	307,584	282,914	265,493	242,304	233,557	254,639	89,996	55,238	53,697	34,758	16,306	19,601	-25,024
Treasury Stock	0	-290,319	-238,109	-238,109	-185,074	-185,074	-185,074	-185,074	-185,074	-135,053	-110,962	-90,000	-77,637	-65,064	-65,064	-65,064	0	0	0	0	0	0	0	0
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31
Accounts Payable	45,028	49,920	47,192	63,407	63,389	73,517	68,400	71,645	71,513	74,656	56,195	50,759	40,309	37,203	34,587	46,788	46,380	48,449	40,183	38,466	38,038	38,367	35,261	37,859	48,290	51,182	53,287	38,466	27,069	36,715	37,365	32,142	22,646	24,691	26,085	21,812	19,432	23,202	18,965	20,154	16,471	24,717	17,459	18,379	18,256	18,635	15,687	10,610	11,000	14,422	14,380	13,870	13,242	13,695	9,968	10,603	10,313	10,430	10,584	11,888	9,377	11,675	12,186	13,755	10,116	9,749	8,581	8,891	8,792	11,872	7,821	3,674	4,059	4,989	6,841	5,137	4,489	8,334	9,059	6,301	2,921	4,085	3,427	2,614	5,975	5,137	4,943	5,591	4,837	4,719	4,925	5,516	4,416
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Other Comprehensive Income	-13,432	-17,129	-14,176	-15,608	-17,087	-24,142	-17,372	-10,962	-8,407	-7,790	-5,491	-6,143	-5,522	-10,179	-13,689	-14,140	-9,446	-14,401	-11,576	-10,502	-10,854	-9,084	-7,943	-3,439	-6,113	-6,176	-7,491	-8,414	-9,519	-7,918	-7,524	-3,057	-2,730	-1,488	67	-2,238	-1,361	-48,398	-45,613	-42,905	171	-37,787	-35,392	-35,438	131	-34,792	-36,464	-35,426	1	-34,761	-33,235	-31,871	-30,341	0	0	0	-27,005	0	0	0	-20,777	218,573	207,986	225,497	-22,362	230,288	215,053	100,735	-20,158	79,709	71,156	60,407	12	138,161	136,898	135,874	-33	50,933	44,877	41,872	-19	28,781	20,450	17,175	-4,671	-10,084	24,158	-5,073	-5,218	-5,435	-5,642	-6,060	0
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	44,428	32,845	35,510	36,855	50,166	52,520	43,371	37,273	39,911	40,436	42,512	45,435	48,897	54,998	57,153	58,837	60,727	63,019	65,523	67,843	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Stock	56	56	56	55	55	55	55	54	54	54	53	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Surpluse	0	0	1,088,825	1,072,685	1,046,760	1,030,665	997,911	982,675	1,024,580	1,002,591	970,846	950,361	920,359	892,290	820,632	807,823	780,931	770,260	753,127	725,273	678,041	630,687	612,576	600,525	585,755	565,406	549,958	541,159	525,758	520,272	507,496	499,176	490,354	485,919	475,209	476,405	457,436	0	0	0	421,232	0	0	0	382,844	0	0	0	362,154	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash	500,979	446,840	399,464	340,413	330,362	266,402	244,953	265,008	349,051	481,549	614,236	548,055	485,928	629,171	133,583	104,080	127,210	137,277	87,482	77,244	67,192	44,174	46,168	43,773	32,424	7,466	26,936	46,348	54,488	47,287	41,029	53,487	82,217	57,757	88,028	139,553	125,888	104,187	126,379	107,558	104,531	116,190	87,334	69,817	62,313	54,818	54,071	201,420	191,762	179,303	181,258	173,669	175,635	178,625	185,156	180,611	169,230	146,312	126,426	118,853	120,439	125,032	122,783	142,578	169,812	175,748	172,137	64,669	60,856	50,081	43,767	33,853	29,536	29,500	24,259	15,251	19,482	21,373	20,171	25,196	24,499	26,822	26,031	23,063	21,400	21,178	14,146	12,966	16,912	24,619	2,402	2,309	9,681
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash And Short Term Investments	500,979	446,840	399,464	340,413	330,362	266,402	244,953	265,008	349,051	481,549	614,236	548,055	485,928	629,171	133,583	104,080	127,210	137,277	87,482	77,244	67,192	44,174	46,168	43,773	32,424	7,466	26,936	46,348	54,488	47,287	41,029	53,487	82,217	57,757	88,028	139,553	125,888	104,187	126,379	107,558	104,531	116,190	87,334	69,817	62,313	54,818	54,071	209,537	199,869	187,404	181,258	181,778	183,709	178,625	185,156	180,611	169,230	146,312	126,426	118,853	120,439	125,032	122,783	142,578	169,812	175,748	172,137	64,669	60,856	50,081	43,767	33,853	29,536	31,508	27,972	26,298	30,599	32,583	36,348	36,211	33,524	30,896	28,012	23,148	21,485	21,277	21,296	21,906	23,839	24,819	4,732	7,698	0
Common Stock	56	56	56	55	55	55	55	54	54	54	53	53	53	52	52	52	51	51	51	50	50	49	48	48	48	47	46	46	46	46	45	45	45	45	44	44	43	0	0	0	41	0	0	0	39	0	0	0	38	0	0	0	37	0	0	0	36	0	0	0	35	0	0	0	35	0	0	0	28	0	0	0	26	0	0	0	26	0	0	0	24	0	0	0	22	0	0	22	22	118,171	12,293	11,920	5,375
Common Stock Shares Outstanding	45,495	45,595	45,472	44,887	44,678	45,819	46,260	47,918	49,849	48,341	47,106	46,367	44,001	43,691	42,659	43,621	43,327	43,052	42,945	42,281	41,465	40,860	40,000	39,691	39,482	38,973	38,370	36,840	37,256	37,079	35,987	35,740	36,172	36,613	37,030	36,914	36,585	36,832	36,618	36,305	36,610	36,190	35,374	34,820	34,128	34,068	34,316	34,341	34,114	34,219	33,981	34,098	33,513	33,540	33,452	33,153	32,063	32,380	31,961	31,453	33,108	32,138	32,549	35,582	33,820	35,833	32,830	30,568	28,902	29,450	28,508	27,795	25,906	27,297	26,743	25,490	27,720	27,571	27,709	28,145	25,321	26,658	24,646	22,783	23,248	21,830	23,203	22,964	10,312	20,052	2,825	2,741	0
Common Stock Total Equity	0	0	56	55	55	55	55	54	54	54	53	53	53	52	52	52	51	51	51	50	50	49	48	48	48	47	46	46	46	46	45	45	45	45	44	44	43	0	0	41	41	0	0	39	39	0	0	38	38	0	0	37	37	0	0	0	36	0	0	0	35	0	0	35	35	0	0	28	28	0	0	26	26	0	0	26	26	0	0	24	24	0	0	22	22	0	0	22	22	118,171	12,293	11,920	0
Current Deferred Revenue	132,285	124,991	124,602	143,298	118,947	113,925	108,579	127,998	112,196	114,726	121,305	119,588	100,053	101,641	107,940	108,602	90,894	88,205	83,012	90,104	81,835	87,777	85,776	95,709	86,104	80,837	85,370	98,492	87,516	93,120	84,852	92,273	53,656	53,347	60,198	47,635	53,725	58,214	52,465	46,434	42,583	47,453	45,784	47,759	41,221	39,581	34,269	35,712	33,401	31,798	30,017	29,533	28,507	28,402	14,777	14,934	14,457	14,359	12,830	12,291	12,131	12,418	12,243	12,540	11,263	25,606	26,187	7,990	7,707	21,841	7,360	6,951	14,507	16,625	15,708	15,173	13,922	14,861	14,983	13,055	12,650	12,931	12,563	12,574	11,598	11,651	9,844	9,098	32,799	6,431	5,097	3,406	0
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9,454	5,629	5,627	5,624	4,041	2,955	2,920	2,638	2,361	1,513	1,397	1,330	1,144	975	1,102	1,164	1,102	1,293	985	1,126	993	0	0	11,801	11,677	9,836	10,057	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Long Term Liab	0	0	1,511	1,558	2,095	16,140	23,906	28,173	51,705	53,313	3,704	39,128	4,253	35,584	29,561	37,810	39,090	60,917	61,292	61,405	41,484	32,593	34,788	36,320	45,823	56,903	55,282	58,496	68,643	78,676	79,904	82,784	39,797	50,756	51,779	50,840	50,762	50,839	50,332	47,699	45,925	43,710	44,823	45,011	46,383	41,224	40,595	19,003	18,966	18,447	18,855	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Good Will	735,810	734,328	735,523	734,895	734,274	731,294	734,487	740,426	738,900	616,387	499,266	499,065	499,309	336,456	335,034	334,842	336,539	334,516	335,699	336,119	335,887	336,517	336,550	338,948	337,751	334,780	332,996	328,216	327,724	311,420	311,170	312,511	147,906	148,727	149,654	122,216	122,720	123,090	111,343	111,343	111,343	111,343	111,343	111,343	113,404	112,683	112,083	28,543	28,543	28,543	28,543	28,543	28,543	28,651	24,982	24,982	24,982	24,982	24,982	24,982	24,982	24,310	24,309	23,164	23,076	3,127	4,663	4,843	4,924	3,127	3,127	3,127	3,127	2,450	2,450	2,450	2,127	2,127	2,127	2,127	2,127	1,627	0	0	382	0	0	0	0	0	0	0	0
Intangible Assets	277,832	218,861	226,707	234,689	242,906	251,004	260,159	269,427	277,616	218,956	155,775	161,816	168,211	111,587	115,710	120,063	124,867	129,163	134,101	138,893	143,686	149,968	155,750	162,458	168,107	174,227	180,206	219,518	190,283	187,571	196,475	206,261	89,665	92,042	94,285	81,279	82,667	84,075	79,561	80,573	81,602	82,530	83,468	84,529	85,158	86,234	87,242	4,157	4,231	4,318	4,414	4,533	4,672	5,164	3,270	3,784	4,233	4,847	5,362	6,142	6,706	7,480	8,034	8,732	9,467	1,974	771	921	1,071	1,672	1,917	2,210	5,631	5,248	5,542	5,835	5,806	6,130	6,426	6,721	6,322	5,933	0	0	382	0	0	0	0	0	0	0	0
Inventory	110,099	116,144	130,577	141,156	147,549	147,096	150,461	137,056	119,924	104,259	101,185	96,208	96,298	103,101	114,245	112,785	108,011	105,813	103,906	103,909	100,868	99,231	103,732	101,868	96,137	92,239	81,523	76,230	69,297	74,125	73,720	71,914	46,594	49,460	46,027	33,190	31,554	31,847	31,542	30,975	31,457	30,705	26,360	26,125	26,903	26,400	25,170	16,993	18,107	17,056	17,382	15,399	9,785	9,345	9,735	10,147	10,502	10,445	9,624	10,834	12,957	13,856	15,533	15,216	13,732	12,665	14,124	16,161	15,724	21,883	14,468	12,165	13,763	14,934	15,961	15,291	14,592	17,197	12,996	10,059	8,783	8,634	8,673	10,345	12,741	12,602	13,140	14,223	12,702	13,825	13,634	12,465	10,414
Liabilities And Stockholders Equity	2,226,878	2,221,575	2,193,872	2,250,838	2,210,758	2,179,685	2,131,458	2,122,588	2,142,496	2,051,471	1,960,994	1,886,623	1,824,504	1,719,277	1,222,446	1,231,647	1,240,810	1,244,270	1,196,978	1,177,060	1,081,242	1,052,375	1,026,475	1,040,955	980,304	923,818	909,901	909,763	935,103	931,415	913,428	923,772	578,747	576,722	601,022	570,926	560,214	547,313	537,251	510,405	492,501	505,165	472,128	457,357	443,731	422,002	416,250	373,928	361,968	358,510	349,453	345,412	343,224	339,737	333,494	331,695	322,260	323,036	314,606	307,117	308,542	293,510	284,065	307,720	328,423	294,914	277,672	157,920	154,630	138,504	122,750	106,800	100,428	103,655	94,592	94,788	99,491	98,705	95,055	91,059	84,467	71,147	65,016	61,418	65,542	70,126	69,468	67,945	72,114	70,330	47,454	47,038	0
Long Term Debt	569,662	568,887	568,114	567,342	566,571	565,803	565,035	0	0	482,822	477,554	472,347	467,201	462,115	0	0	50,000	77,135	76,562	96,990	135,417	167,135	181,062	190,490	194,917	178,923	183,526	206,128	245,731	214,834	216,936	219,046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	305	608	0	0	0	0	6,384	7,375	8,376
Long Term Debt Total	0	0	568,114	567,342	566,571	565,803	565,035	0	0	482,822	477,554	472,347	467,201	462,115	0	0	50,000	77,135	76,562	96,990	135,417	167,135	181,062	190,490	194,917	178,923	183,526	206,128	245,731	214,834	216,936	219,046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments	42,954	41,631	35,039	32,744	32,924	33,807	29,209	19,051	18,391	19,187	19,615	21,255	22,156	22,510	20,961	19,992	19,750	21,494	21,041	19,469	17,082	17,448	16,707	16,444	15,435	15,986	17,424	19,174	20,585	18,756	19,711	21,037	14,484	13,557	10,208	10,443	10,848	10,823	10,872	11,644	11,485	12,398	13,222	12,943	13,228	10,628	9,826	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Debt	113,111	154,892	204,160	263,784	286,375	351,921	375,337	336,534	179,012	41,709	-94,170	-30,273	30,170	-122,691	-86,893	-55,229	-26,541	-7,404	44,317	77,216	68,225	140,669	152,602	164,425	177,701	184,867	167,500	168,190	199,653	175,957	184,317	173,969	-82,217	-57,757	-88,028	-139,553	-125,888	-104,187	-126,379	-107,558	-104,531	-116,190	-87,334	-69,817	-62,313	-54,818	-54,071	-201,420	-191,762	-179,303	-181,258	-173,669	-175,635	-178,625	-185,156	-180,611	-169,230	-146,312	-126,426	-118,853	-120,439	-125,032	-122,783	-142,578	-169,812	-175,748	-172,137	-64,669	-60,856	-48,950	-42,935	-30,171	-18,377	-27,849	-22,025	-12,399	-16,258	-18,126	-16,364	-20,844	-24,194	-26,214	-25,123	-21,859	-19,898	-19,381	-14,146	-12,966	-16,549	-24,619	8,993	6,092	0
Net Invested Capital	1,758,616	568,887	568,114	567,342	1,696,708	1,701,198	565,035	564,269	488,152	482,822	477,554	472,347	1,434,704	1,380,514	887,461	878,500	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Receivables	263,892	272,584	273,899	322,073	299,469	354,098	310,520	290,469	240,894	233,729	209,953	205,658	190,117	188,102	188,918	233,068	218,362	203,391	205,353	203,489	196,238	206,225	174,570	190,678	189,227	171,869	151,010	131,433	150,303	177,019	159,453	153,199	107,957	115,680	117,307	88,107	82,763	95,167	82,560	75,496	58,597	63,999	63,840	65,703	55,116	53,109	46,390	38,973	36,902	45,987	43,105	39,795	42,732	45,070	37,986	39,879	40,826	58,779	67,655	60,779	57,976	47,391	40,784	44,818	37,522	46,927	36,799	37,741	36,050	33,684	31,830	31,155	32,007	33,191	22,432	25,578	24,845	20,157	17,155	16,336	17,266	11,279	11,289	9,878	10,644	14,712	18,518	14,675	18,167	16,552	14,902	15,366	0
Net Tangible Assets	0	0	201,335	172,957	152,957	153,097	97,991	64,888	130,173	275,993	397,531	1,011,011	967,503	918,399	887,461	878,500	845,254	343,854	303,442	255,473	200,044	132,754	96,340	73,096	11,341	-36,510	-63,700	-73,400	-86,400	-71,426	-94,446	-108,267	164,817	150,771	155,409	201,955	184,711	171,736	186,717	173,260	156,052	163,913	138,920	125,921	110,593	97,596	87,244	258,190	250,140	245,114	238,273	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Working Capital	559,779	544,390	511,204	481,001	453,366	472,451	414,256	-175,408	-95,456	550,054	667,176	611,726	552,991	729,528	228,602	229,883	246,242	248,909	218,455	203,085	192,554	166,537	157,224	150,804	154,585	109,511	84,269	96,899	134,496	138,896	120,601	110,662	139,498	137,242	147,049	187,698	171,054	156,808	172,602	158,742	140,711	148,794	124,686	111,475	95,899	87,966	82,366	229,503	220,645	219,586	212,562	209,618	210,339	208,337	206,255	200,628	192,193	185,297	176,745	170,585	167,632	159,351	149,680	167,742	194,363	208,745	195,653	87,102	76,290	70,413	63,083	52,843	51,811	39,076	35,010	31,555	35,713	33,021	26,216	23,205	19,398	13,104	7,313	2,742	-28	5,578	12,135	10,057	7,811	7,177	-20,816	-16,870	0
Non Current Assets Total	1,299,307	1,307,824	1,312,511	1,315,869	1,328,946	1,330,553	1,343,688	1,346,984	1,361,794	1,162,755	976,706	982,624	995,090	755,873	757,281	753,324	757,572	767,191	767,139	763,353	684,108	673,256	667,617	668,724	613,183	608,437	613,920	615,384	619,695	594,348	601,512	613,464	314,619	316,836	315,698	274,604	276,830	278,945	261,355	259,563	258,724	258,125	258,907	260,271	262,847	255,484	260,649	82,123	82,574	77,850	78,148	77,275	74,721	73,656	70,500	71,734	71,516	77,095	79,203	81,705	83,555	76,634	75,695	74,963	76,239	36,546	33,180	26,187	24,784	20,902	19,593	18,993	14,836	15,584	17,555	20,538	21,725	21,702	23,025	23,576	20,928	16,135	13,595	14,891	17,097	16,912	12,169	12,300	12,153	10,898	11,226	8,812	0
Non Current Liabilities Other	6,318	6,428	6,265	6,136	83,509	85,666	8,808	7,352	7,839	10,761	18,743	71,864	73,744	69,303	68,861	66,897	69,470	70,515	74,498	77,558	20,144	20,826	20,351	18,216	9,829	9,625	9,879	8,716	8,210	12,173	12,074	11,771	11,932	11,782	11,620	6,012	7,024	6,013	6,004	5,430	5,175	5,423	5,039	4,942	4,809	5,713	3,277	1,733	1,339	1,014	625	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Current Liabilities Total	670,132	664,778	660,150	654,329	652,175	667,609	665,307	96,835	119,649	601,473	591,310	583,339	580,578	567,002	98,422	104,707	158,560	208,567	212,352	235,953	197,045	220,554	236,201	245,026	250,569	245,451	248,687	273,340	322,584	305,679	308,914	313,621	51,729	62,538	63,399	56,852	57,786	56,852	56,336	53,129	51,101	49,133	49,862	49,953	51,162	46,937	55,495	20,736	20,305	19,461	19,480	19,547	19,846	20,055	20,313	21,754	21,405	17,933	16,747	16,394	17,630	17,412	17,389	17,208	15,963	15,003	13,780	12,554	11,078	11,606	11,520	11,429	11,409	1,901	2,484	3,102	3,741	3,790	4,364	4,909	5,568	458	458	458	763	723	146	320	363	699	17,221	18,330	0
Non Currrent Assets Other	64,371	144,716	151,568	157,378	164,500	165,340	175,625	181,760	191,314	178,431	174,809	172,652	176,208	162,361	161,019	156,912	151,898	137,493	130,774	120,939	120,756	109,389	98,275	93,128	39,841	37,596	36,954	1,856	35,051	32,612	30,733	28,809	27,894	26,971	25,382	24,963	23,273	22,294	21,220	19,661	17,938	17,069	15,775	15,633	15,778	2,557	9,959	9,149	9,716	9,442	9,901	9,501	8,365	8,610	9,125	9,331	9,322	8,938	14,660	9,207	8,902	20,182	20,447	21,402	20,631	18,690	17,704	15,296	13,563	11,361	10,155	9,151	4,478	5,342	7,004	9,281	10,259	9,808	11,288	11,255	9,773	5,768	9,392	10,188	12,071	11,850	7,022	6,952	6,769	5,770	5,988	3,831	0
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	0	0	0	219,684	138,993	215,766	220,968	216,865	225,588	213,484	209,983	209,283	268,497	105,927	101,968	100,651	100,720	111,185	76,905	107,769	96,216	84,199	78,292	620,434	570,588	568,218	573,207	574,388	577,684	553,314	561,009	571,256	282,310	282,810	280,926	240,231	240,652	241,257	224,098	224,385	223,469	224,633	224,793	225,574	226,956	223,299	220,061	65,011	62,952	60,960	61,828	61,931	60,370	59,858	57,319	58,156	58,307	63,967	64,877	65,776	67,375	61,966	63,063	63,673	66,055	28,601	27,934	21,060	19,558	16,160	15,199	14,488	10,109	10,590	12,546	15,116	16,065	15,938	17,714	17,976	16,095	11,701	9,392	10,188	12,071	11,850	7,022	6,952	6,769	5,770	5,988	3,831	2,847
Other Current Assets	52,601	50,236	53,907	103,364	77,362	56,674	60,980	58,843	48,334	44,417	41,472	36,956	41,044	22,631	15,122	14,235	15,177	11,870	13,419	12,017	12,136	9,871	16,122	14,751	13,273	15,763	10,511	12,593	12,674	9,016	9,024	9,853	7,774	6,802	6,071	6,217	7,215	6,262	6,040	7,799	7,674	8,052	7,899	7,532	9,052	7,046	7,164	6,046	6,107	6,518	5,940	6,337	7,266	6,596	6,456	5,711	6,159	6,083	7,040	10,636	9,434	8,921	9,536	9,825	9,806	5,782	5,746	5,973	9,183	11,954	13,092	10,634	10,286	8,438	2,987	7,083	7,730	7,066	5,531	4,877	3,966	4,203	3,447	3,156	3,575	4,623	4,345	4,841	5,253	4,236	2,960	2,697	2,728
Other Current Liab	179,961	183,833	187,412	236,388	235,349	178,581	184,651	187,100	204,297	136,271	127,242	109,690	123,864	84,399	83,573	83,064	89,664	81,235	77,903	71,679	75,714	68,730	62,889	70,151	62,934	60,441	62,145	52,112	57,917	59,926	60,688	66,821	40,001	37,039	44,152	34,352	34,339	26,395	28,208	21,734	28,379	22,623	21,606	16,918	20,772	17,335	2,736	1,807	14,470	14,854	14,346	15,116	16,415	15,647	19,140	33,796	33,781	35,855	87	129	170	14,731	14,432	20,390	15,260	1,460	1,077	17,428	24,935	1,019	13,114	22,164	2,551	15,166	10,182	10,640	10,724	10,960	13,621	11,187	28,265	24,284	27,210	27,393	29,703	29,659	19,418	18,875	14,514	25,798	42,011	45,148	45,145
Other Liab	0	0	0	50,132	46,199	59,944	56,901	59,562	79,738	78,215	71,244	65,557	64,480	60,522	51,732	55,856	57,891	78,694	80,553	81,493	61,628	53,419	55,139	18,216	27,073	26,001	26,211	24,710	25,261	29,269	29,547	29,591	29,907	30,218	30,676	25,853	27,332	26,381	27,313	25,203	22,938	23,080	23,637	24,405	24,701	25,362	21,748	20,736	20,305	19,461	19,480	19,547	19,846	20,055	20,313	21,754	21,405	17,405	16,747	16,394	17,630	17,412	17,389	17,208	15,963	15,003	13,780	12,554	11,078	11,606	11,520	11,429	11,409	1,901	2,484	3,102	3,741	3,790	4,364	4,909	5,568	458	458	458	458	115	146	320	363	699	724	842	842
Other Stockholder Equity	831,973	819,777	798,506	782,366	756,441	740,346	707,592	692,356	786,471	764,482	732,737	712,252	682,250	654,181	635,558	622,749	595,857	585,186	568,053	540,199	492,967	445,613	427,502	415,451	400,681	380,332	364,884	356,085	340,684	335,198	322,422	314,102	305,280	300,845	315,135	341,352	322,383	378,901	377,621	365,176	310,270	357,786	333,731	321,793	292,844	296,513	287,520	290,890	284,517	277,975	271,230	267,346	277,208	261,938	256,442	250,608	259,191	244,459	239,201	235,896	250,889	240,935	230,348	247,859	284,695	250,446	235,211	120,893	162,768	97,553	89,000	78,251	138,365	153,031	151,768	150,744	134,795	65,826	59,770	56,765	126,446	40,847	32,516	29,241	119,955	21,767	34,242	119,400	46,645	-70,330	62,392	62,392	0
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	72,505	72,505	72,505
Property Plant And Equipment Gross	273,021	132,324	130,910	126,601	132,013	132,489	0	0	0	0	111,682	112,460	114,187	107,974	110,403	107,373	110,376	113,918	114,329	115,890	51,500	50,484	50,884	48,290	42,595	40,219	40,713	40,996	42,011	41,034	40,503	42,208	32,309	34,026	34,772	34,373	36,178	37,688	37,257	35,178	35,254	33,492	34,114	34,697	34,107	32,185	28,965	17,112	17,306	16,890	16,320	15,344	14,351	13,512	13,729	13,578	13,209	13,128	14,326	15,929	16,180	14,668	12,632	11,290	10,184	7,945	5,246	5,127	5,226	4,742	4,394	4,505	4,727	4,994	5,009	5,422	5,660	5,764	5,311	5,600	4,833	4,434	4,203	4,703	5,026	5,062	5,147	5,348	5,384	5,128	5,238	4,981	0
Property Plant And Equipment Net	133,589	132,324	130,910	126,601	132,013	132,489	128,074	120,266	119,690	113,928	111,682	112,460	114,187	107,974	110,403	107,373	110,376	113,918	114,329	115,890	51,500	50,484	50,884	48,290	42,595	40,219	40,713	40,996	42,011	41,034	40,503	42,208	32,309	34,026	34,772	34,373	36,178	37,688	37,257	35,178	35,254	33,492	34,114	34,697	34,260	32,185	28,965	17,112	17,307	16,890	16,320	15,344	14,351	13,512	13,729	13,578	13,209	13,128	14,326	15,929	16,180	14,668	12,632	11,290	10,184	7,945	5,246	5,127	5,226	4,742	4,394	4,505	4,727	4,994	5,009	5,422	5,660	5,764	5,311	5,600	4,833	4,434	4,203	4,703	5,026	5,062	5,147	5,348	5,384	5,128	5,238	4,981	0
Property Plant Equipment	0	0	103,212	98,373	93,961	132,489	128,074	120,266	119,690	113,928	111,682	60,538	59,073	57,559	57,866	52,997	54,246	54,877	52,847	52,039	51,500	50,484	50,884	48,290	42,595	40,219	40,713	40,996	42,011	41,034	40,503	42,208	32,309	34,026	34,772	34,373	36,178	37,688	37,257	35,178	35,254	33,492	34,114	34,697	34,107	32,185	28,965	17,112	17,306	16,890	16,320	15,344	14,351	13,512	13,729	13,578	13,209	13,128	14,326	15,929	16,180	14,668	12,632	11,290	10,184	7,945	5,246	5,127	5,226	4,742	4,394	4,505	4,727	4,994	5,009	5,422	5,660	5,764	5,311	5,600	4,833	4,434	4,203	4,703	5,026	5,062	5,147	5,348	5,384	5,128	5,238	4,981	4,913
Retained Earnings	370,357	384,732	379,179	375,728	390,728	419,136	402,362	393,293	368,571	354,590	325,273	304,849	290,722	274,345	265,540	269,839	258,792	236,697	216,714	200,738	197,454	182,661	169,033	162,442	122,583	98,294	92,063	91,226	100,396	100,239	98,256	99,415	99,793	92,138	84,102	66,292	69,033	0	0	38,515	38,515	0	0	14,536	14,536	0	0	-1,642	-1,642	0	0	-12,031	-12,031	0	0	0	-16,923	0	0	0	-17,367	0	0	-30,091	-30,091	0	0	-72,800	-72,800	0	0	-83,165	-83,165	-85,402	-86,817	-86,883	-81,091	0	0	-91,693	-91,693	0	0	-99,000	-99,000	0	0	-92,312	-93,962	-95,360	-95,854	-94,640	0
Retained Earnings Total Equity	0	0	379,179	375,728	390,728	419,136	402,362	393,293	368,571	354,590	325,273	304,849	290,722	274,345	265,540	269,839	258,792	236,697	216,714	200,738	197,454	182,661	169,033	162,442	122,583	98,294	92,063	91,226	100,396	100,239	98,256	99,415	99,793	92,138	84,102	66,292	69,033	0	0	0	38,515	0	0	0	14,536	0	0	0	-1,642	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt	0	0	0	0	0	0	0	564,269	488,152	0	0	0	0	0	0	0	0	0	0	10,373	0	17,708	17,708	17,708	15,208	13,410	10,910	8,410	8,410	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt Total	614,090	601,732	603,624	604,197	616,737	618,323	620,290	601,542	528,063	523,258	520,066	517,782	516,098	506,480	46,690	48,851	100,669	129,873	131,799	154,460	135,417	184,843	198,770	208,198	210,125	192,333	194,436	214,538	254,141	223,244	225,346	227,456	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,131	832	3,682	11,159	1,651	2,234	2,852	3,224	3,247	3,807	4,352	305	608	908	1,204	1,502	1,797	0	7,290	363	0	11,395	8,401	0
Short Term Debt	10,518	10,617	10,951	10,875	10,761	10,658	11,884	564,269	488,152	13,009	12,370	12,236	12,197	10,633	10,463	9,986	10,058	10,281	10,286	10,373	8,993	17,708	17,708	17,708	15,208	13,410	10,910	8,410	8,410	8,410	8,410	8,410	8,327	7,567	7,840	4,825	4,834	3,749	3,656	3,778	5,633	3,453	3,686	2,555	4,736	3,001	20,543	14,173	-122	0	0	0	0	0	12,854	0	0	0	35,157	30,519	35,677	18,701	19,829	18,330	21,182	12,808	12,994	10,322	12,122	12,457	11,779	2,175	12,664	12,215	9,296	11,745	12,918	9,827	8,151	13,735	305	608	908	1,204	1,197	1,189	10,959	12,024	0	15,307	5,011	1,026	0
Short Term Investments	11,867	11,618	11,078	11,053	11,486	12,586	12,312	11,103	10,665	10,529	10,364	10,222	10,246	22,510	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8,117	8,107	8,101	0	8,109	8,074	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2,008	3,713	11,047	11,117	11,210	16,177	11,015	9,025	4,074	1,981	85	85	99	7,150	8,940	6,927	200	2,330	5,389	2,286
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	2,226,878	2,221,575	2,193,872	2,250,838	2,210,758	2,179,685	2,131,458	2,122,588	2,142,496	2,051,471	1,960,994	1,886,623	1,824,504	1,719,277	1,222,446	1,231,647	1,240,810	1,244,270	1,196,978	1,177,060	1,081,242	1,052,375	1,026,475	1,040,955	980,304	923,818	909,901	909,763	935,103	931,415	913,428	923,772	578,747	576,722	601,022	570,926	560,214	547,313	537,251	510,405	492,501	505,165	472,128	457,357	443,731	422,002	416,250	373,928	361,968	358,510	349,453	345,412	343,224	339,737	333,494	331,695	322,260	323,036	314,606	307,117	308,542	293,510	284,065	307,720	328,423	294,914	277,672	157,920	154,630	138,504	122,750	106,800	100,428	103,655	94,592	94,788	99,491	98,705	95,055	91,059	84,467	71,147	65,016	61,418	65,542	70,126	69,468	67,945	72,114	70,330	47,454	47,038	43,905
Total Current Assets	927,571	913,751	881,361	934,969	881,812	849,132	787,770	775,604	780,702	888,716	984,288	903,999	829,414	963,404	465,165	478,323	483,238	477,079	429,839	413,707	397,134	379,119	358,858	372,231	367,121	315,381	295,981	294,379	315,408	337,067	311,916	310,308	264,128	259,886	285,324	296,322	283,384	268,368	275,896	250,842	233,777	247,040	213,221	197,086	180,884	166,518	155,601	291,805	279,394	280,660	271,305	268,137	268,503	266,081	262,994	259,961	250,744	245,941	235,403	225,412	224,987	216,876	208,370	232,757	252,184	258,368	244,492	131,733	129,846	117,602	103,157	87,807	85,592	88,071	77,037	74,250	77,766	77,003	72,030	67,483	63,539	55,012	51,421	46,527	48,445	53,214	57,299	55,645	59,961	59,432	36,228	38,226	0
Total Current Liabilities	367,792	369,361	370,157	453,968	428,446	376,681	373,514	951,012	876,158	338,662	317,112	292,273	276,423	233,876	236,563	248,440	236,996	228,170	211,384	210,622	204,580	212,582	201,634	221,427	212,536	205,870	211,712	197,480	180,912	198,171	191,315	199,646	124,630	122,644	138,275	108,624	112,330	111,560	103,294	92,100	93,066	98,246	88,535	85,611	84,985	78,552	73,235	62,302	58,749	61,074	58,743	58,519	58,164	57,744	56,739	59,333	58,551	60,644	58,658	54,827	57,355	57,525	58,690	65,015	57,821	49,623	48,839	44,631	53,556	47,189	40,074	34,964	33,781	48,995	42,027	42,695	42,053	43,982	45,814	44,278	44,141	41,908	44,108	43,785	48,473	47,636	45,164	45,588	52,150	52,255	57,044	55,096	49,598
Total Liab	1,037,924	1,034,139	1,030,307	1,108,297	1,080,621	1,044,290	1,038,821	1,047,847	995,807	940,135	908,422	875,612	857,001	800,878	334,985	353,147	395,556	436,737	423,736	446,575	401,625	433,136	437,835	466,453	463,105	451,321	460,399	470,820	503,496	503,850	500,229	513,267	176,359	185,182	201,674	165,476	170,116	168,412	159,630	145,229	144,167	147,379	138,397	135,564	136,147	125,489	128,730	83,038	79,054	80,535	78,223	78,066	78,010	77,799	77,052	81,087	79,956	78,577	75,405	71,221	74,985	74,937	76,079	82,223	73,784	64,626	62,619	57,185	64,634	58,795	51,594	46,393	45,190	50,896	44,511	45,797	45,794	47,772	50,178	49,187	49,709	42,366	44,566	44,243	49,236	48,359	45,310	45,908	52,513	52,954	74,265	73,426	58,816
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Stockholder Equity	1,188,954	1,187,436	1,163,565	1,142,541	1,130,137	1,135,395	1,092,637	1,074,741	1,146,689	1,111,336	1,052,572	1,011,011	967,503	918,399	887,461	878,500	845,254	807,533	773,242	730,485	679,617	619,239	588,640	574,502	517,199	472,497	449,502	438,943	431,607	427,565	413,199	410,505	402,388	391,540	399,348	405,450	390,098	378,901	377,621	365,176	348,334	357,786	333,731	321,793	307,584	296,513	287,520	290,890	282,914	277,975	271,230	267,346	265,214	261,938	256,442	250,608	242,304	244,459	239,201	235,896	233,557	218,573	207,986	225,497	254,639	230,288	215,053	100,735	89,996	79,709	71,156	60,407	55,238	52,759	50,081	48,991	53,697	50,933	44,877	41,872	34,758	28,781	20,450	17,175	16,306	21,767	24,158	22,037	19,601	17,376	-26,811	-26,388	0
Treasury Stock	0	0	-290,319	-290,319	-290,319	-290,319	-290,319	-290,319	-238,109	-238,109	-238,109	-238,109	-238,109	-238,109	-185,074	-185,074	-185,074	-185,074	-185,074	-185,074	-185,074	-185,074	-185,074	-185,074	-185,074	-185,074	-185,074	-185,074	-185,074	-185,074	-185,074	-185,074	-185,074	-185,074	-160,074	-135,053	-135,053	0	0	0	-110,962	0	0	0	-90,000	0	0	0	-77,637	0	0	0	-65,064	0	0	0	-65,064	0	0	0	-65,064	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flow

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31
Begin Period Cash Flow	352,835	355,620	489,920	127,210	67,192	32,424	54,488	82,217	125,888	104,531	62,313	191,762	175,635	169,230	120,439	169,812	60,856	29,536	19,482	24,499	21,400	16,912	9,681	2,546
Capital Expenditures	55,016	60,740	58,335	54,866	61,664	54,374	30,541	29,165	20,089	22,602	20,452	20,602	13,112	7,088	3,756	12,330	6,968	3,786	2,098	3,781	2,659	2,073	2,947	511
Cash And Cash Equivalents Changes	0	-1,841	-134,300	362,710	60,018	34,768	-22,064	-27,729	-43,671	21,357	42,218	-129,449	16,127	0	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	0	44,611	10,606	-15,616	8,675	-7,906	-9,575	-1,668	3,634	4,655	21,869	15,425	17,686	0	0	0	0	0	0	0	0	0	0	0
Change In Cash	148,144	-2,785	-134,300	362,710	60,018	34,768	-22,064	-27,729	-43,671	21,357	42,218	-129,449	16,127	6,405	48,791	-49,373	108,956	31,320	10,054	-5,017	3,099	4,488	7,231	7,135
Change In Working Capital	43,673	-73,466	-3,340	37,300	-15,810	-10,718	-44,408	-20,410	-33,795	-1,350	-992	-2,338	2,438	-1,603	24,711	-21,336	-4,381	-7,085	-6,979	-18,299	-3,907	-112	-13,266	-2,884
Change Receivables	0	-75,711	-37,627	33,960	-25,239	-7,872	-32,443	-1,592	-22,956	-21,751	-1,886	-13,465	6,899	0	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	38,739	-60,357	-43,220	12,026	-23,520	-6,192	-39,068	8,047	-18,295	-22,799	-3,609	-9,311	5,863	-1,317	17,190	-21,866	-2,102	-7,645	-7,489	-7,438	-3,885	7,710	-1,351	0
Change To Inventory	38,016	-30,115	-25,695	12,359	-8,123	-6,763	-26,840	-3,362	-10,401	1,418	-5,410	2,536	-9,434	77	-693	174	2,004	-4,336	-1,761	-6,171	3,423	-2,635	-2,288	-1,090
Change To Liabilities	0	10,644	53,263	17,125	19,439	11,823	24,461	-12,086	-2,980	14,328	8,414	11,871	1,273	199	1,782	0	0	5,189	0	0	2,355	0	0	948
Change To Netincome	0	31,609	50,321	38,418	33,155	23,313	-4,475	6,090	10,066	15,723	13,911	9,792	6,836	0	0	0	0	0	0	0	0	0	0	0
Change To Operating Activities	0	291	10,065	-13,221	515	8,371	263	-35,004	3,263	4,733	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	95,558	99,169	84,931	71,595	64,121	51,350	51,511	58,362	25,639	20,272	18,365	13,325	7,983	8,619	9,428	8,954	4,602	3,717	4,199	4,085	3,504	3,022	3,723	3,655
Dividends Paid	4,399	0	0	105,560	9,670	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
End Period Cash Flow	500,979	352,835	355,620	489,920	127,210	67,192	32,424	54,488	82,217	125,888	104,531	62,313	191,762	175,635	169,230	120,439	169,812	60,856	29,536	19,482	24,499	21,400	16,912	9,681
Exchange Rate Changes	0	0	-974	437	153	-1,227	-2,034	-58	-4	-275	33	10	-210	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	126,078	17,041	173,474	131,004	83,344	49,592	-5,707	18,772	13,673	42,561	34,811	18,882	18,131	13,511	39,374	7,205	30,259	15,721	-4,356	-8,083	5,022	-890	-13,657	-19,619
Investments	-59,896	-58,669	-412,498	-279,866	-61,664	-54,374	-34,987	-341,323	0	0	0	8,122	46	0	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	0	0	0	0	37,806	39,567	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	0	0	408,490	-92,321	-77,000	-45,606	252,551	252,551	252,551	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	-20,371	5,648	77,849	32,194	61,338	37,729	20,605	603	30,760	30,518	23,979	16,178	10,389	4,892	444	12,724	43,295	10,365	-2,074	10,602	7,307	-5,038	-1,167	-20,789
Other Cashflows From Financing Activities	14,936	-8,925	-3,699	709,304	48,055	23,836	78,723	300,215	18,188	23,885	28,336	12,131	3,946	1,861	70,439	-11,794	-34,219	-3,798	8,747	-305	3,133	-49	-7,890	-50
Other Cashflows From Investing Activities	0	-11,133	-383,531	-257,024	-45,770	-30,677	-19,646	-327,878	-38,054	-43,325	-8,117	-161,632	-4,427	0	0	0	0	0	0	0	0	0	0	0
Other Non Cash Items	17,981	15,499	22,481	6,630	2,649	2,425	2,113	764	-2,671	1,536	1,973	387	-3,252	-2,727	-13,424	14,077	7,260	3,878	2,593	-1,084	777	3,311	-816	910
Sale Purchase Of Stock	-7,366	-52,210	-16,286	-53,035	-9,670	70,178	44,021	17,691	-50,021	-24,091	-20,962	-12,363	-12,573	0	-65,064	-65,064	0	0	0	0	182	49	-10,113	-5,053
Stock Based Compensation	55,300	68,247	53,160	44,697	34,049	28,885	21,857	19,500	14,921	12,785	11,151	9,214	9,499	9,015	9,725	11,165	11,162	8,129	0	70	242	505	816	0
Total Cash From Financing Activities	23,420	-20,953	47,363	456,269	-23,479	-13,597	-9,877	265,715	-31,833	-206	7,374	-232	-1,840	8,863	9,417	-57,114	105,948	15,611	3,565	7,664	9,714	1,245	25,533	24,886
Total Cash From Operating Activities	181,094	77,781	231,809	185,870	145,008	103,966	24,834	47,937	33,762	65,163	55,263	39,484	31,243	20,599	43,130	19,535	37,227	19,507	-2,258	-4,302	7,681	1,183	-10,710	-19,108
Total Cashflows From Investing Activities	0	-58,669	-412,498	-279,866	-61,664	-54,374	-34,987	-341,323	-45,596	-43,325	-20,452	-168,711	-13,066	0	0	0	0	0	8,747	0	0	2,060	0	1,357

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31
Begin Period Cash Flow	462,697	417,664	356,003	352,835	283,891	268,829	288,361	355,620	482,189	614,965	549,416	489,920	629,171	133,583	104,080	127,210	137,277	87,482	77,244	67,192	44,174	46,168	43,773	32,424	7,466	26,936	46,348	54,488	47,287	41,029	53,487	82,217	57,757	88,028	139,553	125,888	104,187	126,379	107,558	104,531	116,190	87,334	69,817	62,313	54,818	54,071	201,420	191,762	179,303	181,258	173,669	175,635	178,625	185,156	180,611	169,230	146,312	126,426	118,853	120,439	125,032	122,783	142,578	169,812	175,748	172,137	64,669	60,856	50,081	43,767	33,853	29,536	29,500	24,259	15,251	19,482	21,373	20,171	25,196	24,499	26,822	26,031	23,063	21,400	21,178	14,146	12,966	16,912	24,619	2,402	2,309	9,681	0
Capital Expenditures	12,372	14,187	14,817	13,640	17,231	15,867	12,301	15,341	16,302	15,551	13,350	13,132	11,692	9,961	19,438	13,775	14,903	14,811	15,253	16,697	12,902	13,396	13,536	14,540	10,886	6,254	6,564	6,837	7,280	8,081	5,399	8,405	4,232	5,741	6,008	4,108	4,290	5,279	7,441	5,592	6,716	4,767	3,722	5,247	7,621	7,231	4,222	1,528	2,645	2,546	3,650	4,271	2,165	1,404	1,646	1,873	1,569	455	144	1,588	3,386	3,546	3,008	2,390	1,976	3,463	856	673	1,053	987	549	1,197	453	726	369	550	735	1,148	472	1,426	1,128	883	323	325	412	564	449	648	1,053	488	842	564	511
Cash And Cash Equivalents Changes	0	0	61,689	2,992	68,463	14,364	-17,820	-66,848	-127,061	-132,358	65,623	59,496	-139,251	495,588	29,503	-23,130	-10,454	50,245	10,175	10,052	23,018	-1,994	2,395	11,349	24,958	-19,470	-19,412	-8,140	7,201	6,258	-12,458	-28,730	24,460	-30,271	-51,525	13,665	21,701	-22,192	18,821	3,027	11,683	12,243	10,788	7,504	7,495	747	-147,349	9,658	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	0	0	-6,601	38,883	5,731	25,615	-20,690	33,955	-2,240	-16,336	760	28,422	-9,672	-23,039	-999	18,094	259	8,644	-17,253	17,025	-15,617	2,517	6,837	-1,643	-4,905	-7,494	1,608	1,216	1,794	-388	-6,777	3,703	-6,237	-9,029	15,378	3,522	-34,999	10,909	14,748	13,997	-1,736	7,755	6,016	9,834	309	11,620	-1,085	4,581	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Cash	38,282	45,033	61,661	3,168	68,944	15,062	-19,532	-67,259	-126,569	-132,776	65,549	59,496	-139,251	495,588	29,503	-23,130	-10,067	49,795	10,238	10,052	23,018	-1,994	2,395	11,349	24,958	-19,470	-19,412	-8,140	7,201	6,258	-12,458	-28,730	24,460	-30,271	-51,525	13,665	21,701	-22,192	18,821	3,027	-11,659	28,856	17,517	7,504	7,495	747	-147,349	9,658	12,459	-1,955	7,589	-1,966	-2,990	-6,531	4,545	11,381	22,918	19,886	7,573	-1,586	-4,593	2,249	-19,795	-27,234	-5,936	3,611	107,468	3,813	10,775	6,314	9,914	4,317	36	5,241	9,008	-4,231	-1,891	1,202	-5,025	697	-2,323	791	2,968	1,663	222	7,032	1,180	-3,946	-7,707	22,217	93	-7,372	0
Change In Working Capital	8,843	13,898	33,318	-12,386	82,026	-31,758	-60,953	-62,781	7,515	-28,570	11,227	6,488	25,684	-7,088	31,260	-12,556	-7,961	10,775	-14,185	-4,439	7,050	-16,102	-3,519	1,853	-23,625	-44,387	-6,056	29,660	9,646	-11,083	-23,122	4,149	8,293	-22,520	-14,601	-4,967	11,369	-7,837	7,407	-12,289	-1,242	5,208	2,784	-7,742	-3,976	-4,648	5,379	907	6,696	482	-3,315	-1,425	3,761	-6,262	-1,932	2,830	18,164	12,205	1,098	-6,756	-11,084	-8,554	-968	-730	8,455	-9,670	5,230	-8,396	-803	-3,699	-1,439	-1,144	-7,602	550	582	-509	-4,266	-9,546	-2,825	-1,662	-3,620	-1,782	1,063	432	6,735	490	-2,932	-4,405	-1,960	-3,183	-5,298	-2,825	0
Change Receivables	0	0	46,299	-21,543	58,520	-50,348	-32,792	-51,091	-752	-19,636	-2,737	-14,502	7,580	-481	43,181	-16,320	-12,403	820	-3,764	-9,892	10,039	-31,549	15,761	-2,123	-17,376	-19,779	-15,278	19,990	29,506	-16,401	-4,607	-10,090	6,396	-2,029	-21,977	-5,346	12,600	-10,565	-6,433	-17,353	8,377	0	0	-10,263	-4,869	-7,529	1,526	-2,593	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	20,528	-1,098	46,488	-22,156	-60,357	-50,348	-32,792	-49,994	-40,973	-31,444	-4,896	-15,427	36,842	-8,808	38,796	-16,052	-13,824	1,528	-1,993	-7,251	9,987	-31,655	16,108	-632	-17,358	-20,940	-19,640	18,870	33,849	-17,663	-6,977	-1,162	7,837	1,544	-22,045	-5,631	12,229	-10,620	-7,294	-17,114	5,395	-247	1,949	-10,706	-2,208	-6,816	-23	-264	9,149	-2,902	-3,352	2,968	2,822	-6,842	1,895	808	18,076	10,489	-6,998	-4,377	-21,866	0	0	-7,455	-2,102	0	0	-1,769	-7,645	0	0	-4,157	-7,489	0	0	-624	-7,438	0	111	930	-3,885	0	0	766	7,710	3,455	0	3,492	-1,351	0	0	0	0
Change To Inventory	6,326	13,870	11,060	6,760	2,154	356	-15,305	-17,320	-15,557	-3,569	-5,534	-1,035	7,789	11,841	-1,537	-5,734	-1,108	-2,549	-1,530	-2,936	-1,475	4,501	-2,908	-6,881	-3,898	-10,716	-5,293	-6,933	4,383	24	-2,408	-5,361	2,814	-3,582	-7,727	-1,906	117	1,636	-785	450	-697	-4,514	-526	327	-388	-1,485	3,454	955	-1,599	627	-2,503	-5,959	-434	573	-32	-30	-797	-913	542	475	1,048	1,557	-628	-1,803	441	1,221	1,476	-1,134	5,717	-8,696	-2,502	1,145	-1,419	1,027	674	-2,043	2,243	-4,201	-2,937	-1,276	-684	39	1,672	2,396	-2,735	538	1,083	-1,521	1,123	-190	-1,170	-2,051	0
Change To Liabilities	0	0	-15,463	-26,423	23,417	-4,176	14,668	20,098	-1,073	13,944	11,021	-3,502	22,823	7,126	-6,910	-5,914	7,936	11,777	8,362	-8,636	14,103	8,429	-23,209	12,500	2,554	-6,398	12,907	15,398	-25,591	6,257	-8,813	16,061	2,574	-7,129	2,812	-1,237	12,369	-2,518	7,666	-3,189	12,327	9,756	895	-3,913	7,393	1,460	2,532	486	0	819	269	529	199	85	0	0	1,782	1,011	4,880	2,303	0	0	717	787	0	303	0	0	5,189	8,286	3,554	0	0	0	0	0	0	1,161	72	668	2,355	0	0	0	0	0	0	0	0	0	679	4,866	948
Change To Netincome	0	0	11,031	7,074	-2,392	10,086	12,565	13,103	9,505	15,552	14,354	10,910	9,027	16,790	3,091	9,510	3,521	8,755	9,039	11,840	11,175	5,027	5,711	1,400	-9,847	6,883	2,069	-3,580	-1,637	1,937	2,808	2,982	7,446	2,995	-4,627	4,252	4,676	4,118	4,329	2,600	10,236	0	0	3,675	5,484	739	2,044	1,525	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Operating Activities	0	0	0	-26,145	26,329	-8,082	-2,391	-15,565	25,557	-16,300	9,975	-9,167	9,554	-15,504	575	-7,846	7,849	-101	-5,225	-2,008	5,247	3,584	-4,124	3,664	3,010	-8,602	5,970	2,325	-24,613	0	0	0	3,263	0	0	0	4,733	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	95,558	23,555	24,057	24,222	24,617	24,734	25,387	24,431	23,027	21,148	20,286	20,470	20,000	17,659	17,211	16,725	16,679	16,342	15,861	15,239	13,860	12,661	12,519	12,310	12,969	12,600	13,494	12,448	14,457	14,708	14,724	14,473	7,182	6,480	6,266	5,711	5,567	5,314	4,779	4,612	4,633	4,488	4,772	4,472	4,078	3,914	2,998	2,335	2,163	2,026	1,942	1,852	2,126	2,191	2,179	2,123	2,257	2,297	2,401	2,473	2,407	2,063	2,365	2,119	1,897	946	886	873	904	883	948	982	1,014	1,034	1,069	1,082	1,162	1,009	954	960	936	814	1,011	743	601	717	835	869	991	794	1,014	924	0
Dividends Paid	1,731	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
End Period Cash Flow	500,979	462,697	417,664	356,003	352,835	283,891	268,829	288,361	355,620	482,189	614,965	549,416	489,920	629,171	133,583	104,080	127,210	137,277	87,482	77,244	67,192	44,174	46,168	43,773	32,424	7,466	26,936	46,348	54,488	47,287	41,029	53,487	82,217	57,757	88,028	139,553	125,888	104,187	126,379	107,558	104,531	116,190	87,334	69,817	62,313	54,818	54,071	201,420	191,762	179,303	181,258	173,669	175,635	178,625	185,156	180,611	169,230	146,312	126,426	118,853	120,439	125,032	122,783	142,578	169,812	175,748	172,137	64,669	60,856	50,081	43,767	33,853	29,536	29,500	24,259	15,251	19,482	21,373	20,171	25,196	24,499	26,822	26,031	23,063	21,400	21,178	14,146	12,966	16,912	24,619	2,402	2,309	9,681
Exchange Rate Changes	0	0	0	0	0	0	0	0	-588	0	0	-386	594	684	-21	-820	-277	0	0	430	-854	-911	-754	1,292	-530	-230	-1,925	651	1,209	173	-1,740	300	48	-219	283	-116	-139	-255	110	9	73	0	0	-40	-13	0	-58	81	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	26,042	42,820	58,086	-870	64,922	5,308	-21,852	-31,337	43,330	27,438	58,423	44,283	64,756	26,726	28,066	11,456	19,917	41,617	12,010	9,800	34,550	2,391	8,335	4,316	-6,700	-24,530	4,178	21,345	16,187	436	-11,233	13,382	23,598	-9,999	-7,132	7,206	26,558	3,615	16,863	-4,475	7,810	14,742	13,374	-1,115	4,386	1,488	7,247	5,761	13,969	4,812	506	-1,156	9,484	-4,590	2,557	6,060	17,247	17,896	7,546	-3,315	-6,291	-1,069	5,873	8,692	19,076	-1,855	13,901	-863	7,934	2,637	3,044	2,106	-2,211	2,273	646	-5,064	-2,041	-6,355	79	234	208	477	3,043	1,294	4,353	-1,941	-768	-2,534	-621	-2,382	-6,344	-4,310	0
Investments	-12,372	-14,187	-14,817	-13,640	-17,252	-15,867	-6,817	-18,733	-192,385	-193,631	-13,350	-13,132	-236,692	-9,961	-19,438	-13,775	-14,903	-14,811	-15,253	-16,697	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8,122	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	0	0	0	0	0	0	0	0	0	0	0	0	458,490	559,665	-50,000	-32,321	-30,000	-21,000	-39,000	-50,000	-14,500	-10,000	-2,500	17,394	-2,500	-20,500	-40,000	30,500	-2,500	-2,508	227,059	252,551	0	0	0	252,551	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	-14,375	5,553	3,451	-15,000	-28,408	16,774	9,069	8,213	13,981	29,317	20,424	14,127	16,377	8,805	-4,299	11,311	22,095	19,983	15,976	3,284	14,793	13,628	6,588	2,720	24,291	6,231	837	-10,754	157	1,983	-1,159	-378	7,655	8,036	8,751	6,318	9,236	7,299	7,789	6,194	6,823	7,755	6,016	3,385	5,532	6,920	1,375	2,351	4,138	2,994	2,587	670	672	1,276	1,965	979	556	855	904	-1,871	3,323	2,915	2,753	3,733	14,297	6,940	18,093	3,965	4,909	2,815	1,415	1,226	2,237	1,415	66	-5,792	2,619	3,256	2,373	2,354	3,243	2,328	1,292	444	-5,882	-2,584	1,778	1,650	1,398	492	-1,212	-1,845	0
Other Cashflows From Financing Activities	18,883	-2,342	2,610	-6,883	-49,291	-6,388	-1,452	20,091	6,666	18,284	6,814	15,599	20,399	618,178	1,458	16,234	37,282	8,628	2,005	18,606	39,322	11,026	4,814	8,241	34,688	34,790	13,281	9,864	40,005	8,149	3,015	249,046	866	6,777	3,970	6,575	3,295	7,180	1,848	11,562	1,489	14,040	4,148	555	-11,517	1,435	330	-2,674	393	1,036	1,596	921	-2,612	1,823	1,535	-3,091	7,427	1,990	-144	-1,588	-1,845	-3,418	-4,054	-2,477	-29,227	-3,463	-856	-673	106	-184	78	-1,209	1,574	986	6,983	-796	-748	3,774	-6,145	-305	908	1,556	669	-325	-1,846	1,797	1,382	-2,701	24	-21,027	3,012	-12	0
Other Cashflows From Investing Activities	0	0	-3,186	-3,499	-3,577	-3,105	2,793	-7,244	-181,310	-186,806	-7,372	-8,043	-231,115	-5,907	-9,400	-10,602	-11,641	-11,548	-10,864	-11,717	-8,464	-9,122	1,449	-14,540	4,455	-6,254	-11,010	-6,837	-34,535	-8,081	-5,399	-279,863	3,258	-7,571	-29,633	-4,108	-15,415	-22,212	-2,657	-3,041	-6,170	0	0	-1,947	-1,899	-1,758	-157,885	-90	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non Cash Items	-66,917	2,165	1,237	9,662	6,657	1,670	4,381	2,791	5,740	5,839	5,482	5,420	5,627	521	241	241	495	610	616	928	571	709	572	573	782	446	477	408	-115	-878	1,063	694	-97	298	-3,098	226	406	510	450	170	24	-237	19	2,167	1,776	-1,073	242	-558	124	-1,681	-1,057	-638	1,701	-4,771	159	184	-4,456	607	968	1,703	220	5,773	4,629	388	-2,831	3,268	-9,452	3,359	-4,655	3,625	2,669	2,239	-4,389	0	-702	705	-1,215	17	49	8	777	-11	1	0	3,311	0	0	-185	3	3	-6	0	0
Sale Purchase Of Stock	-1,236	-2,665	-2,096	-1,369	52,210	-2,972	-4,148	-52,210	13,431	21,574	11,517	20,826	21,044	10,319	3,503	17,659	43,483	9,696	4,807	20,526	42,449	11,612	6,576	9,541	17,553	10,685	4,867	10,916	1,175	7,877	3,490	5,149	1,426	-25,000	-25,021	-7,039	-7,039	-12,983	2,189	-4,069	-20,962	0	0	8,104	21,312	-5,303	-7,060	3,245	-2,013	-2,560	-3,271	-4,729	0	0	0	4,206	0	0	0	0	0	0	-25,000	-40,064	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	182	0	0	0	49	0	0	0	0	0	0	0	0
Stock Based Compensation	12,187	14,982	14,089	14,042	17,516	17,310	17,213	16,208	14,683	13,666	13,039	11,772	11,663	11,024	11,351	10,659	8,874	8,505	8,260	8,410	8,034	7,085	7,238	6,528	5,542	5,259	5,545	5,511	5,437	4,677	5,495	3,891	3,654	3,966	3,636	3,665	4,175	3,161	2,720	2,729	2,764	2,774	2,687	2,926	2,433	2,361	2,213	2,207	2,245	2,411	2,451	2,392	2,563	2,198	2,098	2,156	2,454	2,413	2,374	2,484	11,165	0	0	3,067	11,162	0	0	2,657	8,129	0	0	2,166	6,979	0	0	0	70	57	0	8	242	11	0	0	505	0	0	185	816	0	0	0	0
Total Cash From Financing Activities	13,130	2,825	3,603	3,862	3,562	9,056	-1,452	-32,119	6,666	18,284	6,814	15,599	20,399	468,178	1,458	-33,766	-30,524	8,628	-1,405	-178	-10,678	-3,474	-5,186	5,741	32,188	5,290	-17,219	-30,136	30,505	5,649	515	229,046	866	-18,223	-21,051	6,575	-3,744	-5,803	1,848	7,493	-19,473	14,040	4,148	8,659	3,018	-718	-6,348	3,816	-1,440	1,470	-1,060	-810	-2,208	3,762	1,988	5,321	5,671	1,990	27	1,729	157	3,190	-24,622	-35,839	2,239	5,466	93,567	4,676	2,841	3,677	6,870	2,223	220	1,256	1,010	1,079	163	2,635	569	4,297	2,428	5,096	1,821	369	-1,436	1,923	117	641	-355	22,469	3,375	44	24,886
Total Cash From Operating Activities	38,414	57,007	72,903	12,770	82,153	21,175	-9,551	-15,996	59,632	42,989	71,773	57,415	76,448	36,687	47,504	25,231	34,820	56,428	27,263	26,497	47,452	15,787	21,871	18,856	4,186	-18,276	10,742	28,182	23,467	8,517	-5,834	21,787	27,830	-4,258	-1,124	11,314	30,848	8,894	24,304	1,117	14,526	19,509	17,096	4,132	12,007	8,719	11,469	7,289	16,614	7,358	4,156	3,115	11,649	-3,186	4,203	7,933	18,816	18,351	7,690	-1,727	-2,905	2,477	8,881	11,082	21,052	1,608	14,757	-190	8,987	3,624	3,593	3,303	-1,758	2,999	1,015	-4,514	-1,306	-5,207	551	1,660	1,336	1,360	3,366	1,619	4,765	-1,377	-319	-1,886	432	-1,894	-5,502	-3,746	0
Total Cashflows From Investing Activities	0	0	-14,817	-13,640	-17,252	-15,867	-6,817	-18,733	-192,385	-193,631	-13,350	-13,132	-236,692	-9,961	-19,438	-13,775	-14,903	-14,811	-15,253	-16,697	-12,902	-13,396	-13,536	-14,540	-10,886	-6,254	-11,010	-6,837	-47,980	-8,081	-5,399	-279,863	-4,284	-7,571	-29,633	-4,108	-5,264	-25,028	-7,441	-5,592	-15,205	-13,736	-8,969	-5,247	-7,540	-7,231	-152,412	-1,528	-13,066	-10,421	222	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8,747	7,173	6,187	0	0	0	0	0	0	0	0	0	2,060	5,167	0	0	0	192	0	0	1,357

Income Statement

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31
Cost Of Revenue	650,272	706,960	577,365	478,916	460,115	414,979	394,077	378,823	236,629	207,040	177,186	143,473	109,751	104,490	108,236	123,231	99,772	69,189	54,508	52,033	42,461	36,418	32,767	26,578
Depreciation And Amortization	95,558	99,169	84,931	71,595	64,121	51,350	51,511	58,362	25,639	20,272	18,365	13,325	7,983	8,619	9,428	8,954	4,602	3,717	4,199	4,085	3,504	3,022	3,723	3,655
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Ebit	-34,868	-2,323	89,507	35,526	78,352	44,392	5,754	6,481	41,746	49,583	35,299	27,083	8,372	2,790	-6,652	5,004	18,262	9,174	-1,945	10,864	8,890	-1,027	-730	-13,717
Ebitda	-34,868	96,846	174,438	107,121	142,473	95,742	57,265	64,843	67,385	69,855	53,664	40,408	16,355	11,409	2,776	13,958	22,864	12,891	2,254	14,949	12,394	1,995	2,993	-10,062
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Extraordinary Items	0	0	0	0	0	0	20,005	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit	496,840	588,987	554,653	413,292	436,912	372,330	322,088	313,800	247,930	233,860	203,399	170,554	135,784	117,917	105,221	128,634	113,309	85,521	67,010	71,906	59,666	51,272	54,134	40,787
Income Before Tax	-20,108	-2,453	66,007	29,349	73,933	35,616	-879	-1,948	46,244	48,504	35,029	27,032	16,089	9,957	1,192	20,722	24,277	11,169	-2,054	10,926	7,549	-5,028	-1,007	-20,689
Income Tax Expense	263	-8,101	-11,842	-2,845	12,595	-2,113	-21,484	-2,551	15,484	17,986	11,050	10,871	5,700	5,065	748	7,998	-19,018	804	20	324	242	10	160	100
Interest Expense	14,760	130	23,500	6,177	4,419	8,776	6,633	8,429	2,388	1,079	122	29	62	4	15	15	20	8	8	9	0	0	0	0
Interest Income	0	0	0	0	4,419	8,776	6,633	8,429	2,388	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	-20,371	5,648	77,849	32,194	61,338	37,729	20,605	603	30,760	30,518	23,979	16,161	10,389	4,892	444	12,724	43,295	10,365	-2,074	10,602	7,307	-5,038	-1,167	-20,789
Net Income Applicable To Common Shares	0	5,648	77,849	32,194	61,338	37,729	20,605	603	30,760	30,518	23,979	16,178	10,389	4,892	444	12,724	43,295	10,365	0	10,602	7,307	0	0	0
Net Income From Continuing Ops	-34,404	5,648	77,849	32,194	61,338	37,729	20,605	603	30,760	30,518	23,979	16,178	10,389	0	0	0	0	0	0	0	0	0	0	0
Net Interest Income	12,755	-130	-23,500	-6,177	-4,419	-8,776	-6,633	-8,429	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Operating Income Net Other	0	-130	-23,500	-6,177	-4,419	-8,776	-6,633	-8,429	-2,388	-1,079	-270	-51	-71	0	0	0	0	0	0	0	0	0	0	0
Non Recurring	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-34,868	-2,323	89,507	35,526	78,352	44,392	5,754	6,481	48,632	49,583	35,299	27,083	16,222	9,526	669	17,340	18,224	9,256	-2,705	10,547	6,984	-5,903	-430	-19,533
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Operating Expenses	1,181,980	1,298,270	1,042,511	856,682	818,675	742,917	710,411	686,142	439,370	391,317	345,286	286,944	229,313	211,724	211,473	234,525	194,857	145,454	123,817	113,221	94,190	91,155	87,481	83,990
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reconciled Depreciation	96,451	99,169	84,931	71,595	64,121	51,350	51,511	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Research Development	97,115	104,969	75,716	70,161	68,644	64,843	66,022	57,799	35,160	27,802	29,105	23,726	22,042	21,007	17,569	18,196	15,050	11,222	9,611	9,105	8,950	9,970	11,031	11,273
Selling And Marketing Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Selling General Administrative	464,340	486,341	389,430	307,605	289,916	263,095	250,312	249,520	167,581	156,475	138,995	119,736	97,520	86,227	85,668	93,098	80,035	65,043	59,698	52,083	42,779	44,767	43,683	56,130
Tax Provision	-2,701	-8,101	-11,842	-2,845	12,595	-2,113	-21,484	-2,551	15,484	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Operating Expenses	531,708	591,310	465,146	377,766	358,560	327,938	316,334	307,319	202,741	184,277	168,100	143,471	119,562	107,234	103,237	111,294	95,085	76,265	69,309	61,188	51,729	54,737	54,714	57,412
Total Other Income Expense Net	14,760	-130	-23,500	-6,177	-4,419	-8,776	-6,633	-8,429	3,443	-1,079	-178	-99	-133	-726	-792	3,382	-38	82	-354	-146	-953	-2,438	150	-2,908
Total Revenue	1,147,112	1,295,947	1,132,018	892,208	897,027	787,309	716,165	692,623	484,559	440,900	380,585	314,027	245,535	222,407	213,457	251,865	213,081	154,710	121,518	123,939	102,127	87,690	86,901	67,365

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31
Cost Of Revenue	153,443	166,699	164,530	165,600	175,921	188,964	173,294	168,781	161,741	149,623	136,441	129,560	125,548	116,908	116,396	120,064	124,689	116,658	113,368	105,400	109,567	105,358	99,890	100,164	102,876	101,929	102,910	86,362	97,645	95,229	94,890	91,059	65,236	61,531	55,326	54,536	57,762	52,997	49,012	47,269	49,126	41,999	44,318	41,743	40,827	38,244	36,008	28,394	27,052	29,991	27,198	25,510	25,905	26,186	25,825	26,574	27,430	26,708	25,714	28,384	30,889	31,582	31,014	29,746	27,041	25,339	24,473	22,919	18,964	18,700	16,041	15,378	15,002	12,798	12,338	14,370	15,644	13,646	11,525	11,218	11,711	10,800	10,497	9,453	8,482	8,527	10,042	9,367	9,007	8,359	8,241	7,160	6,471	6,036	5,201	6,031
Depreciation And Amortization	95,558	23,555	24,057	24,222	24,617	24,734	25,387	24,431	23,027	21,148	20,286	20,470	20,000	17,659	17,211	16,725	16,679	16,342	15,861	15,239	13,860	12,661	12,519	12,310	12,969	12,600	13,494	12,448	14,457	14,708	14,724	14,473	7,182	6,480	6,266	5,711	5,567	5,314	4,779	4,612	4,633	4,488	4,772	4,472	4,078	3,914	2,998	2,335	2,163	2,026	1,942	1,852	2,126	2,191	2,179	2,123	2,257	2,297	2,401	2,473	2,407	2,063	2,365	2,119	1,897	946	886	873	904	883	948	982	1,014	1,034	1,069	1,082	1,162	1,009	954	960	936	814	1,011	743	601	717	835	869	991	794	1,014	924	0	-	-	-
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Ebit	-23,365	3,712	7,748	-22,963	-38,357	18,465	12,485	5,084	11,589	29,392	28,916	19,610	20,214	10,152	-6,991	12,151	22,182	24,646	18,763	12,761	18,930	17,495	7,334	633	15,680	9,714	-15,898	-17,236	-181	4,928	-118	1,852	11,970	13,859	-728	4,668	7,907	8,283	7,779	5,342	6,422	6,229	4,587	-303	5,713	7,278	-494	1,204	4,073	2,959	2,217	-877	1,075	2,967	1,260	-688	2,431	-1,409	-1,278	-341	9,982	3,543	3,782	4,861	9,429	3,178	4,211	3,494	5,750	2,033	1,225	950	1,854	1,301	-35	-5,064	2,410	3,287	2,798	2,369	3,382	2,509	2,617	382	-322	-2,940	1,629	1,150	1,132	457	-935	-1,234	0	0	0	0
Ebitda	72,193	27,267	31,805	1,259	-13,740	43,199	37,872	29,515	34,616	50,540	49,202	40,080	40,214	27,811	10,220	28,876	38,861	40,988	34,624	28,000	32,790	30,156	19,853	12,943	28,649	22,314	-2,404	-4,788	14,276	19,636	14,606	16,325	19,152	20,339	5,538	10,379	13,474	13,597	12,558	9,954	11,055	10,717	9,359	4,169	9,791	11,192	2,504	3,539	6,236	4,985	4,159	975	3,201	5,158	3,439	1,435	4,688	888	1,123	2,132	12,389	5,606	6,147	6,980	11,326	4,124	5,097	4,367	6,654	2,916	2,173	1,932	2,868	2,335	1,034	-3,982	3,572	4,296	3,752	3,329	4,318	3,323	3,628	1,125	279	-2,223	2,464	2,019	2,123	1,251	79	-310	0	-	-	-
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Extraordinary Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit	105,404	131,964	134,443	125,029	121,753	159,095	158,092	150,047	149,293	146,779	136,298	122,283	123,654	96,791	83,225	109,622	123,603	112,147	104,045	97,117	102,183	98,909	88,783	82,455	95,068	84,853	77,975	64,192	74,329	81,508	78,017	79,945	65,080	63,703	57,462	61,685	63,779	59,546	56,040	54,495	56,624	52,040	49,368	45,367	49,342	46,087	39,376	35,749	35,879	34,448	33,807	31,650	31,363	30,100	28,868	27,586	27,223	27,249	26,929	23,820	31,166	32,763	32,360	32,344	30,905	29,813	27,349	25,242	24,931	22,230	19,931	18,535	18,479	17,890	16,260	14,381	18,525	19,088	17,682	16,611	16,841	15,559	14,644	12,621	10,774	10,546	14,900	15,052	15,388	14,320	12,599	11,827	43,626	0	0	0
Income Before Tax	-18,517	7,382	12,209	-21,182	-35,514	17,317	10,774	4,970	6,804	23,327	22,957	12,919	13,876	10,961	-6,817	11,329	21,970	23,478	17,134	11,351	16,616	14,658	6,438	-2,096	14,039	6,982	-2,208	-19,692	-1,837	2,207	-1,999	-319	11,217	13,213	11,952	9,862	13,397	12,891	12,518	9,698	10,919	10,742	9,422	3,946	9,683	11,260	2,358	3,731	6,102	4,603	4,301	1,083	1,667	3,162	3,545	1,583	1,469	1,000	1,511	-2,789	4,336	4,889	5,226	6,271	7,294	7,288	5,454	4,241	5,191	3,199	1,927	1,286	2,188	1,451	83	-5,775	2,618	3,380	2,477	2,451	3,043	2,584	1,461	460	-5,862	-2,559	1,803	1,590	1,483	516	-1,186	-1,820	0	0	0	0
Income Tax Expense	-4,142	1,829	8,758	-6,182	-7,106	543	1,705	-3,243	-7,177	-5,990	2,533	-1,208	-2,501	2,156	-2,518	18	-125	3,495	1,158	8,067	1,823	1,030	-150	-4,816	-10,252	751	-3,045	-8,938	-1,994	224	-840	59	3,562	5,177	3,201	3,544	4,162	5,591	4,729	3,504	4,096	2,987	3,406	561	4,168	4,340	983	1,380	1,964	1,609	1,714	413	995	1,886	1,580	604	913	146	607	-918	1,013	1,975	2,473	2,538	-7,003	348	-12,639	276	282	384	78	60	-49	36	17	17	-1	124	104	97	-200	257	170	16	20	25	25	-60	85	25	25	25	25	25	25	25
Interest Expense	4,848	3,670	4,461	1,781	2,843	1,148	1,711	114	23,500	6,065	5,959	6,691	6,177	809	174	822	4,419	1,168	1,629	1,410	8,776	2,837	896	2,729	6,633	2,732	196	2,456	8,429	0	0	0	2,388	0	472	517	1,079	706	40	256	270	25	63	223	51	34	73	96	62	191	71	0	4	159	53	0	15	0	194	182	15	673	722	1,410	20	0	0	0	8	0	0	0	8	6	4	24	9	12	56	2	0	41	32	46	0	0	0	0	45	169	357	770	465	686	478	580
Interest Income	0	0	0	0	2,843	0	0	0	0	0	0	0	0	0	174	822	212	1,168	1,629	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	-14,375	5,553	3,451	-15,000	-28,408	16,774	9,069	8,213	13,981	29,317	20,424	14,127	16,377	8,805	-4,299	11,311	22,095	19,983	15,976	3,284	14,793	13,628	6,588	2,720	24,291	6,231	837	-10,754	157	1,983	-1,159	-378	7,655	8,036	8,751	6,318	9,235	7,300	7,789	6,194	6,823	7,755	6,016	3,385	5,515	6,920	1,375	2,351	4,138	2,994	2,587	670	672	1,276	1,965	979	556	854	904	-1,871	3,323	2,914	2,753	3,733	14,297	6,940	18,093	3,965	4,909	2,815	1,849	1,226	2,237	1,415	66	-5,792	2,619	3,256	2,373	2,354	3,243	2,327	1,291	444	-5,882	-2,584	1,778	1,650	1,398	491	-1,211	-1,845	0	0	0	0
Net Income Applicable To Common Shares	0	0	3,451	-15,000	-28,408	16,774	9,069	8,213	13,981	29,317	20,424	14,127	16,377	8,805	-4,299	11,311	22,095	19,983	15,976	3,284	14,793	13,628	6,588	2,720	24,291	6,231	837	-10,754	157	1,983	-1,159	-378	7,655	8,036	8,751	6,318	9,235	7,300	7,789	6,194	6,823	7,755	6,016	3,385	5,532	6,920	1,375	2,351	4,138	2,994	2,587	670	672	1,276	1,965	979	556	855	904	0	3,323	2,915	2,753	3,733	14,297	6,940	18,093	3,965	4,100	3,116	2,133	1,016	2,237	1,415	66	0	2,619	3,256	2,373	2,354	3,243	2,328	1,292	444	0	-1,778	1,778	1,650	1,398	492	0	0	0	0	0	0
Net Income From Continuing Ops	-14,375	5,553	3,451	-15,000	-28,408	16,774	9,069	8,213	13,981	29,317	20,424	14,127	16,377	8,805	-4,299	11,311	22,095	19,983	15,976	3,284	14,793	13,628	6,588	2,720	24,291	6,231	837	-10,754	157	1,983	-1,159	-378	7,655	8,036	8,751	6,318	9,235	7,300	7,789	6,194	6,823	7,755	6,016	3,385	5,532	6,920	1,375	2,351	0	2,994	2,587	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Interest Income	4,848	3,670	4,461	1,781	2,843	-1,148	-1,711	-114	-4,785	-6,065	-5,959	-6,691	-6,338	809	174	-822	-212	-1,168	-1,629	-1,410	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Non Operating Income Net Other	0	0	4,461	1,781	2,843	-1,148	-1,711	-114	-4,785	-6,065	-5,959	-6,691	-6,338	809	174	-822	-212	-1,168	-1,629	-1,410	-2,314	-2,837	-896	-2,729	-1,641	-2,732	196	-2,456	-1,656	-2,721	-1,881	-2,171	-753	-646	-472	-517	-77	-706	-40	-256	-135	25	63	-223	-108	34	-73	96	0	-191	71	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Non Recurring	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-23,365	3,712	7,748	-22,963	-38,357	18,465	12,485	5,084	11,589	29,392	28,916	19,610	20,214	10,152	-6,991	12,151	22,182	24,646	18,763	12,761	18,930	17,495	7,334	633	15,680	9,714	-2,404	-17,236	-181	4,928	-118	1,852	11,970	13,859	12,424	10,379	13,474	13,597	12,558	9,954	11,055	10,717	9,359	4,169	9,791	11,226	2,431	3,635	6,169	4,794	4,230	1,029	1,522	3,003	3,492	1,509	1,379	944	1,317	-2,971	3,758	4,216	4,504	4,861	5,316	5,233	4,181	3,494	4,555	2,616	1,576	943	1,906	1,301	-35	-5,876	2,435	3,287	2,456	2,369	2,736	2,509	1,357	382	-6,247	-2,742	1,716	1,370	1,282	457	-935	-1,234	0	0	0	0
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Operating Expenses	282,212	294,951	291,225	313,592	336,031	329,594	318,901	313,744	299,445	267,010	243,823	232,233	228,988	203,547	206,612	217,535	226,110	204,159	198,650	189,756	192,820	186,772	181,339	181,986	182,264	177,068	183,289	167,790	172,155	171,809	173,025	169,152	118,346	111,375	103,807	105,842	108,067	98,946	92,494	91,810	94,695	83,322	84,327	82,941	80,378	73,105	72,953	60,508	56,762	59,645	56,775	56,131	55,746	52,126	51,201	52,651	53,274	53,013	51,326	53,860	58,297	60,129	58,870	57,229	52,630	49,919	47,641	44,667	39,340	38,314	34,396	32,970	31,575	29,387	28,633	34,221	31,734	29,447	26,580	25,460	25,493	23,850	23,154	21,692	23,065	21,815	23,226	23,049	23,263	22,222	21,775	20,221	0	0	0	0
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Reconciled Depreciation	23,724	23,555	24,057	24,222	24,617	24,734	25,387	24,431	23,027	21,148	20,286	20,470	20,000	17,659	17,211	16,725	16,679	16,342	15,861	15,239	13,860	12,661	12,519	12,310	12,969	12,600	13,494	12,448	14,457	14,708	14,724	14,473	7,182	6,480	6,266	5,711	5,567	5,314	4,779	4,612	4,633	4,488	4,772	4,472	4,078	3,914	2,998	2,335	2,163	2,026	1,942	1,852	2,126	2,191	2,179	2,123	2,257	2,297	2,401	2,473	2,407	2,063	2,365	2,119	1,897	946	886	873	904	883	948	982	1,014	1,034	1,069	1,082	1,162	1,009	954	960	936	814	1,011	743	601	717	835	869	991	794	1,014	924	0	-	-	-
Research Development	26,819	24,281	23,137	22,878	28,413	25,171	26,355	25,030	21,946	19,477	18,213	16,080	15,482	15,197	20,830	18,652	19,093	16,625	16,848	16,078	16,989	15,805	15,512	16,537	15,894	16,414	16,911	16,803	14,902	15,264	13,794	13,838	9,219	9,176	8,746	8,019	8,132	7,078	6,471	6,121	7,440	6,561	7,150	7,954	6,188	5,545	5,499	6,494	5,903	6,019	5,280	4,840	5,403	6,089	4,950	4,565	4,037	4,981	4,574	3,977	4,257	4,685	4,978	4,276	4,051	3,848	3,766	3,385	3,364	2,878	2,325	2,615	2,027	2,143	2,732	2,709	2,426	2,476	1,837	2,366	2,219	2,256	2,106	2,368	2,681	2,410	2,201	2,678	2,732	2,864	2,903	2,532	2,762	2,692	2,503	3,455
Selling And Marketing Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Selling General Administrative	101,950	103,971	103,558	125,114	131,697	115,459	119,252	119,933	115,758	97,910	89,169	86,593	87,958	71,442	69,386	78,819	82,328	70,876	68,434	68,278	66,264	65,609	65,937	65,285	63,494	58,725	63,468	64,625	59,608	61,316	64,341	64,255	43,891	40,668	39,735	43,287	42,173	38,871	37,011	38,420	38,129	34,762	32,859	33,244	33,354	29,316	31,446	25,620	23,807	23,635	24,297	25,781	24,438	19,851	20,426	21,512	21,807	21,324	21,038	21,499	23,151	23,862	22,878	23,207	21,538	20,732	19,402	18,363	17,012	16,736	16,030	14,977	14,546	14,446	13,563	17,142	13,664	13,325	13,218	11,876	11,563	10,794	10,551	9,871	11,902	10,878	10,983	11,004	12,577	10,803	13,535	13,061	13,569	13,347	14,358	14,856
Tax Provision	-4,142	1,829	8,758	-6,182	-7,106	543	1,705	-3,243	-7,177	-5,990	2,533	-1,208	-2,501	2,156	-2,518	18	-125	3,495	1,158	8,067	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Total Operating Expenses	128,769	128,252	126,695	147,992	160,110	140,630	145,607	144,963	137,704	117,387	107,382	102,673	103,440	86,639	90,216	97,471	101,421	87,501	85,282	84,356	83,253	81,414	81,449	81,822	79,388	75,139	80,379	81,428	74,510	76,580	78,135	78,093	53,110	49,844	48,481	51,306	50,305	45,949	43,482	44,541	45,569	41,323	40,009	41,198	39,551	34,861	36,945	32,114	29,710	29,654	29,577	30,621	29,841	25,940	25,376	26,077	25,844	26,305	25,612	25,476	27,408	28,547	27,856	27,483	25,589	24,580	23,168	21,748	20,376	19,614	18,355	17,592	16,573	16,589	16,295	19,851	16,090	15,801	15,055	14,242	13,782	13,050	12,657	12,239	14,583	13,288	13,184	13,682	14,256	13,863	13,534	13,061	0	0	0	0
Total Other Income Expense Net	4,848	3,670	4,461	1,781	2,843	-1,148	-1,711	-114	-4,785	-6,065	-5,959	-6,691	-6,338	809	174	-822	-212	-1,168	-1,629	-1,410	-2,314	-2,837	-896	-2,729	-1,641	-2,732	196	-2,456	-1,656	-2,721	-1,881	-2,171	-753	-646	3,443	-517	-76	-706	-40	-256	-136	25	63	-223	-108	34	-73	96	-67	-191	71	54	-275	-998	53	74	-514	56	194	-1,315	-2,827	673	722	1,410	-4,113	2,055	-30	747	-1,195	583	351	-7	52	150	118	-406	25	93	-171	82	-323	75	-630	78	-3,487	198	87	220	201	59	-251	-586	0	0	0	0
Total Revenue	258,847	298,663	298,973	290,629	297,674	348,059	331,386	318,828	311,034	296,402	272,739	251,843	249,202	213,699	199,621	229,686	248,292	228,805	217,413	202,517	211,750	204,267	188,673	182,619	197,944	186,782	180,885	150,554	171,974	176,737	172,907	171,004	130,316	125,234	112,788	116,221	121,541	112,543	105,052	101,764	105,750	94,039	93,686	87,110	90,169	84,331	75,384	64,143	62,931	64,439	61,005	57,160	57,268	56,286	54,693	54,160	54,653	53,957	52,643	52,204	62,055	64,345	63,374	62,090	57,946	55,152	51,822	48,161	43,895	40,930	35,972	33,913	33,481	30,688	28,598	28,751	34,169	32,734	29,207	27,829	28,552	26,359	25,141	22,074	19,256	19,073	24,942	24,419	24,395	22,679	20,840	18,987	19,312	17,194	16,373	14,486

Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue	1,147,112
Cost of Revenue	-650,272
Gross Profit	496,840	496,840

Operating Income (+$)
Gross Profit	496,840
Operating Expense	-531,708
Operating Income	-34,868	-34,868

Operating Expense (+$)
Research Development	97,115
Selling General Administrative	464,340
Selling And Marketing Expenses	0
Operating Expense	531,708	561,455

Net Interest Income (+$)
Interest Income	0
Interest Expense	-14,760
Other Finance Cost	-27,515
Net Interest Income	12,755

Pretax Income (+$)
Operating Income	-34,868
Net Interest Income	12,755
Other Non-Operating Income Expenses	0
Income Before Tax (EBT)	-20,108	-49,628 EBIT - interestExpense = -49,628 -20,108 -5,611
Interest Expense	14,760
Earnings Before Interest and Taxes (EBIT)	-34,868	-5,348
Earnings Before Interest and Taxes (EBITDA)	-34,868

After tax Income (+$)
Income Before Tax	-20,108
Tax Provision	--2,701
Net Income From Continuing Ops	-34,404	-17,407
Net Income	-20,371
Net Income Applicable To Common Shares	0

Non-recurring Events
Discontinued Operations	0
Extraordinary Items	0
Effect of Accounting Charges	0
Other Items	0
Non Recurring	0
Other Operating Expenses	1,181,980
Total Other Income/Expenses Net	14,760	-12,755

Technical Analysis of Omnicell
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Omnicell. The general trend of Omnicell is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Omnicell's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitions	Bullish trend (-28.6%)		Bearish trend (28.6%)
Overbought to neutral	Bullish pullback	=	Bearish reversal
Upper to lower neutral	Bullish correction	=	Bearish continuation
Nuetral to oversold	Oversold	=	Oversold
Oversold to neutral	Bullish reversal	=	Bearish correction
Lower to upper neutral	Bullish continuation	=	Bearish pullback
Nuetral to overbought	Overbought	=	Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.

Score

Let's take a look at the Support & Resistance of Omnicell Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 29.03 < 29.71 < 32.15.

The bearish price targets are: 25.69.

Tweet this

Omnicell Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

Moving averages are lagging trend indicators.
There are many types of moving averages.
Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Omnicell Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

MA 20 trending up: The MA 20 is trending up. +1
Close > MA 20: The price is above the MA 20. +1
MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
MA 50 trending up: The MA 50 is trending up. +1
Close > MA 50: The price is above the MA 50. +1
MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
MA 100 trending down: The MA 100 is trending down. -1
Close < MA 100: The price is below the MA 100. -1
MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
MA 200 trending down: The MA 200 is trending down. -1
Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving Average	Amount of candles	vs. MA 50	vs. MA 100	vs. MA 200
MA 20	20
MA 50	50	-
MA 100	100	-	-
MA 200	200	-	-	-

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shows the moving average of the selected period.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

There are various kinds of moving averages:

Simple moving average (SMA);
Exponential moving average (EMA);
Smoothed moving average (SMMA);
Linear weighted moving average (LWMA).

The moving average looks at a certain period of time and it calculates the price average. The various types of averages are using various formulas. Don’t worry, you don’t have to memorize any formula. All moving averages are calculated automatically by basically every charting software you use. But it’s good to know how moving averages are actually calculated.

Simple moving average

SMA is calculated by summing up the price closures of the selected period. The price is then divided by the selected period. For example, when using the 21 day moving average you sum up all the closing prices for each day and divide that by 21. The result is a line on the chart representing the average. Because it’s an average in the selected timeframe, the trend is always lagging. An moving average looks like this on the chart:

Source: Tradingview.com

In this case, the blue line represents a 21 day moving average. Because the average is based on results from the past, the indicator will always lag behind. For example, when price would suddenly go up, the moving average won't immediately follow.

All other moving averages discussed below look the same on the chart. The only difference is that the line will move in different directions based on the maths behind the used indicators and the amount of days used to determine the average.

Exponential moving average

The EMA gives more weight to the latest closing prices by giving them more value in the equation. EMA is calculated by adding a certain percentage to the latest closing prices:

EMA = (CLOSE (i) * P) + (EMA (i - 1) * (1 - P))

Where:

CLOSE (i) = current period close price.
EMA (i - 1) = value of the Moving Average of a preceding period.
P = the percentage of using the price value.

Smoothed moving average

A smoothed moving average is an exponential moving average with a long lookback period. Older prices are reduced in weight but are never left out in the calculation. Unlike SMA and EMA where prices are removed when they are beyond the selected period. SMMA is a combination of the SMA and EMA. The main advantage is that it smooths out fluctuations in price.

Linear weighted moving average

The LWMA gives the latest price the highest weight and then lineary scales down with each price before that. The result is that the LWMA reacts quicker to changes in price than the SMA or EMA. The formula:

LWMA = ((Pn∗W1)+(Pn−1∗W2)+(Pn−2∗W3)...) / ∑W

Where:

P = Price for the period.
n = The most recent period, n-1 is the prior period, and n-2 is two periods prior.
W = The assigned weight to each period, with the highest weight going first and then descending linearly based on the number of periods being used.

Moving averages are widely used by many traders. Which moving average you need depends on your trading strategy. Common practise is using a combination of multiple periods. For example, the EMA21, EMA50, EMA100 and EMA200. How does that look on a chart:

Source: Tradingview.com

The lowest (purple) line on the chart represents the EMA200 then following up the EMA100, EMA50 and EMA21.

You can use moving averages to determine a trend. The 200 moving average is mostly used as a baseline for determining the current trend:

When the 200 moving average is moving up it is considered a bullish trend.
When the 200 moving average is down it is considered a bearish trend.
When moving averages are flatlined, there is no clear trend so you should look for market structure, consolidation or trend reversals. Depending on how you want to trade.

This is not set in stone. Most trading strategies use multiple moving averages each with different settings. While one strategy might use the EMA20, the other uses the SMA21. There can be hundreds of different variations. Moving averages can also be used as support and resistance. More often than not, prices will bounce on moving averages.

Omnicell Inc Daily Moving Averages Chart

2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

MACD is a lagging momentum indicator.
Uses two moving averages.
Can show buy or sell signals based on momentum.
Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Omnicell Inc. The current macd is -0.14479336.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Omnicell price going up in the near term. +2
MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Omnicell. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Omnicell price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1

Omnicell Inc Daily Moving Average Convergence/Divergence (MACD) Chart

2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.

Score

Let's take a look at the Directional Movement Index (DMI) of Omnicell Inc. The current adx is 12.61.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Omnicell shares, leading to potential upward momentum in its price. +1
PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1

Omnicell Inc Daily Directional Movement Index (DMI) Chart

2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

Parabolic SAR (stop and reverse) is a lagging trend indicator.
Shows the current trend.
Shows potential entry signals.
Shows potential exit signals.
Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Omnicell Inc. The current sar is 26.18.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

Leading momentum indicator, meaning the signals are instant.
Ranges between 0 and 100.
Above 70 is considered overbought.
Below 30 is considered oversold.
Above or below 50 can also be used to determine price trend or support and resistance.
RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Omnicell Inc. The current rsi is 55.29. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
Trending up: The RSI is trending up. +1

Measures the speed and change of price movements.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

The RSI measures the magnitude of recent price changes to determine if the asset is overbought or oversold.

Overbought (RSI above 70) means that the trading price is above its intrinsic value. This might indicate a sell or short signal.
Oversold (RSI below 30) means that the trading price is below its intrinsic value. This might indicate a buy or long signal.
RSI levels above or below 50 can also be used to determine a trend.
RSI divergence looks at a deviation between RSI and price movement.
Can be used in many different ways.

Original usage

Keep in mind that almost every indicator can be used in different ways. Even beyond the orginal settings. The relative strength index was developed by J. Welles Wilder. Wilder recommended a smoothing period of 14 days. That means a 14 day moving average (read more about this setting below). Another quote from the wikipedia page:

Wilders also considers the RSI 50 line as both support and resistance. I recommend to always read the original settings first before using an indicator. Many traders and websites are using their own version of the indicator which might be confusing.

How you can use RSI (Divergence)

First and foremost, there is no real right or wrong usage of the RSI indicator. You can use it in any way you want. Wilder recommends using a 14 day average but you can make it 50 or 100 if you like. Just keep in mind that using an indicator is just part of a larger trading plan. In other words, it’s not recommended to do any trading or investing based on a single indicator like the RSI.

The RSI is measured on a scale between 0 and 100. From 30 till 0 is considered oversold. and from 70 -100 is overbought. The RSI is a leading indicator, meaning the signals are instant.

I like to use the RSI as a trend\momentum indicator and not as an overbought or oversold indicator. I use the middle (50) as the baseline. When prices go above RSI 50 the trend is bullish and can indicate long positions. When below 50 it is considered bearish and can indicate short positions. Other traders use the 70 and 30 levels as overbought/oversold depending on the used strategy. The RSI indicator looks like this:

Source: Tradingview.com

The general concensus is that an RSI above 70 indicates that the security is overbought. In other words, the price this security is trading for is to high and should come down. So if RSI hits 70 or above this might indicate a sell signal or taking a short position (expecting the price will go down). Although RSI above 70 indicates the security is trading above it's fair value, that does not mean the price will go down.

Use tradingview to add indicators

I highly recommend using tradingview to add indicators to a chart. It has all the indicators you can think off and can add them for free (up to three indicators) to any chart you want. You can see that the levels 30 and 70 are marked with a dotted line. If you want you can remove these lines or give it another colour using Tradingview. You can also adjust the moving average used. You can also find RSI indicators made by the community that include other settings like RSI divergences.

Tradingview

Use Tradingview to (back)test your strategies and add hundreds of indicators created by the community.

View tool on Tradingview.com

RSI divergence

RSI is not only used to determine momentum but can also spot reversals or continuations of the trend. A reversal means that the trend is going in the opposite direction. From bullish to bearish or from bearish to bullish. These reversals can be spotted by looking at the price and the direction of the RSI. When the price is going up but the RSI is going down that means there is a divergence. This is also the case when RSI goes up but price is going down.

There are four types of divergences:

Regular bullish divergence
Regular bearish divergence
Hidden bullish divergence
Hidden bearish divergence

Regular bullish divergence

With a regular bullish divergence, the price is making lower highs but the oscillator (in this case the RSI) is making higher lows. A regular bullish divergence might indicate the end of the current trend. You’ll see regular bullish divergences mostly at the end of a downtrend. But that does not mean that every regular bullish divergence is a trend reversal.

Price is making lower highs
RSI is making higher lows
Indicating bullish reversal (price might go up)

Source: Tradingview.com

Regular bearish divergence

With a regular bearish divergence the price is making higher highs but the oscillator (in this case the RSI) is making lower highs. This might indicate the end of an uptrend.

Price is making higher highs
RSI is making lower highs
Indicating bearish reversal

Source: Tradingview.com

Hidden bullish divergence

With a hidden bullish divergence, the price is making a higher low while the RSI is making a lower low. This might indicate bullish trend continuation.

Price is making higher lows
RSI is making lower lows
Indicating bullish continuation

Source: Tradingview.com

As you have noticed, you can have multiple divergences in a row.

Hidden bearish divergence

With a hidden bearish divergence, price is making lower highs but RSI is making higher highs. This might indicate bearish trend continuation.

Price is making lower highs
RSI making higher highs
Indicating bearish continuation

Source: Tradingview.com

You can find many cheatsheets of RSI divergences online. Search for "RSI divergence overview" and you'll find a lot of examples. You can print these to learn the various types of divergences.

Omnicell Inc Daily Relative Strength Index (RSI) Chart

3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

Leading momentum indicator, meaning the signals are instant.
Used to determine overbought and oversold areas much like the RSI.
Ranges between 0 and 100.
Above 80 is considered overbought.
Below 20 is considered oversold.
Consists of two lines named K and D.
K compares the highest high and lowest low on the selected price range.
The D line is a moving average of the K line.
Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Omnicell Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Omnicell price going up in the near term. +2
Trending up: The STOCH %K is trending up. +1

Omnicell Inc Daily Stochastic Oscillator Chart

3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

Lagging or leading Momentum indicator
When the CCI is above zero, the price is above the historical average
When the CCI is below zero, the price is below the historical average
Used for spotting trends
- If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
- If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Omnicell Inc. The current cci is 91.27.

Omnicell Inc Daily Commodity Channel Index (CCI) Chart

3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

Lagging momentum indicator
Ranges between +100 and -100
Considered overbought above +50
Considered oversold below -50
It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Omnicell Inc. The current cmo is 22.03.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1

Omnicell Inc Daily Chande Momentum Oscillator (CMO) Chart

3.5 Williams %R

Shows the current price relative to the highest high over the last 14 days.

Lagging momentum indicator
Ranging between 0 and -100
Above -20 is considered overbought
Below -80 is considered oversold
Is prone to give false signals

Score

Let's take a look at the Williams %R of Omnicell Inc. The current willr is -27.76025237.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Omnicell is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

Lagging volatility indicator
Uses 3 bands: one upper, one lower and one in the middle
Works best when the middle band reflects an intermediate trend (MA20).
When the price is moving closer to the upper band, the market might be overbought
When the price is moving closer to the lower band, the market might be oversold

Score

Let's take a look at the Bollinger Bands of Omnicell Inc.

Omnicell Inc Daily Bollinger Bands Chart

4.2 Average True Range (ATR)

Measures market volatility

Leading volatility indicator
Can be used to determine stop-loss positions
Calculated by:
- Current high minus the current low
- Current high minus the previous close
- Current low minus the previous close
The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Omnicell Inc. The current atr is 1.04039971.

Omnicell Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Measures market volatility

Leading momentum indicator
Calculation:
- If the closing price is above the previous closing price: OBV = previous OBV + current volume
- If the closing price is below the previous closing price: OBV = previous OBV - current volume
- If the closing price is the same as the previous closing price than the OBV is the same.
Can be used to confirm price trends
Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Omnicell Inc. The current obv is -3,761,630.

Omnicell Inc Daily On-Balance Volume (OBV) Chart

5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

Lagging momentum indicator
Looks like RSI but uses volume as an extra metric (RSI only considers price)
Above 80 is considered overbought
Below 20 is considered oversold
Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Omnicell Inc. The current mfi is 56.10.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

MFI > 50: +1

Omnicell Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

Type	Notification	Date
Currently no notifications for Omnicell Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

Date	Indicator	Signal
2023-11-30	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2023-12-01	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2023-12-04	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2023-12-05	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2023-12-07	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2023-12-08	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
2023-12-11	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-12	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2023-12-15	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-19	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2023-12-21	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2023-12-26	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-27	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
2023-12-28	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2023-12-29	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-02	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-01-03	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-01-04	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-01-05	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-08	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-01-09	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-11	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-01-12	MFI	SHORT ENTRY	LONG CLOSE	20 crossover to downside
2024-01-17	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-01-18	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-22	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	MFI	LONG ENTRY	SHORT CLOSE	20 crossover to upside
2024-01-24	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-25	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-01-26	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
2024-01-30	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-02-01	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-05	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-02-06	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-08	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-02-12	RSI	LONG ENTRY	SHORT CLOSE	30 crossover to upside
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-14	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-02-15	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-21	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-02-22	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-02-23	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-27	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-02-28	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
2024-02-29	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-03-01	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-04	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
2024-03-05	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-03-06	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-03-08	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-03-11	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-13	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-03-15	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-18	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-19	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-20	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-03-21	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
2024-03-22	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-25	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-26	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-03-27	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-04-01	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-02	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-04-08	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-09	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-04-10	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-04-11	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
2024-04-12	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-04-17	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
2024-04-18	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-19	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-04-22	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.

6.3. Candlestick Patterns

Date	Candlestick Pattern

6.4. Technical Score

Let's check the technical score of Omnicell Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	55.288
Ma 20	Greater than	Ma 50	27.770
Ma 50	Greater than	Ma 100	27.703
Ma 100	Greater than	Ma 200	31.241
Open	Greater than	Close	28.000
Total			2/5 (40.0%)

Create your own Symbol Scanner

Get notifications about Omnicell Inc

I send you an email if I find something interesting about Omnicell Inc.

Omnicell Inc Buy, Hold or Sell?

Let's analyse Omnicell together

Get notifications about Omnicell Inc

Quick analysis of Omnicell (30 sec.)

What can you expect buying and holding a share of Omnicell? (30 sec.)

How much money do you get?

What is your share worth?

+ What do you gain per year?

For what price can you sell your share?

1. Valuation of Omnicell (5 min.)

$28.43

$25.89

$-28.70 - $26.18

$-2.81 - $52.08

2. Growth of Omnicell (5 min.)

Is Omnicell growing?

How much money is Omnicell making?

How much money comes from the company's main activities?

3. Financial Health of Omnicell (5 min.)

4. Comparing to competitors in the Health Information Services industry (5 min.)

Industry Rankings (Health Information Services)

What can you expect buying and holding a share of Omnicell? (5 min.)

What can you expect buying and holding a share of Omnicell?

Speculation

Investing

How much money are you going to get?

When do you get the money?

How sure are you?

Linear %

Fundamentals of Omnicell

About Omnicell Inc

Financial Health

Valuation

1.1. Profitability of Omnicell Inc.

1.1. Profitability

1.1.1. Net Profit Margin

Trends

Compared to industry (Health Information Services)

1.1.2. Return on Assets

Trends

Compared to industry (Health Information Services)

1.1.3. Return on Equity

Trends

Compared to industry (Health Information Services)

1.2. Operating Efficiency of Omnicell Inc.

1.2. Operating Efficiency

1.2.1. Operating Margin

Trends

Compared to industry (Health Information Services)

1.2.2. Operating Ratio

Trends

Compared to industry (Health Information Services)

1.3. Liquidity of Omnicell Inc.

1.3. Liquidity

1.3.1. Current Ratio

Trends

Compared to industry (Health Information Services)

1.3.2. Quick Ratio

Trends

Compared to industry (Health Information Services)

1.4. Solvency of Omnicell Inc.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Trends

Compared to industry (Health Information Services)

1.4.2. Debt to Equity Ratio

Trends

Compared to industry (Health Information Services)

2. Market Valuation of Omnicell Inc

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Trends

Compared to industry (Health Information Services)

Omnicell Inc
Buy, Hold or Sell?